<!DOCTYPE html> <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Systemic antibiotics for treating diabetic foot infections - Selva Olid, A - 2015 | Cochrane Library</title> <meta property="og:title" content="Systemic antibiotics for treating diabetic foot infections - Selva Olid, A - 2015 | Cochrane Library" /> <meta property="og:url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009061.pub2/references" /> <meta property="og:type" content="article" /> <meta property=”og:image” content=”https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png” /> <meta content="initial-scale=1.0, width=device-width" name="viewport" /> <meta name="dc.identifier" scheme="DOI" content="10.1002/14651858.CD009061.pub2" /> <meta name="citation_title" content="Systemic antibiotics for treating diabetic foot infections" /> <meta name="citation_author" content="Anna Selva Olid" /> <meta name="citation_author_institution" content="Biomedical Research Institute Sant Pau (IIB‐Sant Pau)" /> <meta name="citation_author_email" content="ASelva@santpau.cat" /> <meta name="citation_author" content="Ivan Sol&agrave;" /> <meta name="citation_author_institution" content="CIBER Epidemiolog&iacute;a y Salud P&uacute;blica (CIBERESP) ‐ Universitat Aut&ograve;noma de Barcelona" /> <meta name="citation_author" content="Leticia A Barajas‐Nava" /> <meta name="citation_author_institution" content="Health National Institute, Hospital Infantil de M&eacute;xico Federico Gomez (HIMFG). Iberoamerican Cochrane Network" /> <meta name="citation_author" content="Oscar D Gianneo" /> <meta name="citation_author_institution" content="Fondo Nacional de Recursos" /> <meta name="citation_author" content="Xavier Bonfill Cosp" /> <meta name="citation_author_institution" content="CIBER Epidemiolog&iacute;a y Salud P&uacute;blica (CIBERESP) ‐ Universitat Aut&ograve;noma de Barcelona" /> <meta name="citation_author" content="Benjamin A Lipsky" /> <meta name="citation_journal_title" content="Cochrane Database of Systematic Reviews" /> <meta name="citation_publisher" content="John Wiley &amp; Sons, Ltd" /> <meta name="citation_issue" content="9" /> <meta name="citation_doi" content="10.1002/14651858.CD009061.pub2" /> <meta name="citation_date" content="2015" /> <meta name="citation_online_date" content="2015/09/04" /> <meta name="citation_abstract_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009061.pub2/abstract" /> <meta name="citation_fulltext_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009061.pub2/full" /> <meta name="citation_pdf_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009061.pub2/pdf/CDSR/CD009061/CD009061.pdf" /> <meta name="citation_issn" content="1465-1858" /> <meta name="citation_language" content="en" /> <meta name="citation_keywords" content="Anti‐Bacterial Agents [*therapeutic use]; Bacterial Infections [*drug therapy]; Carbapenems [therapeutic use]; Cephalosporins [therapeutic use]; Diabetic Foot [*drug therapy]; Fluoroquinolones [therapeutic use]; Penicillins [therapeutic use]; Randomized Controlled Trials as Topic" /> <script type="text/javascript" src="//script.crazyegg.com/pages/scripts/0056/6375.js" async="async"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <script type="text/javascript">var o={auth:{customerIds:["P#DRAAEAC","EAL00000056729","DRAA3TITLES","TSINGH009S","EAL0001468","EAL00000045347"],individualId:null,brandedCustomer:"EAL0001468",roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=UTF-8" http-equiv="content-type" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/favicon.ico" rel="Shortcut Icon" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" rel="canonical" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-CN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh_TW&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-TW" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;hr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="hr-HR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="x-default" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="en-US" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fr-FR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;de&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="de-DE" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ja&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ja-JP" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ko&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ko-KR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ms&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ms-MY" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fa&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fa-IR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pl&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pl-PL" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pt&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pt-PT" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ru&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ru-RU" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;es&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="es-ES" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ta&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ta-IN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;th&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="th-TH" rel="alternate" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581422282000" rel="stylesheet" type="text/css" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;aui&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581422282000" rel="stylesheet" type="text/css" /> <link href="&#x2f;html&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1513680834000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581718173000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581718256000" rel="stylesheet" type="text/css" /> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 13},getRevision:function(){return"605.1"},getVersion:function(){return"13.0"},isAir:function(){return false},isChrome:function(){return false},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return false},isMac:function(){return true},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="EfT7x5RD";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dreferences\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009061\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009061\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009061\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009061\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article References"},article:{availableLanguage:["en","es","de","ms","hr","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009061.pub2",title:"Systemic antibiotics for treating diabetic foot infections",firstPublishedDate:"Sep 4, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Wounds Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;custom&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581422282000" rel="stylesheet" type="text/css" /> <style type="text/css"></style> <script src="//assets.adobedtm.com/6e626c9ec247e474f6b98eb15a79a185cf7e26a5/satelliteLib-b0f13d7a13ebe8b0b1b00a9f0730a084926e292f.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1581422282000" type="text/javascript"></script> <![endif]--> </head> <body class=" yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div id="js-cookie-message" class="cookie-message cookie-message--hidden system-message-container"> <div class="container"> <a href="#" class="fa fa-times js-cookie-close pull-right" aria-label="Close cookies message"></a> <div class="system-message-wrapper container"> <i class="fa fa-exclamation-triangle" aria-hidden="true"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7XGCZUQPW4C675JNSTYTLUDN7XB/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a href="#" class="btn secondary js-cookie-close js-cookie-accept">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/"> <span class="brand-name">The Cochrane Library</span> <img class="brand-logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_logo.png" alt="Cochrane Library logo" title="Cochrane Library" /> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="owel__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=EfT7x5RD&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009061.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009061.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a href="/en/browse-by-topic" class="btn secondary">Browse</a>
<a href="/en/advanced-search" class="btn primary advanced-search-button">Advanced search</a>
</div>
</div>
<a href="#" class="toggle-menu-switch"><i class="fa fa-bars" aria-hidden="true"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<p class="auxiliary-menu-item access">Access provided by: <strong>Tsinghua University</strong></p>
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="bvrs__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="language-selector-modal-content" style="display: none;" data-modal-title="Language selection" data-size="large"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div> <a href="/en/cdsr/doi/10.1002/14651858.CD009061.pub2/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD009061.pub2/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <button class="btn primary btn-cancel" type="button">Cancel</button> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009061.pub2%2Freferences" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
</a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
<div class="access-provider-mobile">
<p class="access">Access provided by: <strong>Tsinghua University</strong></p>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class=" nav-root-item parent">
<a href="#">Cochrane Reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_14" role="presentation">
<a aria-labelledby="layout_14" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews" role="menuitem">
Search Reviews (CDSR)
</a>
</li>
<li class=" child-nav-item" id="layout_15" role="presentation">
<a aria-labelledby="layout_15" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews&#x2f;topics" role="menuitem">
Browse Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_18" role="presentation">
<a aria-labelledby="layout_18" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;table-of-contents" role="menuitem">
Issues
</a>
</li>
<li class=" child-nav-item" id="layout_17" role="presentation">
<a aria-labelledby="layout_17" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;editorials" role="menuitem">
Editorials
</a>
</li>
<li class=" child-nav-item" id="layout_19" role="presentation">
<a aria-labelledby="layout_19" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;special-collections" role="menuitem">
Special Collections
</a>
</li>
<li class=" child-nav-item" id="layout_20" role="presentation">
<a aria-labelledby="layout_20" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;supplements" role="menuitem">
Supplements
</a>
</li>
<li class=" child-nav-item" id="layout_13" role="presentation">
<a aria-labelledby="layout_13" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;about-cdsr" role="menuitem">
About the CDSR
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_22" role="presentation">
<a aria-labelledby="layout_22" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central" role="menuitem">
Search Trials (CENTRAL)
</a>
</li>
<li class=" child-nav-item" id="layout_114" role="presentation">
<a aria-labelledby="layout_114" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central&#x2f;about-central" role="menuitem">
About CENTRAL
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_29" role="presentation">
<a aria-labelledby="layout_29" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca" role="menuitem">
Browse Clinical Answers
</a>
</li>
<li class=" child-nav-item" id="layout_91" role="presentation">
<a aria-labelledby="layout_91" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca&#x2f;about" role="menuitem">
About Clinical Answers
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_116" role="presentation">
<a aria-labelledby="layout_116" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-library" role="menuitem">
About the Cochrane Library
</a>
</li>
<li class=" child-nav-item" id="layout_34" role="presentation">
<a aria-labelledby="layout_34" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochrane&#x2e;org&#x2f;about-us" role="menuitem">
About Cochrane
</a>
</li>
<li class=" child-nav-item" id="layout_121" role="presentation">
<a aria-labelledby="layout_121" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-reviews" role="menuitem">
About Cochrane Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_92" role="presentation">
<a aria-labelledby="layout_92" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;author-information" role="menuitem">
Information for authors
</a>
</li>
<li class=" child-nav-item" id="layout_188" role="presentation">
<a aria-labelledby="layout_188" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;releases" role="menuitem">
What&#039;s new
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_177" role="presentation">
<a aria-labelledby="layout_177" href="https&#x3a;&#x2f;&#x2f;www&#x2e;wiley&#x2e;com&#x2f;network&#x2f;cochranelibrarytraining" role="menuitem">
Cochrane Library Training
</a>
</li>
<li class=" child-nav-item" id="layout_44" role="presentation">
<a aria-labelledby="layout_44" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;access" role="menuitem">
Access options
</a>
</li>
<li class=" child-nav-item" id="layout_150" role="presentation">
<a aria-labelledby="layout_150" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;permissions" role="menuitem">
Permissions and reprints
</a>
</li>
<li class=" child-nav-item" id="layout_93" role="presentation">
<a aria-labelledby="layout_93" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;media" role="menuitem">
Media information
</a>
</li>
<li class=" child-nav-item" id="layout_97" role="presentation">
<a aria-labelledby="layout_97" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;contact-us" role="menuitem">
Contact us
</a>
</li>
<li class=" child-nav-item" id="layout_125" role="presentation">
<a aria-labelledby="layout_125" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;terms-and-conditions" role="menuitem">
Terms and conditions
</a>
</li>
<li class=" child-nav-item" id="layout_176" role="presentation">
<a aria-labelledby="layout_176" href="https&#x3a;&#x2f;&#x2f;hub&#x2e;wiley&#x2e;com&#x2f;docs&#x2f;cochrane-library&#x2f;cochrane-library-known-issues-DOC-16221&#x3f;referrer&#x3d;cochrane" role="menuitem">
Known issues
</a>
</li>
</ul>
</li>
<li class="about-link"><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img id="etlj__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <section class="content-language-banner system-message-container" data-content-language="en" data-portal-language="en" style="display: none"> <div class="container"> <a href="#0" class="fa fa-times content-language-banner-close pull-right" aria-label="Close"></a> <i class="fa fa-globe" aria-hidden="true"></i> <div class="system-message-title">Content Language Selection</div> <div class="system-message-description">Your language preference is set to <strong class="language">English</strong>. Where translations are available, article sections will display in this language. Return to <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=reset-content-language&p_p_cacheability=cacheLevelPage" class="language secondary">English</a>.</div> </div> </section> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div id="content" class="">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="rjus__column1__0" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools"> <li class="cdsr-nav-link pulldown-menu readcube-menu closed"> <a href="#0" class="pulldown-menu-trigger"> <i class="icon fa fa-file-pdf-o"></i>View PDF <i aria-hidden="true" class="fa fa-caret-up"></i> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/pdf/full/en" class="download media pdf-link-full pdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/epdf/full/en" class="download media pdf-link-full readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/pdf/standard/en" class="download media pdf-link-standard pdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/epdf/standard/en" class="download media pdf-link-standard readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/pdf/abstract/en" class="download media pdf-link-abstract pdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/epdf/abstract/en" class="download media pdf-link-abstract readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="cdsr-nav-link cite-article-link" data-article-id="CD009061.PUB2" data-modal-title="Cite this Review"> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/#"> <i class="icon fa fa-share"></i>Cite this Review </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-english-only-message="Please note, that requesting permissions is available in English only. Apologies for any inconvenience." href="/cdsr/doi/10.1002/14651858.CD009061.pub2/#" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false"> <span class="request-permissions-icon"></span> Request Permissions </a> </li> <li class="cdsr-nav-link comment-on-review"> <a id="comment-on-review" class="js-old-version-modal-trigger" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/comment" data-new-version="" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience."> <i class="icon fa fa-comment"></i>Comment on Review </a> </li> <li class="cdsr-nav-link comment-on"> <span>Read comments on this Review(0)</span> </li> </ul> <ul class="share clearfix"> <li class="cdsr-nav-link print-cdsr-link" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009061.pub2/print" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Data and analysis&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;}]}]"> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/#"> <i class="icon fa fa-print"></i>Print </a> </li> <li class="cdsr-nav-link share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009061.pub2/full"> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/#"> <i class="icon fa fa-share-alt"></i>Share </a> </li> <li class="cdsr-nav-link"> <a href="/c/portal/login" class="article-not-followed cochrane-link signin"> <span class="article-follow-display"><i class="icon fa fa-plus"></i>Follow</span> </a> </li> </ul> <ul id="linked-articles" data-type="cdsr" class="linked-content tools clearfix linked-content-trigger"> <li> <a href="#0"> <span class="linked-to-this"> Linked to this Review <span class="linked-content-count"></span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> </li> </ul> <ul class="linked-content-dropdown"> <li data-type="cca" class="linked-cca"> <p>Cochrane Clinical Answers</p> </li> <li data-type="editorial" class="linked-editorials"> <p>Editorials</p> </li> <li data-type="podcast" class="linked-podcasts"> <p>Podcasts</p> </li> <li data-type="sc" class="linked-sc"> <p>Special Collections</p> </li> </ul> <ul class="nav-long-form"> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/full#CD009061-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/full#CD009061-sec1-0006"> Authors' conclusions </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/full#CD009061-sec1-0001"> Background </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/full#CD009061-sec1-0002"> Objectives </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/full#CD009061-sec1-0003"> Methods </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/full#CD009061-sec1-0004"> Results </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/full#CD009061-sec1-0005"> Discussion </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/appendices#CD009061-sec1-0011"> Appendices </a> </li> </ul> <ul> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/information"> Information </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/information#authors"> Authors </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/information#history"> History </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/information#keywords"> Keywords </a> </li> </ul> <ul> <li class="cdsr-nav-link bold-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/#"> <i class="icon fa fa-globe"></i>Translation notes </a> </li> </ul> <ul> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references"> References </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#dataAndAnalyses"> Data and analyses </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/#"> <i class="icon fa fa-line-chart"></i>Figures and tables </a> </li> <li class="cdsr-nav-link download-stats-data-link " data-download-href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/table_n/CD009061StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/table_n/CD009061StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <i class="icon fa fa-download"></i>Download statistical data </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i>Related content <span class="note podcast-indicator">Podcast available</span> </a> </li> </ul> </nav> </div> <article class="information" data-article-id="CD009061.PUB2"> <header> <h1 class="publication-title"><h1 lang="en" class="publication-title">Systemic antibiotics for treating diabetic foot infections</h1></h1> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div><h2 class="title section-collapse-title"> References <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <section class="references bibliographies" id="references"> <section> <div class="section-header" id="CD009061-bbs1-0001"> <h3 class="title">References to studies included in this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD009061-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD009061-bbs1-0003">ongoing studies</a></li> <li><a class="jump-to" href="#CD009061-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0001"> <div class="reference-title-banner"> <h4 class="title">Arbeit 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0001"> <div class="citation-journal">Arbeit RD, Maki D, Tally FP, Campanaro E, Eisenstein BI. <span class="citation-title">The safety and efficacy of daptomycin for the treatment of complicated skin and skin‐structure infections</span>. <span class="citation"> Clinical Infectious Diseases </span><span class="pubYear">2004</span>;<span class="volume">38</span>:1673‐81. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15227611" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+safety+and+efficacy+of+daptomycin+for+the+treatment+of+complicated+skin+and+skin%E2%80%90structure+infections+&author=RD+Arbeit&author=D+Maki&author=FP+Tally&author=E+Campanaro&author=BI+Eisenstein&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD009061-bib-0002"> <div class="citation-journal">Lipsky BA, Stoutenburgh U. <span class="citation-title">Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi‐synthetic penicillins for complicated skin and skin‐structure infections</span>. <span class="citation"> Journal of Antimicrobial Chemotherapy </span><span class="pubYear">2005</span>;<span class="volume">55</span>:240‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15659542" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Daptomycin+for+treating+infected+diabetic+foot+ulcers:+evidence+from+a+randomized,+controlled+trial+comparing+daptomycin+with+vancomycin+or+semi%E2%80%90synthetic+penicillins+for+complicated+skin+and+skin%E2%80%90structure+infections+&author=BA+Lipsky&author=U+Stoutenburgh&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0002"> <div class="reference-title-banner"> <h4 class="title">Bouter 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0003"> <div class="citation-journal">Bouter KP, Visseren FL, Loenhout RM, Bartelink AK, Erkelens DW, Diepersloot RJ. <span class="citation-title">Treatment of diabetic foot infection: an open randomised comparison of imipenem/cilastatin and piperacillin/clindamycin combination therapy</span>. <span class="citation"> International Journal of Antimicrobial Agents </span><span class="pubYear">1996</span>;<span class="volume">7</span>:143‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18611748" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treatment+of+diabetic+foot+infection:+an+open+randomised+comparison+of+imipenem/cilastatin+and+piperacillin/clindamycin+combination+therapy+&author=KP+Bouter&author=FL+Visseren&author=RM+Loenhout&author=AK+Bartelink&author=DW+Erkelens&author=RJ+Diepersloot&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0003"> <div class="reference-title-banner"> <h4 class="title">Clay 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0004"> <div class="citation-journal">Clay PG, Graham MR, Lindsey CC, Lamp KC, Freeman C, Glaros A. <span class="citation-title">Clinical efficacy, tolerability, and cost savings associated with the use of open‐label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower‐extremity Infections in older males</span>. <span class="citation"> The American Journal of Geriatric Pharmacotherapy </span><span class="pubYear">2004</span>;<span class="volume">2</span>(3):181‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15561650" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clinical+efficacy,+tolerability,+and+cost+savings+associated+with+the+use+of+open%E2%80%90label+metronidazole+plus+ceftriaxone+once+daily+compared+with+ticarcillin/clavulanate+every+6+hours+as+empiric+treatment+for+diabetic+lower%E2%80%90extremity+Infections+in+older+males+&author=PG+Clay&author=MR+Graham&author=CC+Lindsey&author=KC+Lamp&author=C+Freeman&author=A+Glaros&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0004"> <div class="reference-title-banner"> <h4 class="title">Erstad 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0005"> <div class="citation-journal">Erstad BL, McIntyre KE. <span class="citation-title">Prospective, randomized comparison of ampicillin/sulbactam and cefoxitin for diabetic foot infections</span>. <span class="citation"> Vascular Surgery </span><span class="pubYear">1997</span>;<span class="volume">31</span>(4):419‐26. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prospective,+randomized+comparison+of+ampicillin/sulbactam+and+cefoxitin+for+diabetic+foot+infections+&author=BL+Erstad&author=KE+McIntyre&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0005"> <div class="reference-title-banner"> <h4 class="title">Giordano 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0006"> <div class="citation-journal">Giordano P, Song J, Pertel P, Herrington J, Kowalsky S. <span class="citation-title">Sequential intravenous/oral moxifloxacin versus intravenous pipreacillin‐tazobactam followed by oral amoxicillin‐clavulanate for the treatment of complicated skin and skin structure infection</span>. <span class="citation"> International Journal of Antimicrobial Agents </span><span class="pubYear">2005</span>;<span class="volume">26</span>:357‐65. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16229991" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Sequential+intravenous/oral+moxifloxacin+versus+intravenous+pipreacillin%E2%80%90tazobactam+followed+by+oral+amoxicillin%E2%80%90clavulanate+for+the+treatment+of+complicated+skin+and+skin+structure+infection+&author=P+Giordano&author=J+Song&author=P+Pertel&author=J+Herrington&author=S+Kowalsky&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0006"> <div class="reference-title-banner"> <h4 class="title">Graham 2002a {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0007"> <div class="citation-journal">Graham DR, Lucasti C, Malafaia O, Nichols RL, Holtom P, Perez NQ, et al. <span class="citation-title">Ertapenem once daily versus piperacillin‐tazobactam 4 times per day for treatment of complicated skin and skin‐structure infections in adults: results of a prospective, randomized, double‐blind multicenter study</span>. <span class="citation"> Clinical Infectious Disease </span><span class="pubYear">2002</span>;<span class="volume">34</span>:1460‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Ertapenem+once+daily+versus+piperacillin%E2%80%90tazobactam+4+times+per+day+for+treatment+of+complicated+skin+and+skin%E2%80%90structure+infections+in+adults:+results+of+a+prospective,+randomized,+double%E2%80%90blind+multicenter+study+&author=DR+Graham&author=C+Lucasti&author=O+Malafaia&author=RL+Nichols&author=P+Holtom&author=NQ+Perez&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0007"> <div class="reference-title-banner"> <h4 class="title">Graham 2002b {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0008"> <div class="citation-journal">Graham DR, Talan DA, Nichols RL, Lucasti C, Corrado M, Morgan N, et al. <span class="citation-title">Once‐daily, high‐dose levofloxacin versus ticarcillin‐clavulanate alone or followed by amoxicillin‐clavulanate for complicated skin and skin‐structure infections: a randomized, open‐label trial</span>. <span class="citation"> Clinical Infectious Diseases </span><span class="pubYear">2002</span>;<span class="volume">35</span>:381‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12145720" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Once%E2%80%90daily,+high%E2%80%90dose+levofloxacin+versus+ticarcillin%E2%80%90clavulanate+alone+or+followed+by+amoxicillin%E2%80%90clavulanate+for+complicated+skin+and+skin%E2%80%90structure+infections:+a+randomized,+open%E2%80%90label+trial+&author=DR+Graham&author=DA+Talan&author=RL+Nichols&author=C+Lucasti&author=M+Corrado&author=N+Morgan&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0008"> <div class="reference-title-banner"> <h4 class="title">Grayson 1994 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0009"> <div class="citation-journal">Grayson ML, Gibbons GW, Habershaw GM, Freeman DV, Pomposelli FB, Rosenblum BI, et al. <span class="citation-title">Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb‐threatening foot infections in diabetic patients</span>. <span class="citation"> Clinical Infectious Disease </span><span class="pubYear">1994</span>;<span class="volume">18</span>:683‐93. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Use+of+ampicillin/sulbactam+versus+imipenem/cilastatin+in+the+treatment+of+limb%E2%80%90threatening+foot+infections+in+diabetic+patients+&author=ML+Grayson&author=GW+Gibbons&author=GM+Habershaw&author=DV+Freeman&author=FB+Pomposelli&author=BI+Rosenblum&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD009061-bib-0010"> <div class="citation-journal">McKinnon PS, Paladino JA, Grayson ML, Gibbons GW, Karchmer AW. <span class="citation-title">Cost‐effectiveness ofaAmpicillin/sulbactam versus imipenem/cilastatin in the treatment of limb‐threatening foot infections in diabetic patients</span>. <span class="citation"> Clinical Infectious Disease </span><span class="pubYear">1997</span>;<span class="volume">24</span>:57‐63. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Cost%E2%80%90effectiveness+ofaAmpicillin/sulbactam+versus+imipenem/cilastatin+in+the+treatment+of+limb%E2%80%90threatening+foot+infections+in+diabetic+patients+&author=PS+McKinnon&author=JA+Paladino&author=ML+Grayson&author=GW+Gibbons&author=AW+Karchmer&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0009"> <div class="reference-title-banner"> <h4 class="title">Harkless 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0011"> <div class="citation-journal">Harkless L, Boghossian J, Pollak R, Caputo W, Dona A, Gray S, et al. <span class="citation-title">An open‐label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers</span>. <span class="citation"> Surgical Infections </span><span class="pubYear">2005</span>;<span class="volume">6</span>:27‐40. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15865549" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=An+open%E2%80%90label,+randomized+study+comparing+efficacy+and+safety+of+intravenous+piperacillin/tazobactam+and+ampicillin/sulbactam+for+infected+diabetic+foot+ulcers+&author=L+Harkless&author=J+Boghossian&author=R+Pollak&author=W+Caputo&author=A+Dona&author=S+Gray&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0010"> <div class="reference-title-banner"> <h4 class="title">Lauf 2014 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0012"> <div class="citation-journal">Lauf L, Ozsvár Z, Mitha I, Regöly‐Mérei J, Embil JM, Cooper A, et al. <span class="citation-title">Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis</span>. <span class="citation"> Diagnostic Microbiology and Infectious Disease </span><span class="pubYear">2014</span>;<span class="volume">78</span>:469‐80. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/24439136" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Phase+3+study+comparing+tigecycline+and+ertapenem+in+patients+with+diabetic+foot+infections+with+and+without+osteomyelitis+&author=L+Lauf&author=Z+Ozsv%C3%A1r&author=I+Mitha&author=J+Reg%C3%B6ly%E2%80%90M%C3%A9rei&author=JM+Embil&author=A+Cooper&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0011"> <div class="reference-title-banner"> <h4 class="title">Lipsky 1990 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0013"> <div class="citation-journal">Lipsky BA, Pecoraro RE, Larson SA, Hanley ME, Ahroni JE. <span class="citation-title">Outpatient management of uncomplicated lower‐extremity infections in diabetic patients</span>. <span class="citation"> Archives of Internal Medicine </span><span class="pubYear">1990</span>;<span class="volume">150</span>:790‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2183732" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Outpatient+management+of+uncomplicated+lower%E2%80%90extremity+infections+in+diabetic+patients&author=BA+Lipsky&author=RE+Pecoraro&author=SA+Larson&author=ME+Hanley&author=JE+Ahroni&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0012"> <div class="reference-title-banner"> <h4 class="title">Lipsky 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0014"> <div class="citation-journal">Lipsky BA, Baker PD, Landon GC, Fernau R. <span class="citation-title">Antibiotic therapy for diabetic foot infections: comparison of two parenteral‐to‐oral regimens</span>. <span class="citation"> Clinical Infectious Diseases </span><span class="pubYear">1997</span>;<span class="volume">24</span>:643‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9145738" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Antibiotic+therapy+for+diabetic+foot+infections:+comparison+of+two+parenteral%E2%80%90to%E2%80%90oral+regimens+&author=BA+Lipsky&author=PD+Baker&author=GC+Landon&author=R+Fernau&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0013"> <div class="reference-title-banner"> <h4 class="title">Lipsky 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0015"> <div class="citation-journal">Lipsky BA, Itani K, Norden C and the Linezolid Diabetic Foot Infections Study Group. <span class="citation-title">Treating foot infections in diabetic patients: a randomized, multicenter, open‐label trial of linezolid versus ampicillin‐sulbactam/amoxicillin‐clavulanate</span>. <span class="citation"> Clinical Infectious Disease </span><span class="pubYear">2004</span>;<span class="volume">38</span>:17‐34. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treating+foot+infections+in+diabetic+patients:+a+randomized,+multicenter,+open%E2%80%90label+trial+of+linezolid+versus+ampicillin%E2%80%90sulbactam/amoxicillin%E2%80%90clavulanate+&author=BA+Lipsky&author=K+Itani&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0014"> <div class="reference-title-banner"> <h4 class="title">Noel 2008a {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0016"> <div class="citation-journal">Noel GJ, Bush K, Bagchi P, Ianus J, Strauss RS. <span class="citation-title">A randomized, double‐blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin‐structure infections</span>. <span class="citation"> Clinical Infectious Diseases </span><span class="pubYear">2008</span>;<span class="volume">46</span>:647‐55. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18225981" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized,+double%E2%80%90blind+trial+comparing+ceftobiprole+medocaril+with+vancomycin+plus+ceftazidime+for+the+treatment+of+patients+with+complicated+skin+and+skin%E2%80%90structure+infections+&author=GJ+Noel&author=K+Bush&author=P+Bagchi&author=J+Ianus&author=RS+Strauss&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0015"> <div class="reference-title-banner"> <h4 class="title">RELIEF Study {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0017"> <div class="citation-journal">Gynssens IC, Dryden M, Kujath P, Nathwani D, Schaper N, Hampel B, et al. <span class="citation-title">A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections</span>. <span class="citation"> Journal of Antimicrobial Chemotherapy </span><span class="pubYear">2011</span>;<span class="volume">66</span>:2632‐42. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21896561" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized+trial+of+the+efficacy+and+safety+of+sequential+intravenous/oral+moxifloxacin+monotherapy+versus+intravenous+piperacillin/tazobactam+followed+by+oral+amoxicillin/clavulanate+for+complicated+skin+and+skin+structure+infections+&author=IC+Gynssens&author=M+Dryden&author=P+Kujath&author=D+Nathwani&author=N+Schaper&author=B+Hampel&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD009061-bib-0018"> <div class="citation-journal">Schaper N, Dryden M, Kujath P, Nathwani D, Arvis P, Reimnitz P, et al. <span class="citation-title">Efficacy of moxifloxacin in the treatment of diabetic foot infections: results of the RELIEF study</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2010</span>;<span class="volume">53 Suppl1</span>:462‐3. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+moxifloxacin+in+the+treatment+of+diabetic+foot+infections:+results+of+the+RELIEF+study+&author=N+Schaper&author=M+Dryden&author=P+Kujath&author=D+Nathwani&author=P+Arvis&author=P+Reimnitz&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0016"> <div class="reference-title-banner"> <h4 class="title">Saltoglu 2010 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0019"> <div class="citation-journal">Saltoglu N, Dalkiran A, Tetiker T, Bayram H, Tasova Y, Dalay C, et al. <span class="citation-title">Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital</span>. <span class="citation"> Infectious Diseases </span><span class="pubYear">2010</span>;<span class="volume">16</span>:1252‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Piperacillin/tazobactam+versus+imipenem/cilastatin+for+severe+diabetic+foot+infections:+a+prospective,+randomized+clinical+trial+in+a+university+hospital+&author=N+Saltoglu&author=A+Dalkiran&author=T+Tetiker&author=H+Bayram&author=Y+Tasova&author=C+Dalay&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0017"> <div class="reference-title-banner"> <h4 class="title">Siami 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0020"> <div class="citation-journal">Siami G, Christou N, Eiseman I, Tack KJ and the Clinafloxacin Severe Skin and Soft Tissue Infections Study Group. <span class="citation-title">Clinafloxacin versus piperacillin‐tazobactam in treatment of patients with severe skin and soft tissue infections</span>. <span class="citation"> Antimicrobial Agents and Chemotherapy </span><span class="pubYear">2001</span>;<span class="volume">45</span>(2):525‐31. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11158750" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clinafloxacin+versus+piperacillin%E2%80%90tazobactam+in+treatment+of+patients+with+severe+skin+and+soft+tissue+infections+&author=G+Siami&author=N+Christou&author=I+Eiseman&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0018"> <div class="reference-title-banner"> <h4 class="title">SIDESTEP Study {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0021"> <div class="citation-other">Abramson MA. <span class="citation-title">The SIDESTEP study of diabetic foot infections (DFI): a multicenter,double‐blinded, randomized, controlled trial (RCT) of ertapenem (E)v s. piperacillin/tazobactam (P/T)</span>. Diabetologia. <span class="pubYear">2005</span>; Vol. 48 Suppl 1:A81‐2. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+SIDESTEP+study+of+diabetic+foot+infections+(DFI):+a+multicenter,double%E2%80%90blinded,+randomized,+controlled+trial+(RCT)+of+ertapenem+(E)v+s.+piperacillin/tazobactam+(P/T)+&author=MA+Abramson&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD009061-bib-0022"> <div class="citation-other">Lipsky BA, Armstrong D, Citron D, Halperin GJ, Sheehan P, Tice A, et al. <span class="citation-title">The SIDESTEP study of diabetic foot infections (DFI): a multicenter, double‐blinded, randomized, controlled trial (RCT) of ertapenem (E) vs. piperacillin/tazobactam (P/T)</span>. Society of Hospital Medicine. <span class="pubYear">2005 Annual Meeting Abstracts</span>:28. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+SIDESTEP+study+of+diabetic+foot+infections+(DFI):+a+multicenter,+double%E2%80%90blinded,+randomized,+controlled+trial+(RCT)+of+ertapenem+(E)+vs.+piperacillin/tazobactam+(P/T)+&author=BA+Lipsky&author=D+Armstrong&author=D+Citron&author=GJ+Halperin&author=P+Sheehan&author=A+Tice&publication_year=2005AnnualMeetingAbstracts&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD009061-bib-0023"> <div class="citation-journal">Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern DE, Abramson MA. <span class="citation-title">Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double‐blinded, multicentre trial</span>. <span class="citation"> Lancet </span><span class="pubYear">2005</span>;<span class="volume">366</span>:1695‐703. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16291062" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Ertapenem+versus+piperacillin/tazobactam+for+diabetic+foot+infections+(SIDESTEP):+prospective,+randomised,+controlled,+double%E2%80%90blinded,+multicentre+trial+&author=BA+Lipsky&author=DG+Armstrong&author=DM+Citron&author=AD+Tice&author=DE+Morgenstern&author=MA+Abramson&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0019"> <div class="reference-title-banner"> <h4 class="title">STIC Study {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0024"> <div class="citation-journal">Vick‐Fragoso R, Hernández‐Oliva G, Cruz‐Alcázar J, Amábile‐Cuevas CF, Arvis P, Reimnitz P, et al. <span class="citation-title">Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections</span>. <span class="citation"> Infection </span><span class="pubYear">2009</span>;<span class="volume">37</span>(5):407‐17. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19768381" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+sequential+intravenous/oral+moxifloxacin+vs+intravenous/oral+amoxicillin/clavulanate+for+complicated+skin+and+skin+structure+infections+&author=R+Vick%E2%80%90Fragoso&author=G+Hern%C3%A1ndez%E2%80%90Oliva&author=J+Cruz%E2%80%90Alc%C3%A1zar&author=CF+Am%C3%A1bile%E2%80%90Cuevas&author=P+Arvis&author=P+Reimnitz&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD009061-bbs2-0020"> <div class="reference-title-banner"> <h4 class="title">Tan 1993 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0025"> <div class="citation-journal">Tan JS, Wishnow M, Talan DA, Duncanson FP, Norden CW and the Piperacillin/Tazobactam Skin And Skin Strucutre Study Group. <span class="citation-title">Treatment of hospitalized patients with complicated skin and skin structure infections: double‐blind, randomized, multicenter study of piperacillin‐tazobactam versus ticarcillin‐clavulanate</span>. <span class="citation"> Antimicrobial Agents and Chemotherapy </span><span class="pubYear">1993</span>;<span class="volume">37</span>(8):1580‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8215266" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treatment+of+hospitalized+patients+with+complicated+skin+and+skin+structure+infections:+double%E2%80%90blind,+randomized,+multicenter+study+of+piperacillin%E2%80%90tazobactam+versus+ticarcillin%E2%80%90clavulanate+&author=JS+Tan&author=M+Wishnow&author=DA+Talan&author=FP+Duncanson&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD009061-bbs1-0002"> <h3 class="title">References to studies excluded from this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD009061-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD009061-bbs1-0003">ongoing studies</a></li> <li><a class="jump-to" href="#CD009061-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0021"> <div class="reference-title-banner"> <h4 class="title">Acevedo 1990 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0026"> <div class="citation-journal">Acevedo A, Schoop W, Shnell A, Toledo L. <span class="citation-title">Antibiotic treatment for diabetic foot. Advantages of intravenous regional route as alternative for systemic route</span> [Tratamiento antibiótico del pie diabético. Ventajas de la vía regional intravenosa como alternativa a la vía sistémica]. <span class="citation"> Revista Médica de Chile </span><span class="pubYear">1990</span>;<span class="volume">118</span>(8):881‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2152232" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Antibiotic+treatment+for+diabetic+foot.+Advantages+of+intravenous+regional+route+as+alternative+for+systemic+route+&author=A+Acevedo&author=W+Schoop&author=A+Shnell&author=L+Toledo&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0022"> <div class="reference-title-banner"> <h4 class="title">Akova 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0027"> <div class="citation-journal">Akova M, Ozcebe O, Gullu I, Unal S, Gur D, Akalin S, et al. <span class="citation-title">Efficacy of sulbactam‐ampicillin for the treatment of severe diabetic foot infections</span>. <span class="citation"> Journal of Chemotherapy (Florence, Italy) </span><span class="pubYear">1996</span>;<span class="volume">8</span>:284‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8873834" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+sulbactam%E2%80%90ampicillin+for+the+treatment+of+severe+diabetic+foot+infections&author=M+Akova&author=O+Ozcebe&author=I+Gullu&author=S+Unal&author=D+Gur&author=S+Akalin&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0023"> <div class="reference-title-banner"> <h4 class="title">Al‐Ebous 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0028"> <div class="citation-journal">Al‐Ebous AD, Hiasat B, Sarayrah M, Al‐Jahmi M, Al‐Zuriqat AN. <span class="citation-title">Management of diabetic foot in a Jordanian hospital</span>. <span class="citation"> La Revue de Santé de la Méditerranée Orientale </span><span class="pubYear">2005</span>;<span class="volume">11</span>(3):490‐3. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Management+of+diabetic+foot+in+a+Jordanian+hospital&author=AD+Al%E2%80%90Ebous&author=B+Hiasat&author=M+Sarayrah&author=M+Al%E2%80%90Jahmi&author=AN+Al%E2%80%90Zuriqat&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0024"> <div class="reference-title-banner"> <h4 class="title">Beam 1989 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0029"> <div class="citation-journal">Beam TR, Gutierrez I, Powell S, Hewitt R, Hocko M, Brackett M, et al. <span class="citation-title">Prospective study of the efficacy and safety or oral and intravenous ciprofloxacin in the treatment of diabetic foot infections</span>. <span class="citation"> Reviews of Infectious Diseases </span><span class="pubYear">1989</span>;<span class="volume">11 Suppl 5</span>:1163. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prospective+study+of+the+efficacy+and+safety+or+oral+and+intravenous+ciprofloxacin+in+the+treatment+of+diabetic+foot+infections+&author=TR+Beam&author=I+Gutierrez&author=S+Powell&author=R+Hewitt&author=M+Hocko&author=M+Brackett&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0025"> <div class="reference-title-banner"> <h4 class="title">Bradsher 1984 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0030"> <div class="citation-journal">Bradsher RW, Snow RM. <span class="citation-title">Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen</span>. <span class="citation"> The American Journal of Medicine </span><span class="pubYear">1984</span>;<span class="volume">19</span>:63‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Ceftriaxone+treatment+of+skin+and+soft+tissue+infections+in+a+once+daily+regimen&author=RW+Bradsher&author=RM+Snow&publication_year=1984&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0026"> <div class="reference-title-banner"> <h4 class="title">Cenizal 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0031"> <div class="citation-journal">Cenizal MJ, Skiest D, Luber S, Bedimo R, Davis P, Fox P, et al. <span class="citation-title">Prospective randomized trial of empiric therapy with trimethoprim‐sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin‐resistant Staphylococcus aureus</span>. <span class="citation"> Antimicrobial Agents and Chemotherapy  </span><span class="pubYear">2007</span>;<span class="volume">51</span>(7):2628‐30. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17502411" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prospective+randomized+trial+of+empiric+therapy+with+trimethoprim%E2%80%90sulfamethoxazole+or+doxycycline+for+outpatient+skin+and+soft+tissue+infections+in+an+area+of+high+prevalence+of+methicillin%E2%80%90resistant+Staphylococcus+aureus+&author=MJ+Cenizal&author=D+Skiest&author=S+Luber&author=R+Bedimo&author=P+Davis&author=P+Fox&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0027"> <div class="reference-title-banner"> <h4 class="title">Chantelau 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0032"> <div class="citation-journal">Chantelau E, Tanudjaja T, Altenhöfer F, Ersanli Z, Lacigova S, Metzger C. <span class="citation-title">Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1996</span>;<span class="volume">13</span>:156‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8641121" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Antibiotic+treatment+for+uncomplicated+neuropathic+forefoot+ulcers+in+diabetes:+a+controlled+trial+&author=E+Chantelau&author=T+Tanudjaja&author=F+Altenh%C3%B6fer&author=Z+Ersanli&author=S+Lacigova&author=C+Metzger&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0028"> <div class="reference-title-banner"> <h4 class="title">Chen 2013 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0033"> <div class="citation-journal">Chen F, Zheng N, Wang Y, Wen JL, Tu WF, Du YQ, et al. <span class="citation-title">Sequential intravenous/oral moxifloxacin monotherapy for complicated skin and skin structure infections: A meta‐analysis of randomised controlled trials</span>. <span class="citation"> International Journal of Clinical Practice </span><span class="pubYear">2013</span>;<span class="volume">67</span>:934‐42. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Sequential+intravenous/oral+moxifloxacin+monotherapy+for+complicated+skin+and+skin+structure+infections:+A+meta%E2%80%90analysis+of+randomised+controlled+trials+&author=F+Chen&author=N+Zheng&author=Y+Wang&author=JL+Wen&author=WF+Tu&author=YQ+Du&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0029"> <div class="reference-title-banner"> <h4 class="title">Crouzet 2011 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0034"> <div class="citation-journal">Crouzet J, Lavigne JP, Richard JL, Sotto A, Nimes University Hospital Working Group on the Diabetic Foot (GP30). <span class="citation-title">Diabetic foot infection: a critical review of recent randomized clinical trials on antibiotic therapy</span>. <span class="citation"> International Journal of Infectious Diseases </span><span class="pubYear">2011</span>;<span class="volume">15</span>:601‐10. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diabetic+foot+infection:+a+critical+review+of+recent+randomized+clinical+trials+on+antibiotic+therapy+&author=J+Crouzet&author=JP+Lavigne&author=JL+Richard&author=A+Sotto&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0030"> <div class="reference-title-banner"> <h4 class="title">Daniel 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0035"> <div class="citation-journal">Daniel R, and the Trovafloxacin Study Group. <span class="citation-title">Comparison of the efficacy and safety of once‐daily oral trovafloxacin and 3‐times‐daily amoxicillin/clavulanic acid for the treatment of complicated skin and soft‐tissue infections</span>. <span class="citation"> Drugs </span><span class="pubYear">1999</span>;<span class="volume">58 Suppl 2</span>:288‐90. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+the+efficacy+and+safety+of+once%E2%80%90daily+oral+trovafloxacin+and+3%E2%80%90times%E2%80%90daily+amoxicillin/clavulanic+acid+for+the+treatment+of+complicated+skin+and+soft%E2%80%90tissue+infections+&author=R+Daniel&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0031"> <div class="reference-title-banner"> <h4 class="title">Darwish 1993 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0036"> <div class="citation-journal">Darwish AA, Reddy A,  Kamal M, Yaneza A, Al‐Teheawy MM. <span class="citation-title">Management of diabetic foot lesions with limited use of antibiotics</span>. <span class="citation"> Annals of Saudi Medicine </span><span class="pubYear">1993</span>;<span class="volume">13</span>(1):101‐3. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17587974" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Management+of+diabetic+foot+lesions+with+limited+use+of+antibiotics&author=AA+Darwish&author=A+Reddy&author=M+%C2%A0Kamal&author=A+Yaneza&author=MM+Al%E2%80%90Teheawy&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0032"> <div class="reference-title-banner"> <h4 class="title">Deresinski 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0037"> <div class="citation-journal">Deresinski SC. <span class="citation-title">The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials</span>. <span class="citation"> Diagnostic Microbiology and Infectious Disease </span><span class="pubYear">2008</span>;<span class="volume">61</span>:103‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18384998" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+efficacy+and+safety+of+ceftobiprole+in+the+treatment+of+complicated+skin+and+skin+structure+infections:+evidence+from+2+clinical+trials+&author=SC+Deresinski&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0033"> <div class="reference-title-banner"> <h4 class="title">Edmonds 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0038"> <div class="citation-journal">Edmonds M, Foster A. <span class="citation-title">The use of antibiotics in the diabetic foot</span>. <span class="citation"> American Journal of Surgery </span><span class="pubYear">2004</span>;<span class="volume">187 Suppl 5A</span>:25‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+use+of+antibiotics+in+the+diabetic+foot&author=M+Edmonds&author=A+Foster&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0034"> <div class="reference-title-banner"> <h4 class="title">Embil 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0039"> <div class="citation-journal">Embil JM, Soto NE, Melnick DA. <span class="citation-title">A post hoc subgroup analysis of meropenem versus imipenem/cilastatin in a multicenter, double‐blind, randomized study of complicated skin and skin‐structure infections in patients with diabetes mellitus</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2006</span>;<span class="volume">28</span>(8):1164‐74. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16982293" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+post+hoc+subgroup+analysis+of+meropenem+versus+imipenem/cilastatin+in+a+multicenter,+double%E2%80%90blind,+randomized+study+of+complicated+skin+and+skin%E2%80%90structure+infections+in+patients+with+diabetes+mellitus+&author=JM+Embil&author=NE+Soto&author=DA+Melnick&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0035"> <div class="reference-title-banner"> <h4 class="title">Fernández Montequín 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0040"> <div class="citation-journal">Fernández JI, McCook J, Lima B, Velasco N, Montalvo J, Mahía M. <span class="citation-title">Antibiotic treatment in patients amputated for ischemic diabetic foot</span> [Antibioticoterapia en pacientes amputados por pie diabético isquémico]. <span class="citation"> Angiologia </span><span class="pubYear">1991</span>;<span class="volume">43</span>(5):200‐3. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1755544" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Antibiotic+treatment+in+patients+amputated+for+ischemic+diabetic+foot&author=JI+Fern%C3%A1ndez&author=J+McCook&author=B+Lima&author=N+Velasco&author=J+Montalvo&author=M+Mah%C3%ADa&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0036"> <div class="reference-title-banner"> <h4 class="title">File 1983 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0041"> <div class="citation-journal">File TM, Tan JS. <span class="citation-title">Amdinocillin plus cefoxitin versus cefoxitin alone in therapy of mixed soft tissue infections (including diabetic foot infections)</span>. <span class="citation"> The American Journal of Medicine </span><span class="pubYear">1983</span>;<span class="volume">29</span>:100‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Amdinocillin+plus+cefoxitin+versus+cefoxitin+alone+in+therapy+of+mixed+soft+tissue+infections+(including+diabetic+foot+infections)+&author=TM+File&author=JS+Tan&publication_year=1983&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0037"> <div class="reference-title-banner"> <h4 class="title">File 1994 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0042"> <div class="citation-journal">File TM, Tan JS. <span class="citation-title">Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections</span>. <span class="citation"> European Journal of Surgery </span><span class="pubYear">1994</span>;<span class="volume">Suppl 573</span>:51‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+piperacillin/tazobactam+in+skin+and+soft+tissue+infections&author=TM+File&author=JS+Tan&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0038"> <div class="reference-title-banner"> <h4 class="title">Foster 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0043"> <div class="citation-journal">Foster A, McColgan M, Edmonds M. <span class="citation-title">Should oral antibiotics be given to &quot;clean&quot; foot ulcers with no cellulitis?</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1998</span>;<span class="volume">15 Suppl 2</span>:10. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Should+oral+antibiotics+be+given+to+" clean"+foot+ulcers+with+no+cellulitis?&author=A+Foster&author=M+McColgan&author=M+Edmonds&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0039"> <div class="reference-title-banner"> <h4 class="title">Gentry 1989a {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0044"> <div class="citation-journal">Gentry L, Ramírez‐Ronda CH, Rodríguez‐Noriega E, Thadepalli H, Leal del Rosal P, Ramirez C. <span class="citation-title">Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections</span>. <span class="citation"> Archives of Internal Medicine </span><span class="pubYear">1989</span>;<span class="volume">149</span>:2579‐83. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2684078" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Oral+ciprofloxacin+vs+parenteral+cefotaxime+in+the+treatment+of+difficult+skin+and+skin+structure+infections+&author=L+Gentry&author=CH+Ram%C3%ADrez%E2%80%90Ronda&author=E+Rodr%C3%ADguez%E2%80%90Noriega&author=H+Thadepalli&author=P+LealdelRosal&author=C+Ramirez&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0040"> <div class="reference-title-banner"> <h4 class="title">Gentry 1989b {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0045"> <div class="citation-journal">Gentry LO, Rodriguez‐Gomez G, Zeluff BJ, Khoshdel A, Price M. <span class="citation-title">A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections</span>. <span class="citation"> The American Journal of Medicine </span><span class="pubYear">1989</span>;<span class="volume">87 Suppl 6C</span>:57‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparative+evaluation+of+oral+ofloxacin+versus+intravenous+cefotaxime+therapy+for+serious+skin+and+skin+structure+infections+&author=LO+Gentry&author=G+Rodriguez%E2%80%90Gomez&author=BJ+Zeluff&author=A+Khoshdel&author=M+Price&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0041"> <div class="reference-title-banner"> <h4 class="title">Hughes 1987 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0046"> <div class="citation-journal">Hughes CE, Johnson CC, Bamberger DM, Reinhardt JF, Peterson LR, Mulligan ME, et al. <span class="citation-title">Treatment and long‐term follow‐up of foot infections in patients with diabetes or ischemia: a randomized, prospective, double‐blind  comparison of cefoxitin and ceftizoxime</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">1987</span>;<span class="volume">10 Suppl A</span>:36‐49. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3319172" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treatment+and+long%E2%80%90term+follow%E2%80%90up+of+foot+infections+in+patients+with+diabetes+or+ischemia:+a+randomized,+prospective,+double%E2%80%90blind%C2%A0+comparison+of+cefoxitin+and+ceftizoxime+&author=CE+Hughes&author=CC+Johnson&author=DM+Bamberger&author=JF+Reinhardt&author=LR+Peterson&author=ME+Mulligan&publication_year=1987&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0042"> <div class="reference-title-banner"> <h4 class="title">Itani 2010 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0047"> <div class="citation-journal">Itani KM, Dryden MS, Bhattacharyya H, Kunkel MJ, Baruch AM, Weigelt JA. <span class="citation-title">Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft‐tissue infections proven to be caused by methicillin resistant Staphylococcus aureus</span>. <span class="citation"> American Journal of Surgery </span><span class="pubYear">2010</span>;<span class="volume">199</span>:804‐16. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/20227056" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+linezolid+versus+vancomycin+for+the+treatment+of+complicated+skin+and+soft%E2%80%90tissue+infections+proven+to+be+caused+by+methicillin+resistant+Staphylococcus+aureus+&author=KM+Itani&author=MS+Dryden&author=H+Bhattacharyya&author=MJ+Kunkel&author=AM+Baruch&author=JA+Weigelt&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0043"> <div class="reference-title-banner"> <h4 class="title">Joshi 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0048"> <div class="citation-journal">Joshi S, Maroli S, Moulick ND, Badhane S, Joshi S, Sthalekar N, et al. <span class="citation-title">Efficacy and tolerability of a combination of ofloxacin and tinidazole in the management of infectious diabetic foot ulcer</span>. <span class="citation"> Journal of the Indian Medical Association </span><span class="pubYear">2003</span>;<span class="volume">101</span>:329‐32. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14575233" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+tolerability+of+a+combination+of+ofloxacin+and+tinidazole+in+the+management+of+infectious+diabetic+foot+ulcer+&author=S+Joshi&author=S+Maroli&author=ND+Moulick&author=S+Badhane&author=S+Joshi&author=N+Sthalekar&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0044"> <div class="reference-title-banner"> <h4 class="title">Lipksy 2011 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0049"> <div class="citation-journal">Lipsky BA, Itani KM, Weigelt JA, Joseph W, Paap CM, Reisman A, et al. <span class="citation-title">The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin‐resistant Staphylococcus aureus: results from three randomized controlled trials</span>. <span class="citation"> International Journal of Infectious Diseases </span><span class="pubYear">2011</span>;<span class="volume">15</span>:140‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+role+of+diabetes+mellitus+in+the+treatment+of+skin+and+skin+structure+infections+caused+by+methicillin%E2%80%90resistant+Staphylococcus+aureus:+results+from+three+randomized+controlled+trials+&author=BA+Lipsky&author=KM+Itani&author=JA+Weigelt&author=W+Joseph&author=CM+Paap&author=A+Reisman&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0045"> <div class="reference-title-banner"> <h4 class="title">Lipsky 1999a {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0050"> <div class="citation-journal">Lipsky BA, Miller B, Schwartz R, Henry DC, Nolan T, McCabe A, et al. <span class="citation-title">Sparfloxacin versus ciprofloxacin for the treatment of community‐acquired, complicated skin and skin‐structure infections</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">1999</span>;<span class="volume">21</span>(4):675‐90. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10363733" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Sparfloxacin+versus+ciprofloxacin+for+the+treatment+of+community%E2%80%90acquired,+complicated+skin+and+skin%E2%80%90structure+infections+&author=BA+Lipsky&author=B+Miller&author=R+Schwartz&author=DC+Henry&author=T+Nolan&author=A+McCabe&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0046"> <div class="reference-title-banner"> <h4 class="title">Nelson 2006b {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0051"> <div class="citation-journal">Nelson EA, O'Meara S, Golder S, Dalton J, Craig D, Iglesias C. <span class="citation-title">Systematic review of antimicrobial treatments for diabetic foot ulcers</span>. <span class="citation"> Diabetic Medicine  </span><span class="pubYear">2006</span>;<span class="volume">23</span>(4):348‐59. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16620262" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Systematic+review+of+antimicrobial+treatments+for+diabetic+foot+ulcers&author=EA+Nelson&author=S+O'Meara&author=S+Golder&author=J+Dalton&author=D+Craig&author=C+Iglesias&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0047"> <div class="reference-title-banner"> <h4 class="title">Noel 2008b {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0052"> <div class="citation-journal">Noel GJ, Strauss RS, Amsler K, Heep M, Pypstra R, Solomkin JS. <span class="citation-title">Results of a double‐blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by Gram‐positive bacteria</span>. <span class="citation"> Antimicrobial Agents and Chemotherapy </span><span class="pubYear">2008</span>;<span class="volume">52</span>(1):37‐44. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17954698" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Results+of+a+double%E2%80%90blind,+randomized+trial+of+ceftobiprole+treatment+of+complicated+skin+and+skin+structure+infections+caused+by+Gram%E2%80%90positive+bacteria+&author=GJ+Noel&author=RS+Strauss&author=K+Amsler&author=M+Heep&author=R+Pypstra&author=JS+Solomkin&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0048"> <div class="reference-title-banner"> <h4 class="title">Pérez‐Ruvalcaba 1987 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0053"> <div class="citation-journal">Pérez‐Ruvalcaba JA, Quintero‐Pérez NP, Morales‐Reyes JJ, Huitrón‐Ramírez JA, Rodríguez‐Chagollán JJ, Rodríguez‐Noriega E. <span class="citation-title">Double‐blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections</span>. <span class="citation"> The American Journal of Medicine </span><span class="pubYear">1987</span>;<span class="volume">82 Suppl 4A</span>:242‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Double%E2%80%90blind+comparison+of+ciprofloxacin+with+cefotaxime+in+the+treatment+of+skin+and+skin+structure+infections+&author=JA+P%C3%A9rez%E2%80%90Ruvalcaba&author=NP+Quintero%E2%80%90P%C3%A9rez&author=JJ+Morales%E2%80%90Reyes&author=JA+Huitr%C3%B3n%E2%80%90Ram%C3%ADrez&author=JJ+Rodr%C3%ADguez%E2%80%90Chagoll%C3%A1n&author=E+Rodr%C3%ADguez%E2%80%90Noriega&publication_year=1987&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0049"> <div class="reference-title-banner"> <h4 class="title">Peters 2012 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0054"> <div class="citation-journal">Peters EJG, Lipsky BA, Berendt AR, Embil JM, Lavery LA, Senneville E, et al. <span class="citation-title">A systematic review of the effectiveness of interventions in the management of infection in the diabetic foot</span>. <span class="citation"> Diabetes/Metabolism Research and Reviews </span><span class="pubYear">2012</span>;<span class="volume">28 Suppl 1</span>:142‐62. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+systematic+review+of+the+effectiveness+of+interventions+in+the+management+of+infection+in+the+diabetic+foot+&author=EJG+Peters&author=BA+Lipsky&author=AR+Berendt&author=JM+Embil&author=LA+Lavery&author=E+Senneville&publication_year=2012&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0050"> <div class="reference-title-banner"> <h4 class="title">Peterson 1989 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0055"> <div class="citation-journal">Peterson LR, Lissack LM, Canter K, Fasching CE, Clabots C, Gerding D. <span class="citation-title">Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both</span>. <span class="citation"> The American Journal of Medicine </span><span class="pubYear">1989</span>;<span class="volume">86</span>:801‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2658581" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Therapy+of+lower+extremity+infections+with+ciprofloxacin+in+patients+with+diabetes+mellitus,+peripheral+vascular+disease,+or+both+&author=LR+Peterson&author=LM+Lissack&author=K+Canter&author=CE+Fasching&author=C+Clabots&author=D+Gerding&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0051"> <div class="reference-title-banner"> <h4 class="title">Siami 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0056"> <div class="citation-journal">Siami FS, LaFleur BJ, Siami GA. <span class="citation-title">Cinafloxacin versus piperacillin/tazobactam in the treatment of severe skin and soft‐tissue infections in adults at a veterans affairs medical center</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2002</span>;<span class="volume">24</span>:59‐72. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11833836" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Cinafloxacin+versus+piperacillin/tazobactam+in+the+treatment+of+severe+skin+and+soft%E2%80%90tissue+infections+in+adults+at+a+veterans+affairs+medical+center+&author=FS+Siami&author=BJ+LaFleur&author=GA+Siami&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0052"> <div class="reference-title-banner"> <h4 class="title">Siebert 1985 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0057"> <div class="citation-journal">Siebert T, Evans P. <span class="citation-title">Ticarcillin plus clavulanic acid versus moxalactam therapy of osteomyelitis, septic arthritis, and skin and soft tissue infections</span>. <span class="citation"> The American Journal of Medicine </span><span class="pubYear">1985</span>;<span class="volume">79 Suppl 5B</span>:141‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Ticarcillin+plus+clavulanic+acid+versus+moxalactam+therapy+of+osteomyelitis,+septic+arthritis,+and+skin+and+soft+tissue+infections+&author=T+Siebert&author=P+Evans&publication_year=1985&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0053"> <div class="reference-title-banner"> <h4 class="title">Smith 1992 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0058"> <div class="citation-journal">Smith OB, Richards CS, Taylor AT, Nesbit RR, Fisher JF, Willis EB. <span class="citation-title">Prospective, controlled, randomized, evaluator‐blind, comparative study of oral ciprofloxacin with and without oral metronidazole versus intravenous ticarcillin/clavulanic acid followed by oral amoxicillin/clavulanic acid in the treatment of diabetic foot infections</span>. <span class="citation"> ASHP Midyear Clinical Meeting  </span><span class="pubYear">1992</span>;<span class="volume">27</span>:P‐159R. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prospective,+controlled,+randomized,+evaluator%E2%80%90blind,+comparative+study+of+oral+ciprofloxacin+with+and+without+oral+metronidazole+versus+intravenous+ticarcillin/clavulanic+acid+followed+by+oral+amoxicillin/clavulanic+acid+in+the+treatment+of+diabetic+foot+infections+&author=OB+Smith&author=CS+Richards&author=AT+Taylor&author=RR+Nesbit&author=JF+Fisher&author=EB+Willis&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0054"> <div class="reference-title-banner"> <h4 class="title">Smith 1993 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0059"> <div class="citation-journal">Smith JW, Nichols RL. <span class="citation-title">Comparison of oral fleroxacin with oral amoxicillin/clavulanate for treatment of skin and soft tissue infections</span>. <span class="citation"> The American Journal of Medicine </span><span class="pubYear">1993</span>;<span class="volume">94 Suppl 3A</span>:150‐3. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+oral+fleroxacin+with+oral+amoxicillin/clavulanate+for+treatment+of+skin+and+soft+tissue+infections+&author=JW+Smith&author=RL+Nichols&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0055"> <div class="reference-title-banner"> <h4 class="title">Stevens 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0060"> <div class="citation-journal">Stevens DL. <span class="citation-title">Teicoplanin for skin and soft tissue infections: an open study and a randomized, comparative trial versus cefazolin</span>. <span class="citation"> Journal of Infection and Chemotherapy </span><span class="pubYear">1999</span>;<span class="volume">5</span>:40‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11810488" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Teicoplanin+for+skin+and+soft+tissue+infections:+an+open+study+and+a+randomized,+comparative+trial+versus+cefazolin+&author=DL+Stevens&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0056"> <div class="reference-title-banner"> <h4 class="title">Stevens 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0061"> <div class="citation-journal">Stevens DL, Smith LG, Bruss JB, McConnell‐Martin MA, Duvall SE, Todd WM, et al. <span class="citation-title">Randomized comparison of linezolid (PNU‐100766) versus oxacillin‐dicloxacillin for treatment of complicated skin and soft tissue infections</span>. <span class="citation"> Antimicrobial Agents and Chemotherapy </span><span class="pubYear">2000</span>;<span class="volume">44</span>(12):3408‐13. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11083648" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Randomized+comparison+of+linezolid+(PNU%E2%80%90100766)+versus+oxacillin%E2%80%90dicloxacillin+for+treatment+of+complicated+skin+and+soft+tissue+infections+&author=DL+Stevens&author=LG+Smith&author=JB+Bruss&author=MA+McConnell%E2%80%90Martin&author=SE+Duvall&author=WM+Todd&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0057"> <div class="reference-title-banner"> <h4 class="title">Stevens 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0062"> <div class="citation-journal">Stevens DL, Herr D, Lampiris H, Hunt JL, Batts DH, Hafkin B. <span class="citation-title">Linezolid versus vancomycin for the treatment of methicillin‐resistant Staphylococcus aureus infections</span>. <span class="citation"> Clinical Infectious Diseases </span><span class="pubYear">2002</span>;<span class="volume">34</span>:1481‐90. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12015695" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Linezolid+versus+vancomycin+for+the+treatment+of+methicillin%E2%80%90resistant+Staphylococcus+aureus+infections+&author=DL+Stevens&author=D+Herr&author=H+Lampiris&author=JL+Hunt&author=DH+Batts&author=B+Hafkin&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0058"> <div class="reference-title-banner"> <h4 class="title">Stupin 2014 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0063"> <div class="citation-journal">Stupin VA, Prividentsev AI, Goriunov SV, Zhilina SV, Vasin VI. <span class="citation-title">[Vasin new fluoroquinolones in treatment of patients with infectious lesions in diabetic foot syndrome]</span>. <span class="citation"> Khirurgiia </span><span class="pubYear">2014</span>;<span class="volume">10</span>:102‐8. [PUBMED: 25484159] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Vasin+new+fluoroquinolones+in+treatment+of+patients+with+infectious+lesions+in+diabetic+foot+syndrome]+&author=VA+Stupin&author=AI+Prividentsev&author=SV+Goriunov&author=SV+Zhilina&author=VI+Vasin&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0059"> <div class="reference-title-banner"> <h4 class="title">Vardakas 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0064"> <div class="citation-journal">Vardakas KZ, Horianopoulou M, Falagas ME. <span class="citation-title">Factors associated with treatment failure in patients with diabetic foot infections: an analysis of data from randomized controlled trials</span>. <span class="citation"> Journal Diabetes Research and Clinical Practice </span><span class="pubYear">2008</span>;<span class="volume">80</span>:344‐51. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18291550" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Factors+associated+with+treatment+failure+in+patients+with+diabetic+foot+infections:+an+analysis+of+data+from+randomized+controlled+trials+&author=KZ+Vardakas&author=M+Horianopoulou&author=ME+Falagas&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD009061-bbs2-0060"> <div class="reference-title-banner"> <h4 class="title">Weigelt 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0065"> <div class="citation-journal">Weigelt J, Itani K, Stevens D, Lau W, Dryden M, Knirsch C, Linezolid CSSTI Study Group. <span class="citation-title">Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections</span>. <span class="citation"> Antimicrobial Agents Chemotherapy </span><span class="pubYear">2005</span>;<span class="volume">49</span>:2260–6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15917519" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Linezolid+versus+vancomycin+in+treatment+of+complicated+skin+and+soft+tissue+infections&author=J+Weigelt&author=K+Itani&author=D+Stevens&author=W+Lau&author=M+Dryden&author=C+Knirsch&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD009061-bbs1-0003"> <h3 class="title">References to ongoing studies</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD009061-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD009061-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD009061-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD009061-bbs2-0061"> <div class="reference-title-banner"> <h4 class="title">NCT01199783 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0066"> <div class="citation-other">NCT01199783. <span class="citation-title">Application of daptomycin in MRSA infected diabetic foot in comparison to vancomycin treatment</span>. clinicaltrials.gov/show/ NCT01199783 (accessed September 2014) 29 April 2010. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD009061-bbs2-0062"> <div class="reference-title-banner"> <h4 class="title">NCT01370616 {published data only} </h4> </div> <div class="bibliography-section" id="CD009061-bib-0067"> <div class="citation-other">NCT01370616. <span class="citation-title">A phase III, randomized, double‐blind, active comparator‐controlled clinical trial to study the efficacy and safety of ertapenem sodium (MK‐0826) versus piperacillin/tazobactam sodium in the treatment of diabetic foot infections in Chinese adults</span>. clinicaltrials.gov/show/ NCT01370616 (accessed September 2014)<span class="pubYear">2011</span>. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+phase+III,+randomized,+double%E2%80%90blind,+active+comparator%E2%80%90controlled+clinical+trial+to+study+the+efficacy+and+safety+of+ertapenem+sodium+(MK%E2%80%900826)+versus+piperacillin/tazobactam+sodium+in+the+treatment+of+diabetic+foot+infections+in+Chinese+adults+&author=+NCT01370616&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD009061-bbs1-0004"> <h3 class="title">Additional references</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD009061-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD009061-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD009061-bbs1-0003">ongoing studies</a></li> </ul> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0063"> <div class="reference-title-banner"> <h4 class="title">Bader 2008</h4> </div> <div class="bibliography-section" id="CD009061-bib-0068"> <div class="citation-journal">Bader MS. <span class="citation-title">Diabetic foot infection</span>. <span class="citation"> American Family Physician </span><span class="pubYear">2008</span>;<span class="volume">78</span>(1):71‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18649613" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diabetic+foot+infection&author=MS+Bader&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0064"> <div class="reference-title-banner"> <h4 class="title">Berendt 2008</h4> </div> <div class="bibliography-section" id="CD009061-bib-0069"> <div class="citation-journal">Berendt AR, Peters EJ, Bakker K, Embil JM, Eneroth M, Hinchliffe RJ, et al. <span class="citation-title">Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment</span>. <span class="citation"> Diabetes/Metabolism Research and Reviews </span><span class="pubYear">2008</span>;<span class="volume">24 Suppl 1</span>:145‐61. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diabetic+foot+osteomyelitis:+a+progress+report+on+diagnosis+and+a+systematic+review+of+treatment+&author=AR+Berendt&author=EJ+Peters&author=K+Bakker&author=JM+Embil&author=M+Eneroth&author=RJ+Hinchliffe&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0065"> <div class="reference-title-banner"> <h4 class="title">Bero 2013</h4> </div> <div class="bibliography-section" id="CD009061-bib-0070"> <div class="citation-other">Bero LA. <span class="citation-title">Why the Cochrane risk of bias tool should include funding source as a standard item [editorial]</span>. Cochrane Database of Systematic Reviews<span class="pubYear">2013</span>; Vol. 10.1002/14651858.ED000075. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Why+the+Cochrane+risk+of+bias+tool+should+include+funding+source+as+a+standard+item+[editorial]+&author=LA+Bero&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0066"> <div class="reference-title-banner"> <h4 class="title">Blanes 2011</h4> </div> <div class="bibliography-section" id="CD009061-bib-0071"> <div class="citation-journal">Blanes JI, Representatives of Spanish Society of Surgeons (ACS), Representatives of Spanish Society of Angiology and Vascular Surgery (SEACV), Representatives of Spanish Society of Emergency Medicine (SEMES), Spanish Internal Medicine Society (SEMI), Representatives of Spanish Society of Critical Care Medicine and Coronary Units (SEMICYUC), Representatives of Spanish Society of Chemotherapy (SEQ). <span class="citation-title">Consensus document on treatment of infections in diabetic foot</span> [Documento de consenso sobre el tratamiento de las infecciones en el pie del diabético]. <span class="citation"> Revista Española de Quimioterapia </span><span class="pubYear">2011</span>;<span class="volume">24</span>(4):233‐62. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/22173195" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Consensus+document+on+treatment+of+infections+in+diabetic+foot&author=JI+Blanes&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0067"> <div class="reference-title-banner"> <h4 class="title">Boulton 2005</h4> </div> <div class="bibliography-section" id="CD009061-bib-0072"> <div class="citation-journal">Boulton AJ, Vileikyte L, Ragnarson‐Tennvall G, Apelqvist J. <span class="citation-title">The global burden of diabetic foot disease</span>. <span class="citation"> Lancet </span><span class="pubYear">2005</span>;<span class="volume">366</span>(9498):1719‐24. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16291066" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+global+burden+of+diabetic+foot+disease&author=AJ+Boulton&author=L+Vileikyte&author=G+Ragnarson%E2%80%90Tennvall&author=J+Apelqvist&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0068"> <div class="reference-title-banner"> <h4 class="title">Bradley 1999</h4> </div> <div class="bibliography-section" id="CD009061-bib-0073"> <div class="citation-other">Bradley M, Cullum N, Nelson EA, Petticrew M, Sheldon T, Torgerson D. <span class="citation-title">Systematic reviews of wound care management: (2) Dressings and topical agents used in the healing of chronic wounds</span>. Health Technology Assessment<span class="pubYear">1999</span>; Vol. 3, issue 17. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Systematic+reviews+of+wound+care+management:+(2)+Dressings+and+topical+agents+used+in+the+healing+of+chronic+wounds+&author=M+Bradley&author=N+Cullum&author=EA+Nelson&author=M+Petticrew&author=T+Sheldon&author=D+Torgerson&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0069"> <div class="reference-title-banner"> <h4 class="title">CDA 2013</h4> </div> <div class="bibliography-section" id="CD009061-bib-0074"> <div class="citation-journal">Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Bowering K, Embil JM. <span class="citation-title">Foot Care</span>. <span class="citation"> Canadian Journal of Diabetes </span><span class="pubYear">2013</span>;<span class="volume">37 Suppl 1</span>:145‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Foot+Care&author=K+Bowering&author=JM+Embil&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0070"> <div class="reference-title-banner"> <h4 class="title">Crouzed 2011</h4> </div> <div class="bibliography-section" id="CD009061-bib-0075"> <div class="citation-journal">Crouzet J, Lavigne JP, Richard JL, Sotto A. <span class="citation-title">Diabetic foot infection: a critical review of recent randomized clinical trials on antibiotic therapy</span>. <span class="citation"> International Journal of Infectious Diseases </span><span class="pubYear">2011</span>;<span class="volume">15</span>:e601‐10. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21737333" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diabetic+foot+infection:+a+critical+review+of+recent+randomized+clinical+trials+on+antibiotic+therapy+&author=J+Crouzet&author=JP+Lavigne&author=JL+Richard&author=A+Sotto&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0071"> <div class="reference-title-banner"> <h4 class="title">Edmonds 2005</h4> </div> <div class="bibliography-section" id="CD009061-bib-0076"> <div class="citation-journal">Edmondes M. <span class="citation-title">Infection in the neuroischemic foot</span>. <span class="citation"> International Journal of Low Extremity Wounds </span><span class="pubYear">2005</span>;<span class="volume">4</span>(3):145‐53. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Infection+in+the+neuroischemic+foot&author=M+Edmondes&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0072"> <div class="reference-title-banner"> <h4 class="title">Frykberg 2006</h4> </div> <div class="bibliography-section" id="CD009061-bib-0077"> <div class="citation-journal">Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR, et al. <span class="citation-title">Diabetic foot disorders. A clinical practice guideline (2006 revision)</span>. <span class="citation"> Journal of Foot and Ankle Surgery </span><span class="pubYear">2006</span>;<span class="volume">45 Suppl 5</span>:1‐66. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diabetic+foot+disorders.+A+clinical+practice+guideline+(2006+revision)&author=RG+Frykberg&author=T+Zgonis&author=DG+Armstrong&author=VR+Driver&author=JM+Giurini&author=SR+Kravitz&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0073"> <div class="reference-title-banner"> <h4 class="title">Gamble 2005</h4> </div> <div class="bibliography-section" id="CD009061-bib-0078"> <div class="citation-journal">Gamble C, Hollis S. <span class="citation-title">Uncertainty method improved on best‐worst case analysis in a binary meta‐analysis</span>. <span class="citation"> Journal of Clinical Epidemiology </span><span class="pubYear">2005</span>;<span class="volume">58</span>(6):579‐88. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15878471" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Uncertainty+method+improved+on+best%E2%80%90worst+case+analysis+in+a+binary+meta%E2%80%90analysis&author=C+Gamble&author=S+Hollis&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0074"> <div class="reference-title-banner"> <h4 class="title">Higgins 2003</h4> </div> <div class="bibliography-section" id="CD009061-bib-0079"> <div class="citation-journal">Higgins JPT, Thompson, SG, Deeks JJ, Altman DG. <span class="citation-title">Measuring inconsistency in meta‐analyses</span>. <span class="citation"> BMJ </span><span class="pubYear">2003</span>;<span class="volume">327</span>:557‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12958120" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Measuring+inconsistency+in+meta%E2%80%90analyses&author=JPT+Higgins&author=+Thompson&author=+SG&author=JJ+Deeks&author=DG+Altman&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0075"> <div class="reference-title-banner"> <h4 class="title">Higgins 2011</h4> </div> <div class="bibliography-section" id="CD009061-bib-0080"> <div class="citation-other">Higgins JPT, Altman DG, Sterne JAC (editors). <span class="citation-title">Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011) The Cochrane Collaboration, 2011</span>. Available from www.cochrane‐handbook.org.. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0076"> <div class="reference-title-banner"> <h4 class="title">IDSA 2012</h4> </div> <div class="bibliography-section" id="CD009061-bib-0081"> <div class="citation-journal">Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJG, Armstrong DG, et al. <span class="citation-title">Executive summary: 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections</span>. <span class="citation"> Clinical Infectious Diseases </span><span class="pubYear">2012</span>;<span class="volume">54:</span>(12):1679‐84. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/22619239" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Executive+summary:+2012+Infectious+Diseases+Society+of+America+clinical+practice+guideline+for+the+diagnosis+and+treatment+of+diabetic+foot+infections+&author=BA+Lipsky&author=AR+Berendt&author=PB+Cornia&author=JC+Pile&author=EJG+Peters&author=DG+Armstrong&publication_year=2012&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0077"> <div class="reference-title-banner"> <h4 class="title">International Working Group Diabetic Foot 2011</h4> </div> <div class="bibliography-section" id="CD009061-bib-0082"> <div class="citation-journal">Lipsky BA, Peters EJG, Berendt AR, Senneville E, Bakker K, Embil JM, et al. <span class="citation-title">Specific guidelines for the treatment of diabetic foot infections 2011</span>. <span class="citation"> Diabetes/Metabolism Research and Reviews </span><span class="pubYear">2012</span>;<span class="volume">28 Suppl 1</span>:234‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Specific+guidelines+for+the+treatment+of+diabetic+foot+infections+2011&author=BA+Lipsky&author=EJG+Peters&author=AR+Berendt&author=E+Senneville&author=K+Bakker&author=JM+Embil&publication_year=2012&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0078"> <div class="reference-title-banner"> <h4 class="title">Lavery 2003</h4> </div> <div class="bibliography-section" id="CD009061-bib-0083"> <div class="citation-journal">Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. <span class="citation-title">Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non‐Hispanic whites from a diabetes disease management cohort</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2003</span>;<span class="volume">26</span>(5):1435‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12716801" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diabetic+foot+syndrome:+evaluating+the+prevalence+and+incidence+of+foot+pathology+in+Mexican+Americans+and+non%E2%80%90Hispanic+whites+from+a+diabetes+disease+management+cohort+&author=LA+Lavery&author=DG+Armstrong&author=RP+Wunderlich&author=J+Tredwell&author=AJ+Boulton&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0079"> <div class="reference-title-banner"> <h4 class="title">Lefebvre 2011</h4> </div> <div class="bibliography-section" id="CD009061-bib-0084"> <div class="citation-other">Lefebvre C, Manheimer E, Glanville J, on behalf of the Cochrane Information Retrieval Methods Group. <span class="citation-title">Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</span>. Available from www.cochrane‐handbook.org. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0080"> <div class="reference-title-banner"> <h4 class="title">Lipsky 2004a</h4> </div> <div class="bibliography-section" id="CD009061-bib-0085"> <div class="citation-journal">Lipsky BA. <span class="citation-title">Medical treatment of diabetic foot infections</span>. <span class="citation"> Clinical Infectious Diseases </span><span class="pubYear">2004</span>;<span class="volume">39 Suppl 2</span>:104‐14. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Medical+treatment+of+diabetic+foot+infections&author=BA+Lipsky&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0081"> <div class="reference-title-banner"> <h4 class="title">Lipsky 2004b</h4> </div> <div class="bibliography-section" id="CD009061-bib-0086"> <div class="citation-journal">Lipsky BA, Berebdt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, et al. <span class="citation-title">Diagnosis and treatment of diabetic foot infections</span>. <span class="citation"> Clinical Infectious Diseases </span><span class="pubYear">2004</span>;<span class="volume">39</span>(7):885‐910. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15472838" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diagnosis+and+treatment+of+diabetic+foot+infections&author=BA+Lipsky&author=AR+Berebdt&author=HG+Deery&author=JM+Embil&author=WS+Joseph&author=AW+Karchmer&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0082"> <div class="reference-title-banner"> <h4 class="title">Lipsky 2007</h4> </div> <div class="bibliography-section" id="CD009061-bib-0087"> <div class="citation-journal">Lipsky BA, Giordano P, Choudhri S, Song J. <span class="citation-title">Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin‐tazobactam/amoxicillin‐clavulanate</span>. <span class="citation"> Journal of Antimicrobial Chemotherapy </span><span class="pubYear">2007</span>;<span class="volume">60</span>(2):370‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17553812" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treating+diabetic+foot+infections+with+sequential+intravenous+to+oral+moxifloxacin+compared+with+piperacillin%E2%80%90tazobactam/amoxicillin%E2%80%90clavulanate+&author=BA+Lipsky&author=P+Giordano&author=S+Choudhri&author=J+Song&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0083"> <div class="reference-title-banner"> <h4 class="title">Lipsky 2014</h4> </div> <div class="bibliography-section" id="CD009061-bib-0088"> <div class="citation-journal">Lipsky BA, Hoey C, Cruciani M, Mengoli C. <span class="citation-title">Topical antimicrobial agents for preventing and treating foot infections in people with diabetes (Protocol)</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2014</span>, Issue Issue 3. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Topical+antimicrobial+agents+for+preventing+and+treating+foot+infections+in+people+with+diabetes+(Protocol)+&author=BA+Lipsky&author=C+Hoey&author=M+Cruciani&author=C+Mengoli&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0084"> <div class="reference-title-banner"> <h4 class="title">Lundh 2012</h4> </div> <div class="bibliography-section" id="CD009061-bib-0089"> <div class="citation-journal">Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. <span class="citation-title">Industry sponsorship and research outcome</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2012</span>;<span class="volume">12</span>:Art. No.: MR000033. DOI: 10.1002/14651858.MR000033.pub2. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Industry+sponsorship+and+research+outcome&author=A+Lundh&author=S+Sismondo&author=J+Lexchin&author=OA+Busuioc&author=L+Bero&publication_year=2012&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0085"> <div class="reference-title-banner"> <h4 class="title">McKittrick 1946</h4> </div> <div class="bibliography-section" id="CD009061-bib-0090"> <div class="citation-journal">McKittrick LS. <span class="citation-title">Recent advances in the management of gangrene and infections in patients with diabetes mellitus</span>. <span class="citation"> Journal of Digestive Diseases </span><span class="pubYear">1946</span>;<span class="volume">13</span>:142‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Recent+advances+in+the+management+of+gangrene+and+infections+in+patients+with+diabetes+mellitus+&author=LS+McKittrick&publication_year=1946&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0086"> <div class="reference-title-banner"> <h4 class="title">MedlinePlus</h4> </div> <div class="bibliography-section" id="CD009061-bib-0091"> <div class="citation-other"><span class="citation-title">MedlinePlus</span>. US National Library of Medicine. National Institutes of Health Page last updated on 29 January 2015; Vol. Bethesda, US:http://www.nlm.nih.gov/medlineplus/. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0087"> <div class="reference-title-banner"> <h4 class="title">Nelson 2006a</h4> </div> <div class="bibliography-section" id="CD009061-bib-0092"> <div class="citation-journal">Nelson EA, O'Meara S, Craig D, Iglesias C, Golder S, Dalton J, et al. <span class="citation-title">A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers</span>. <span class="citation"> Health Technology Assessment </span><span class="pubYear">2006</span>;<span class="volume">10</span>(12):iii‐iv, ix‐x, 1‐221. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16595081" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+series+of+systematic+reviews+to+inform+a+decision+analysis+for+sampling+and+treating+infected+diabetic+foot+ulcers+&author=EA+Nelson&author=S+O'Meara&author=D+Craig&author=C+Iglesias&author=S+Golder&author=J+Dalton&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0088"> <div class="reference-title-banner"> <h4 class="title">NICE 2011</h4> </div> <div class="bibliography-section" id="CD009061-bib-0093"> <div class="citation-other">National Institute for Health and Clinical Excellence. <span class="citation-title">NICE clinical guideline 119. Diabetic foot problems. Inpatient management of diabetic foot problems</span>. NHS<span class="pubYear">March 2011</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0089"> <div class="reference-title-banner"> <h4 class="title">OMS 2014</h4> </div> <div class="bibliography-section" id="CD009061-bib-0094"> <div class="citation-book">World Health Organization. <span class="citation">Antimicrobial resistance: global report on surveillance</span>. Vol. <span class="volume">ISBN 978 92 4 156474 8</span>, France: World Health Organization, <span class="pubYear">2014</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0090"> <div class="reference-title-banner"> <h4 class="title">Parmar 1998</h4> </div> <div class="bibliography-section" id="CD009061-bib-0095"> <div class="citation-journal">Parmar MKB, Torri V, Stewart L. <span class="citation-title">Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints</span>. <span class="citation"> Statistics in Medicine </span><span class="pubYear">1998</span>;<span class="volume">17</span>:2815‐34. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9921604" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Extracting+summary+statistics+to+perform+meta%E2%80%90analyses+of+the+published+literature+for+survival+endpoints+&author=MKB+Parmar&author=V+Torri&author=L+Stewart&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0091"> <div class="reference-title-banner"> <h4 class="title">Pecoraro 1990</h4> </div> <div class="bibliography-section" id="CD009061-bib-0096"> <div class="citation-journal">Pecoraro RE, Reiber GE, Burgess EM. <span class="citation-title">Pathways to diabetic limb amputation: basis for prevention</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1990</span>;<span class="volume">13</span>:513‐21. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2351029" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pathways+to+diabetic+limb+amputation:+basis+for+prevention&author=RE+Pecoraro&author=GE+Reiber&author=EM+Burgess&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0092"> <div class="reference-title-banner"> <h4 class="title">Prompers 2007</h4> </div> <div class="bibliography-section" id="CD009061-bib-0097"> <div class="citation-journal">Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, et al. <span class="citation-title">High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study</span> [Diabetologia]. <span class="citation"> 2007 </span> 50;<span class="volume">1</span>:18‐25. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0093"> <div class="reference-title-banner"> <h4 class="title">Prompers 2008</h4> </div> <div class="bibliography-section" id="CD009061-bib-0098"> <div class="citation-journal">Prompers L, Huijberts M, Schaper N, Apelqvist J, Bakker K, Edmonds M, et al. <span class="citation-title">Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2008</span>;<span class="volume">10</span>:1826‐34. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Resource+utilisation+and+costs+associated+with+the+treatment+of+diabetic+foot+ulcers.+Prospective+data+from+the+Eurodiale+Study+&author=L+Prompers&author=M+Huijberts&author=N+Schaper&author=J+Apelqvist&author=K+Bakker&author=M+Edmonds&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0094"> <div class="reference-title-banner"> <h4 class="title">Raspovic 2014</h4> </div> <div class="bibliography-section" id="CD009061-bib-0099"> <div class="citation-journal">Raspovic KM, Wukick DK. <span class="citation-title">Self‐reported quality of life and diabetic foot infections</span>. <span class="citation"> Journal of Foot and Ankle Surgery </span><span class="pubYear">2014</span>;<span class="volume">53</span>(6):716‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/25128305" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Self%E2%80%90reported+quality+of+life+and+diabetic+foot+infections&author=KM+Raspovic&author=DK+Wukick&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0095"> <div class="reference-title-banner"> <h4 class="title">Regan 1949</h4> </div> <div class="bibliography-section" id="CD009061-bib-0100"> <div class="citation-journal">Regan JS, Bowen BD, Fernbach PA. <span class="citation-title">Reduction in mortality and loss of limbs in diabetic gangrene and infection</span>. <span class="citation"> Archives of Surgery </span><span class="pubYear">1949</span>;<span class="volume">59</span>(3):594‐600. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18147735" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Reduction+in+mortality+and+loss+of+limbs+in+diabetic+gangrene+and+infection&author=JS+Regan&author=BD+Bowen&author=PA+Fernbach&publication_year=1949&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0096"> <div class="reference-title-banner"> <h4 class="title">Reiber 1999</h4> </div> <div class="bibliography-section" id="CD009061-bib-0101"> <div class="citation-journal">Reiber GE, Vileikyte L, Boyko EJ, Aguila M, Smith DG, Lavery LA, et al. <span class="citation-title">Causal pathways for incident lower‐extremity ulcers in patients with diabetes from two settings</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22</span>:157‐62. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10333919" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Causal+pathways+for+incident+lower%E2%80%90extremity+ulcers+in+patients+with+diabetes+from+two+settings+&author=GE+Reiber&author=L+Vileikyte&author=EJ+Boyko&author=M+Aguila&author=DG+Smith&author=LA+Lavery&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0097"> <div class="reference-title-banner"> <h4 class="title">RevMan 2014 [Computer program]</h4> </div> <div class="bibliography-section" id="CD009061-bib-0102"> <div class="citation-other">The Nordic Cochrane Centre, The Cochrane Collaboration. <span class="citation-title">Review Manager (RevMan)</span>. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, <span class="pubYear">2014</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0098"> <div class="reference-title-banner"> <h4 class="title">Selva 2011</h4> </div> <div class="bibliography-section" id="CD009061-bib-0103"> <div class="citation-journal">Selva A, Barajas‐Nava LA, Gianneo OD, Solà I, Bonfill X, Lipsky BA. <span class="citation-title">Systemic antibiotics for treating diabetic foot infections</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2011</span>. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Systemic+antibiotics+for+treating+diabetic+foot+infections&author=A+Selva&author=LA+Barajas%E2%80%90Nava&author=OD+Gianneo&author=I+Sol%C3%A0&author=X+Bonfill&author=BA+Lipsky&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0099"> <div class="reference-title-banner"> <h4 class="title">SIGN 2011</h4> </div> <div class="bibliography-section" id="CD009061-bib-0104"> <div class="citation-other">Scottish Intercollegiate Guidelines Network (SIGN). <span class="citation-title">Search filters</span>. http://www.sign.ac.uk/methodology/filters.html#random (accessed  28 January 2011). <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0100"> <div class="reference-title-banner"> <h4 class="title">Sterne 2013</h4> </div> <div class="bibliography-section" id="CD009061-bib-0105"> <div class="citation-other">Sterne JAC. <span class="citation-title">Why the Cochrane risk of bias tool should not include funding source as a standard item [editorial]</span>. Cochrane Database of Systematic Reviews<span class="pubYear">2013</span>; Vol. 10.1002/14651858.ED000076. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Why+the+Cochrane+risk+of+bias+tool+should+not+include+funding+source+as+a+standard+item+[editorial]+&author=JAC+Sterne&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0101"> <div class="reference-title-banner"> <h4 class="title">Tierney 2007</h4> </div> <div class="bibliography-section" id="CD009061-bib-0106"> <div class="citation-journal">Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. <span class="citation-title">Practical methods for incorporating summary time‐to‐event data into meta‐analysis</span>. <span class="citation"> Trials </span><span class="pubYear">2007</span>;<span class="volume">8</span>:1‐16. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17210080" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Practical+methods+for+incorporating+summary+time%E2%80%90to%E2%80%90event+data+into+meta%E2%80%90analysis&author=JF+Tierney&author=LA+Stewart&author=D+Ghersi&author=S+Burdett&author=MR+Sydes&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD009061-bbs2-0102"> <div class="reference-title-banner"> <h4 class="title">West 1995</h4> </div> <div class="bibliography-section" id="CD009061-bib-0107"> <div class="citation-journal">West NJ. <span class="citation-title">Systemic antimicrobial treatment of foot infections in diabetic patients</span>. <span class="citation"> American Journal of Health‐System Pharmacy </span><span class="pubYear">1995</span>;<span class="volume">52</span>(11):1199‐207. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7656109" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Systemic+antimicrobial+treatment+of+foot+infections+in+diabetic+patients&author=NJ+West&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> </section> <section class="characteristicStudies" id="characteristicStudies"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title"> Characteristics of studies <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="characteristicIncludedStudiesContent" lang=""> <div class="section-header" id="CD009061-sec2-0028"> <h3 class="title">Characteristics of included studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD009061-sec2-0029" class="jump-to">excluded studies</a></li> <li><a href="#CD009061-sec2-0030" class="jump-to">ongoing studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Arbeit 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design:</b> 2 identical multicentre, international, phase III randomised trials; non inferiority trial </p> <p><b>Follow‐up period:</b> 28 days </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 1092 </p> <p>For the diabetic participants subgroup, the data came from Lipsky 2005: N:133</p> <p><b>Sex (%male):</b> 54% </p> <p><b>Age (mean):</b> Intervention Group: 60 years; Control Group: 63 years </p> <p><b>Inclusion criteria:</b> people with diabetes; between the ages of 18‐85 years; requiring hospitalisation for an infected ulcer that was known or suspected to be caused by a Gram‐positive organism (based on a Gram‐stained smear) </p> <p><b>Exclusion criteria:</b> minor or superficial skin infections; uncomplicated cellulitis; myositis; multiple infected ulcers at distant sites; infected third‐degree burn wounds; osteomyelitis; known bacteraemic shock; hypotension, or any disorder that could interfere with the treatment evaluation; pregnancy; infection due to an organism known to be resistant to any study drug; &lt; 40 kg in weight; hypersensitivity reaction to study drugs; haemodialysis or peritoneal dialysis; impaired renal function (creatinine clearance &lt; 30 mL/min); immunosuppression; serum creatine phosphokinase &gt; 50% above the upper limit of normal; statin use; systemic antibiotic treatment for more than 24 h within the previous 48 h (unless the infecting Gram‐positive organism was resistant to that therapy, or it was clinically ineffective) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 61):</b> daptomycin 4 mg/kg iv every 24 h over 30 minutes </p> <p><b>Control (n = 72):</b> preselected comparator (previous to randomizations) based on the investigator’s assessment of the participant’s likelihood of infection with MRSA: either vancomycin 1 g iv every 12 h over 60 minutes or a semi‐synthetic penicillin (nafcillin, oxacillin, cloxacillin or flucloxacillin, according to the investigator’s choice) </p> <p>The investigator could add aztreonam to cover Gram‐negative bacteria if they were suspected or proven to be part of a polymicrobial infection, or metronidazole to cover possible or proven infection with obligate anaerobic bacteria </p> <p><b>Treatment duration:</b> 7‐14 days </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome</b> </p> <p> <ul id="CD009061-lst1-0019"> <li> <p>Rate of clinical success in treating the diabetic foot infection</p> </li> </ul> </p> <p><b>Secondary outcome</b> </p> <p> <ul id="CD009061-lst1-0020"> <li> <p>Rate of microbiological success in eradicating the causative pathogen(s)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Funding source:</b> Cubist Pharmaceuticals (makers of daptomycin); 4 authors were employees of Cubist Pharmaceuticals, and the other was an investigator for Cubist clinical trials </p> <p><b>Other:</b> no sample size calculation. This was a subgroup analysis of another RCT </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Described as a randomised study, but no information provided about the sequence generation</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No information provided</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30 participants were not clinically evaluable (22.5%) with no differences between the study groups. The reasons were not explained </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>All outcomes mentioned in the methods section were also reported in results section.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>This study was a subgroup analysis of another study so it was not big enough to identify differences between the comparison groups. The original study recruited 1092 participant with a power of 80% to detect non‐inferiority </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No information provided</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A blinded investigator categorized the clinical outcome</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bouter 1996 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design:</b> RCT, 1 centre (the Netherlands) </p> <p><b>Follow‐up period (mean):</b> follow‐up until completion of antibiotic therapy (mean of 23.6‐24.3 days) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 46 participants randomised </p> <p><b>Sex (%male):</b> 43.5% </p> <p><b>Age (mean(SD)):</b> 71.4 years (9.8) </p> <p><b>Inclusion criteria:</b> participants hospitalised for diabetic foot lesions; Wagner stages II, III or IV; ankle/brachial index of at least 0.45; and normal renal and liver function </p> <p><b>Exclusion criteria:</b> hypersensitivity to the study drugs; having received antimicrobial therapy effective against the infecting pathogens within the 48 h before enrolment; high probability of death within 48 h; infection with <i>Xanthomonas maltophilia</i> or other micro‐organisms resistant to the study drugs </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 22):</b> imipenem/cilastatin 500 mg iv every 6 h </p> <p><b>Control (n = 24):</b> piperacillin 3000 mg iv every 6 h plus clindamycin 600 mg iv every 8 h. In case of chronic osteomyelitis, antibiotic therapy was continued with oral quinolone (ciprofloxacin 500 mg or ofloxacin 400 mg every 12 h) and/or clindamycin 600 mg every 8 h depending on culture results </p> <p><b>Treatment duration:</b> minimum of 10 days. Mean duration of antibiotic treatment 23.6 days for imipenem‐cilastatin group and 24.3 days for piperacillin + clindamycin group </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD009061-lst1-0021"> <li> <p>Clinical response after completion of antibiotic therapy</p> </li> <li> <p>Adverse effects</p> </li> <li> <p>Infection‐related mortality</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Funding source:</b> not described </p> <p><b>Other:</b> no sample size calculation </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Computer‐generated table of random numbers</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No details provided</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>All outcomes in mentioned in the methods section were also reported in results section. Primary outcome not described </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Described as 'open'</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No details provided. Attempt to contact authors was unsuccessful</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Clay 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design:</b> open‐label RCT, 1 centre (USA) </p> <p><b>Follow‐up period:</b> not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 70 participants randomised </p> <p><b>Sex (%male):</b> 100% </p> <p><b>Age (mean)</b>: 63.8 years (10.8) </p> <p><b>Inclusion criteria:</b> ≥18 years; with type 1 or 2 diabetes mellitus and clinical diagnosis of a diabetic lower extremity infection (i.e. at least 2 of the following: local heat, purulent drainage from a wound, erythema, fever and stage 1, 2 or 3 ulcer severity using the Wagner scale) </p> <p><b>Exclusion criteria:</b> bone involvement (osteomyelitis); hypersensitivity to the study antibiotics; having received iv antibiotic for &gt; 24 h immediately before study enrolment; uncontrolled use of oral antibiotics before hospitalisation; neutropenia (≤1000/mm³); thrombocytopenia (≤ 50.000/mm³) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 36):</b> metronidazole 1 g + ceftriaxone 1 g iv over 90 minutes once a day </p> <p><b>Control (n = 34):</b> ticarcillin/clavulanate 3.1 g over 30 minutes every 6 h </p> <p><b>Treatment duration (mean, SD):</b> Intervention Group: 6.7 days (3.3); Control Group: 6.1 days (4.3) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD009061-lst1-0022"> <li> <p>Treatment success at or before 96 h and at the end of the study (or at discharge or a change to oral antibiotics) </p> </li> <li> <p>Adverse events</p> </li> <li> <p>Costs</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Funding source: the trial received a</b> grant from Roche Pharmaceuticals and,one of the study authors was an employee of Cubist Pharmaceutical. </p> <p><b>Other:</b> sample size calculation not reported </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Computer generated schedule</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No data provided</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No deviations described.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Safety not clearly reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Described as open label</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The final treatment outcome was based on the non‐study provider's discharge assessment of the efficacy of study treatment </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Erstad 1997 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design:</b> double blind, RCT; 1 centre (USA) </p> <p><b>Follow‐up period</b>: 5 days </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 36 participants randomised </p> <p><b>Sex:</b> not described </p> <p><b>Age (mean):</b> Intervention Group: 60.7 years; Control Group: 57.8 years </p> <p><b>Inclusion criteria:</b> ≥18 years; insulin or non insulin‐dependent diabetes; followed by the Vascular Surgery Service; at least Grade 1 (own classification) foot infection (cellulitis, no skin break); without antimicrobial therapy within the previous 4 days </p> <p><b>Exclusion criteria:</b> hypersensitivity to penicillin or cephalosporins; creatinine clearance &lt; 15 mL/minute; history of drug or alcohol abuse; concomitant infection at a site other than the foot; imminently terminal illness; neutropenia (&lt; 1500/m³); pregnancy or breastfeeding </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 18):</b> ampicillin/sulbactam 3 g iv every 6 h </p> <p><b>Control (n = 18):</b> cefoxitin 2 g iv every 6 h </p> <p><b>Treatment duration:</b> at least 5 days. The maximum duration was left to the discretion of the treating surgeon </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD009061-lst1-0023"> <li> <p>Successful treatment clinical outcome (cure or improvement)</p> </li> <li> <p>Bacteriological eradication</p> </li> <li> <p>Rate of amputation and revascularization</p> </li> <li> <p>Duration of hospitalisation</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Funding source:</b> Roerig Division, Pfizer Inc </p> <p><b>Other:</b> no sample size calculation performed </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The study was described as randomised but the method used to generate the allocation sequence was not described. Attempt to contact authors unsuccessful </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described. Attempt to contact authors unsuccessful</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3 participants (8%) did not complete 5‐day treatment (1 from the intervention group and 2 from control the group). Reasons explained. Intention to treat analysis </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes described in the methods were reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The study was described as double blinded but no description of the methods used</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The authors did not describe who did the clinical evaluations and whether this person was blinded </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Giordano 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design:</b> prospective, randomised, double‐blind, multicentre phase IIIb non‐inferiority trial </p> <p><b>Follow‐up period:</b> 10‐42 days post therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 617 participants, only 78 participants had diabetic foot infections </p> <p>For all study participants:</p> <p><b>Sex (%male):</b> 65% </p> <p><b>Age (mean):</b> 52.6 years </p> <p><b>Inclusion criteria:</b> hospitalised patients ≥18 years; with cSSI of bacterial origin based on Gram‐strained smear; need for 1 week of antibiotic therapy (complicated skin and skin structure infections included: infected ischaemic ulcers, DFIs, infected decubitus ulcers, major abscesses, carbuncles, skin infections requiring significant surgical intervention in addition to antimicrobial therapy, deep soft tissue infection, infection resulting from bites); with at least 3 of the following signs and symptoms: drainage or discharge, erythema, fluctuance, heat or localised warmth, pain or tenderness, swelling or induration, fever or leucocytosis or &gt;15% immature neutrophils. Appropriate specimens obtained prior to initiation of the study drug </p> <p><b>Exclusion criteria:</b> necrotizing fasciitis; Fournier’s gangrene; ecthyma gangrenosum; streptococcal necrotizing fasciitis; streptococcal gangrene; clostridial necrotizing fasciitis or synergistic necrotizing fasciitis; folliculitis or furunculosis; osteomyelitis if the infected bone was not resected; secondary infections of a chronic skin disease; infections of prosthetic materials; when a surgical procedure alone was considered the definitive therapy; uncomplicated infections; infected burns. Pregnancy or nursing; immunological compromise; hypersensitivity to the study drugs; renal insufficiency; need for haemodialysis or peritoneal dialysis; severe hepatic insufficiency; electrocardiographic QTc prolongation; uncorrected hypokalaemia; seizure disorder; fluoroquinolone‐associated tendinopathy. Having received antibiotics within 3 days of study enrolment for a dosing duration of &gt; 24 h or if concomitant systemic antibiotic therapy was needed for treatment of another infection </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 37):</b> moxifloxacin 400 mg iv once daily for 3 days followed by oral moxifloxacin 400 mg once daily </p> <p><b>Control (n = 41) :</b> piperacillin‐tazobactam 3.0 g/0.375 g iv every 6 h for 3 days, followed by amoxicillin‐clavulanate 800 mg every 12 h </p> <p><b>Treatment duration:</b> 7‐14 days </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome</b> </p> <p> <ul id="CD009061-lst1-0024"> <li> <p>Clinical response rate</p> </li> </ul> </p> <p><b>Secondary outcomes</b> </p> <p> <ul id="CD009061-lst1-0025"> <li> <p>Bacteriological response rate</p> </li> <li> <p>Safety and tolerability</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Funding source:</b> supported by Bayer Pharmaceuticals Corporation, 4 authors were employees of Bayer </p> <p><b>Other:</b> sample size calculation not reported </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Described as randomised, but the methods used were not detailed</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The efficacy‐valid populations consisted only of 40% of the randomised participants. The most common reasons for excluding subjects were: use of prohibited therapy; concomitant or post‐therapy antibiotics; insufficient treatment duration; essential data missing; and, lost to follow‐up. The proportion of participants for each reason was similar in both groups. No sample size calculation </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The trial report presented results on all outcome measures that were pre‐specified in the methods section as relevant </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The study was double‐blinded and double‐dummy but the method used to assure the blinding was not described </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Graham 2002a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design</b>: randomised double‐blind, multicentre, clinical trial of equivalence </p> <p><b>Follow‐up period:</b> 10‐21 days after completing antibiotic therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 540 participants randomised, 98 of whom had a diabetic foot infection </p> <p>For all study participants:</p> <p><b>Sex (%male):</b> 351 (65%) </p> <p><b>Age (mean, SD):</b> Intervention Group 48.7 years (16.5); Control Group: 48 years (17.4) </p> <p><b>Inclusion criteria:</b> men and women ≥18 years; with cSSSIs requiring parenteral antimicrobial therapy; signs and symptoms of acute (in the absence of chronic) infection or indwelling foreign material. Surgical drainage had to have been completed ≤ 48 h after initiation of therapy </p> <p>Patients recently treated with antimicrobial therapy for &gt; 24 h could be enrolled if there was clinical evidence of treatment failure after ≥ 3 days of therapy and if the pathogen was susceptible to both study drugs. Polymicrobial infections with resistant pathogens could remain in the study at investigator’s discretion if ≥ 1 of the isolated organisms was susceptible to both study drugs </p> <p><b>Exclusion criteria:</b> pregnancy; lactation; allergy or intolerance to any beta‐lactam (except to mild rash); progressive or terminal illness; immunosuppressive therapy; AIDS; infected burn wounds; necrotizing fasciitis; osteomyelitis; septic arthritis; gangrene or need for amputation; deep‐vein thrombosis; current treatment with other systemic antimicrobials; other concurrent infection; undergoing renal dialysis; infection with a pathogen known to be resistant to either of the study medications; &gt; 24 h of systemic antimicrobial therapy during the 72 h before study; specified abnormal laboratory test results </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 53):</b> ertapenem 1 g iv once daily </p> <p><b>Control (n = 45):</b> piperacillin‐tazobactam 3.4 g iv every 6 h </p> <p><b>Treatment duration:</b> 7‐14 days </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome</b> </p> <p> <ul id="CD009061-lst1-0026"> <li> <p>Clinical response: proportion of participants with an investigator assessment of 'cure' at the TOC assessment (10‐21 days after the completion of study therapy) </p> </li> </ul> </p> <p><b>Secondary outcomes</b> </p> <p> <ul id="CD009061-lst1-0027"> <li> <p>Microbiologic response</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Funding source:</b> supported by Merck &amp; Co, 4 study authors were employees of Merk and Co </p> <p><b>Other:</b> sample size calculation reported </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Described as randomised but the sequence generation was not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No information provided</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Only 32% and 34% of randomised participants in each group were clinically evaluable. Reasons for exclusions were not clearly reported. The results of analyses of 'modified intention to treat' and 'only clinically evaluable patients' groups did not show many differences </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>All the outcomes described in the methods sections are reported in the results section</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The ertapenem group also received placebo infusions of saline every 6 h</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The outcome assessors were the investigators</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Graham 2002b </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design:</b> Multicentre, international, RCT. Designed as a non‐inferiority study </p> <p><b>Follow‐up period:</b> 3–4 weeks after completion of therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 400 participants randomised, only 67 of whom had a diabetic foot infection </p> <p>For all study participants:</p> <p><b>Sex (%men):</b> 243 (61%) </p> <p><b>Age (mean):</b> Intervention Group: 51.9 years; Control Group: 49.8 years </p> <p><b>Inclusion criteria:</b> men and women ≥18 years; with bacterial SSSI in the presence of a complicating factor (pre‐existing skin lesions or underlying conditions that adversely affected the immunologic or tissue‐healing response or the delivery of drug to the infected area); with at least 2 of the following signs and symptoms: pain, swelling, erythema or induration. Multiple skin sites of infection permitted unless multiple infected ulcers at distant sites (the most severely affected side was chosen for the study) </p> <p><b>Exclusion criteria:</b> furuncles; simple abscesses or minor superficial infections not warranting systemic antimicrobial therapy; cellulitis not associated with complicating factors; multiple infected ulcers at distant sites; conditions for which surgery alone is curative or removal of the infected site (amputation); conditions that required emergent surgical intervention; perirectal abscess or hidradenitis suppurativa; myositis not associated with SSSI; osteomyelitis; burn wound infections; micro‐organism resistance; use of non‐study antimicrobial regimen or topical antimicrobial; prior systemic antimicrobial therapy &gt; 24 h in the 48 h prior to admission; shock; hypotension or oliguria; neutropaenia; HIV infection with ≤ 200 CD4; creatinine clearance &lt; 30 mL/minute; pregnancy or lactation; seizure disorders; unstable psychiatric disorder; underweight (≤ 40 kg); allergy; prior treatment with any investigational agent in the 30 days before </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 36):</b> levofloxacin 750 mg iv or po every 24 h </p> <p><b>Control (n = 31):</b> ticarcillin‐clavulanate 3.1 g iv every 4‐6 h. Switched to oral amoxicillin‐clavulanate 875 mg every 12 h at the investigator’s discretion </p> <p><b>Treatment duration:</b> 7‐14 days </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome</b> </p> <p> <ul id="CD009061-lst1-0028"> <li> <p>Clinical efficacy (2‐5 days after completion of therapy)</p> </li> </ul> </p> <p><b>Secondary outcomes</b> </p> <p> <ul id="CD009061-lst1-0029"> <li> <p>Microbiological efficacy</p> </li> <li> <p>Safety</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Funding source:</b> supported by Johnson &amp; Johnson Research and Development, 2 authors were employees of Johnson &amp; Johnson </p> <p><b>Other:</b> sample size calculation not reported </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Described as randomised. No details provided. Stratified by centre</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Described as randomised but no specific details provided</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>33% of total sample not evaluable. The reasons varied between the treatment groups: twice as many participants were not evaluable as lost to follow‐up in Control group. Twice as many participants not evaluable for insufficient course of therapy in the Intervention group. More than 3 times as many non‐evaluable participants for effective concomitant therapy in the Control group. Withdrawals with no data available: 7 participants in Intervention group and 20 in the Control </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The outcomes described in methods section were the same as those reported in results section </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Open‐label study</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Investigators assessed outcomes</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Grayson 1994 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design:</b> double‐blind, single‐centre (USA), randomised, non‐inferiority trial </p> <p><b>Follow‐up period:</b> 13 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 93 participants with 96 infection episodes randomised </p> <p><b>Sex (%male):</b> 72% </p> <p><b>Age (mean)</b>: 60 years </p> <p><b>Inclusion criteria:</b> adults with diabetes mellitus and limb‐threatening infection involving the lower extremity, who required hospitalisation </p> <p><b>Exclusion criteria:</b> hypersensitivity to beta‐lactam antibiotics; requirement for other antibiotic treatment; plasmatic creatinine ≥ 3.5 mg/dL; pregnancy; severe illness with probability of death within 48 h; immune depression; participation in a clinical study of an investigational drug; recently received antibiotic therapy with a similar antimicrobial spectrum </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 47 participants, 48 infection episodes):</b> ampicillin‐sulbactam 2 g/1 g iv every 6 h </p> <p><b>Control (n = 46 participants, 48 infection episodes):</b> imipenem‐cilastatin 500 mg iv every 6 h </p> <p><b>Treatment duration (mean</b> (<b>SD</b>)<b>):</b> Intervention Group: 13 (6.5) days; Control Group: 15 (8.6) days </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD009061-lst1-0030"> <li> <p>Clinical resolution of infection</p> </li> <li> <p>Microbiological resolution of infection</p> </li> <li> <p>Amputations</p> </li> <li> <p>Recurrence of wound infection</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Financial support:</b> supported by Pfizer Pharmaceuticals </p> <p><b>Other:</b> sample size calculation performed and reached </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants were assigned by the pharmacy to receive either intervention or control on the basis of a computer‐generated randomisation code </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The pharmacy assigned participants to receive one or other treatment</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Analysis was by episode unit and not by participant unit. 92 participants were randomised (the trial publication reported 47 intervention vs 46 control). 5 participants were randomised twice because they experience more than one infection during the study period. 9 protocol violations during the study (3 Intervention Group vs 6 Control Group; non‐significant difference) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Main variables were not described in the methods section</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The study is described as double‐blinded but no specific details provided</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The clinical assessment was made in a blinded fashion by the study physicians</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Harkless 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design:</b> randomised, open‐label, multicentre study </p> <p><b>Follow‐up period:</b> 14‐21 days </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 314 participants randomised </p> <p><b>Age (median (min‐max)):</b> Intervention A: 62 years (26‐101); Intervention B: 60.1 years (26‐92) </p> <p><b>Inclusion criteria:</b> adults with diabetes mellitus; open infected foot ulcer that met the University of Texas Grade IB, ID, IIB or IID classification of foot ulcers; at least 1 full‐or partial‐thickness infected ulcer at or below the ankle and purulent drainage or 2 of the following: erythema, local oedema, fluctuance, induration, increased local warmth or fever </p> <p><b>Exclusion criteria:</b> pregnancy or lactation; anticipated amputation within 2 months; need for topical antibiotics at the ulcer site or other systemic antibacterials; creatine clearance &lt; 40 ml/min; renal replacement therapy; requiring immunosuppressive drugs; hypersensitivity to penicillins; beta‐lactamase inhibitors or vancomycin; organism known or suspected to be resistant to study drugs; osteomyelitis; thrombocytopenia </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention A (n = 155):</b> piperacillin‐tazobactam 4 g/0.5 g iv every 8 h </p> <p><b>Intervention B (n = 159):</b> ampicillin‐sulbactam 2 g/1 g iv every 6 h </p> <p><b>Treatment duration:</b> 4‐14 days, maximum of 21 days. Vancomycin 1 g every 12 h to participants for whom MRSA or MR‐<i>Staphylococcus epidermidis</i> had been identified as an organism involved in the infection </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome</b> </p> <p> <ul id="CD009061-lst1-0031"> <li> <p>Clinical success at day 4, 7, end‐of treatment visit, TOC visit (14‐21 days after the completion of therapy) </p> </li> </ul> </p> <p><b>Secondary outcomes</b> </p> <p> <ul id="CD009061-lst1-0032"> <li> <p>Bacteriologic response rates</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Funding source:</b> Wyeth Pharmaceuticals; 3 authors were employee of Wyeth Pharmaceuticals </p> <p><b>Other:</b> sample size calculation performed but not reached </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Did not describe how the allocation sequence was generated. Attempt to contact authors was unsuccessful </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insufficient information to assess this domain. Attempt to contact authors unsuccessful</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Sample size estimated at 150 participants per group, 314 participants were randomised (155 vs 159) to the safety population. 294 participants were evaluable (139 vs 150) with some non‐significant differences that could be unbalanced between groups (e.g. resistance to study drug: 6 (4.3%) vs 19 (12.7%); 29.7% and 31.4% in each group dropped out </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The main outcome described in the methods section was described in the results</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Open‐label study</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insufficient information to assess this domain. Attempt to contact authors was unsuccessful</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lauf 2014 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design:</b> multicentre, international, phase III randomised non inferiority trial. The study contained a sub study </p> <p><b>Follow‐up period:</b> 25‐27 weeks after last dose of antibiotic </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N of the main study:</b> 955 </p> <p><b>N of the sub study:</b> 118 </p> <p><b>Sex (main study; %male):</b> 62.9 (tigecycline group); 67.5% (ertapenem group) </p> <p><b>Age (mean; main study):</b> 59 years </p> <p><b>Inclusion criteria:</b> hospitalised men and women; ≥ 18 years with diabetes mellitus; with a foot infection that did not extend above the knee. Infections of a PEDIS infection grade from 2 to 4 and a perfusion grade from 1 to 2, of acute onset or a worsening within 14 days prior; participants with osteomyelitis at baseline were not evaluable in the primary study but were included in the secondary study </p> <p><b>Exclusion criteria:</b> participants receiving more than 48 h of a prior antibiotic treatment; necrotizing fasciitis; crepitant cellulitis; wet gangrene; gas gangrene; ecthyma gangrenosum; or implanted prosthetic material or devices that were not to be removed; infection known or suspected to be caused by a pathogen resistant to study drugs. Severely impaired arterial supply of the foot or requiring amputation within 1 month. Renal replacement therapy; plasmapheresis; hypersensitivity to study drugs; neutropenia or immunosuppressive treatment; creatinine clearance &lt; 30 mL/min; hepatic disease; lactating women or fertile women not using contraception </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 483):</b> tigecycline 150 mg iv every 24 h ± placebo vancomycin </p> <p><b>Control (n = 472):</b> ertapenem 1 g iv every 24 h ± vancomycin </p> <p><b>Treatment duration:</b> 28 days for the main study and 42 days for sub study in participants with osteomyelitis </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome</b> </p> <p> <ul id="CD009061-lst1-0033"> <li> <p><i>C</i>linical response at TOC visit (12‐92 days) in participants without osteomyelitis </p> </li> </ul> </p> <p><b>Secondary outcomes</b> </p> <p> <ul id="CD009061-lst1-0034"> <li> <p><i>C</i>linical response rate at TOC visit (25‐27 weeks after last dose) in people with osteomyelitis (sub study) </p> </li> <li> <p>Microbiologic response of eradication at TOC visit (after 12 days<i>)</i> </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Funding source:</b> sponsored by Pfizer Inc, 7 authors were employees of Pfizer </p> <p><b>Other:</b> sample size calculation not reported; the sub study was underpowered </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Computer generated. participants stratified by the presence or absence of osteomyelitis and by infection severity (grade 2‐3 vs 4) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trans‐telephonic randomizations</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not ITT analysis: 11 participants did not receive the study drug and were not considered in the analysis (MITT: Modified ITT) but there were no differences between groups </p> <p>Withdrawals were similar between groups and reasons reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Available protocol: NCT00366249. Same outcomes as those reported in the protocol</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Described as double‐blinded. Dose adjustment was done by an unblinded dispenser at the request of the investigator at the investigational site’s standard of care </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A blinded investigator assessed the outcome</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lipsky 1990 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design</b>: single‐centred RCT, conducted in USA </p> <p><b>Follow‐up period:</b> 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 56 participants randomised (intervention: 27; control: 29) </p> <p><b>Sex (%male):</b> 100% </p> <p><b>Age (SE):</b> Intervention Group: 59.4 years 2.3); Control Group: 62.7 years (2.4) </p> <p><b>Inclusion criteria:</b> people with diabetes mellitus; lower extremity infections not threatening to life; not received systemic or topical antimicrobials within the preceding 2 weeks; all type of lesions </p> <p><b>Exclusion criteria:</b> systemic toxicity (high fever, hypotension, metabolic decompensation); infection threatening to life or limb (extensive cellulitis, lymphangitis, or necrosis; gangrene; crepitus or gas in tissues; presumed deep‐space infection or osteomyelitis); unable to perform daily wound care; non‐compliance; unwilling to visit; allergy to study drugs. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 27):</b> clindamycin hydrochloride 300 mg po every 6 h </p> <p><b>Control (n = 29):</b> cephalexin 500 mg po every 6 h </p> <p><b>Treatment duration</b>: 2 weeks </p> <p><b>Co‐interventions:</b> wound care with debridement and toenail removal if necessary </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD009061-lst1-0035"> <li> <p>Clinical response</p> </li> <li> <p>Microbiological response</p> </li> <li> <p>Size of ulceration</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Funding source:</b> Department of Veterans Affairs and a grant‐in‐aid from the Upjohn Company, Kalamazoo, Michigan, USA </p> <p><b>Other:</b> sample size calculation not performed </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A printed randomizations scheme was provided from the sponsor (Upjohn), but no information was provided about sequence generation </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No information was provided</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>60 participants randomised (29 Control Group vs 27 Intervention Group). 4 participants excluded (distribution between groups not reported) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes reported in methods section were reported in the results section. Primary outcome not identified </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Open‐label</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The physician investigators, who were blinded to the antibiotic regimen, determined the outcome of the infection </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lipsky 1997 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design:</b> randomised controlled trial, multicentre (12 centres), national (USA) </p> <p><b>Follow‐up period:</b> not described </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 180 participants randomised </p> <p><b>Age (mean (range)):</b> 61.5 years (31‐90) </p> <p><b>Sex (%men):</b> 84% </p> <p><b>Inclusion criteria:</b> ≥18 years; diabetes mellitus; foot infection requiring antibiotic therapy; purulent drainage or erythema or swelling </p> <p><b>Exclusion criteria:</b> osteomyelitis if all of the infected bone was not to be removed soon; presence of micro‐organisms resistant to the study drugs; underweight; seizures; major psychiatric disorder; pregnancy or lactation; renal replacement therapy; poor prognosis; antibiotic 48 h before study; antibiotic for any other reason; allergy to study drugs </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 55):</b> ofloxacin 400 mg iv every 12 h. Changed when appropriate to ofloxacin 400 mg po every 12 h </p> <p><b>Control (n = 53):</b> ampicillin‐sulbactam 1‐2 g/0.5‐1 g iv every 6 h (initial dose depended on severity). Switched to amoxicillin‐clavulanate 500 mg/125 mg po every 8 h when appropriate </p> <p><b>Co‐interventions:</b> wound care; additional antibiotic could be added if participant did not respond: in Intervention Group metronidazole added (n = 5); in Control Group, gentamicin, trimethoprim‐sulfamethoxazole or another (n = 42) </p> <p><b>Treatment duration:</b> 14‐28 days </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD009061-lst1-0036"> <li> <p>Clinical response</p> </li> <li> <p>Microbiological response</p> </li> <li> <p>Adverse events</p> </li> <li> <p>Superinfection</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Funding source:</b> Department of Veterans Affairs and the Robert Wood Johnson Pharmaceutical Research Institute </p> <p><b>Other:</b> no sample size calculation </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Described as randomised but the sequence generation was not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No information reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19% of participants excluded with no balanced reasons. No ITT analyses</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No data on superinfection. Author contacted and no data available</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Initial dose of ampicillin‐ofloxacin chosen by investigator</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No information reported</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lipsky 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design:</b> RCT, multicentre (45 centres), international </p> <p><b>Follow‐up period:</b> 15 to 21 days after treatment completed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 371 participants randomised </p> <p><b>Sex (%male):</b> 69% </p> <p><b>Age (mean (SD)):</b> Intervention Group: 63 years (12); Control Group: 62 years (13) </p> <p><b>Inclusion criteria:</b> men and women ≥ 18 years; with diabetes mellitus (American Diabetes Association definition) with food infection (≥1 of the following: cellulitis, paronychia, infected ulcer, deep soft‐tissue infection, septic arthritis, abscess, osteomyelitis). Could have been debrided </p> <p><b>Exclusion criteria:</b> amputation of all infected tissue; critical ischaemia in the affected limb unless revision from vascular surgeon; wound with prosthesis infection requiring &gt; 28 days of antibiotics; extensive gangrene; antibiotics &gt; 72 h in the week before; need of additional antibiotic; renal failure; neutropenia; pregnancy‐lactation; allergy to study drugs. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 241):</b> linezolid 600 mg iv or po every 12 h </p> <p><b>Control (n = 120):</b> ampicillin‐sulbactam 1.5‐3 g iv or po every 6 h or amoxicillin‐clavulanate 500mg‐875 mg iv or po every 8‐12 h. Addition of vancomycin (1 g iv every 12 h) if MRSA suspected </p> <p><b>Treatment duration</b>:≥ 7 days and ≤ 28 days </p> <p><b>Co‐interventions:</b> switch to aztreonam (1‐2 g iv every 8‐12 h) if Gram‐negative pathogens suspected (5% Intervention Group vs 2.5% Control Group) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD009061-lst1-0037"> <li> <p>Clinical response (cure, improvement, failure, missing intermediate)</p> </li> <li> <p>Safety</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Funding source:</b> Pharmacia Corporations and Department of Veterans Affairs; Pfizer </p> <p><b>Other:</b> sample size calculation not performed </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Described as randomised 2:1 ratio, but no details provided</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No details provided</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No ITT analysis. 16% vs 10% participants withdrew, reasons no reported</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The outcomes reported in the methods were the same reported in results</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Open‐label trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No data reported</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Noel 2008a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design:</b> multicentre (129 sites), international, RCT,non‐inferiority trial </p> <p><b>Follow‐up period:</b> 7‐14 days after the end of therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 828 participants randomised, 257 with DFI </p> <p>For all study participants:</p> <p><b>Sex (male):</b> Intervention Group: 63%; Control Group 64% </p> <p><b>Age (mean):</b> Intervention Group: 52.9 years; Control Group: 51.9 years </p> <p><b>Inclusion criteria:</b> ≥18 years with complicated SSSI. SSSI was defined as an infection involving subcutaneous tissues or requiring surgery that required iv therapy, along with one or more of the following: </p> <p> <ul id="CD009061-lst1-0038"> <li> <p>infection 30 days after surgery or trauma (including partial thickness burns over &lt; 10% body surface), with purulent drainage or ≥ 3 symptoms (temperature &gt; 38 ºC, swelling, erythema ≥ 10mm, pain or tenderness); </p> </li> <li> <p>abscess (without open wound) in the 7 days before with purulent drainage or aspirate and loculated fluid requiring intervention in within 48 h and with erythema and/or induration of ≥ 20 mm or with tenderness; </p> </li> <li> <p>cellulitis for 7 days before, with oedema, erythema or induration and 1 symptom (fever for 3 days before, WBC ≥ 10 x 10<sup>9</sup> cells/L or ≥ 10% bands, lymphangitis and adenopathy); </p> </li> <li> <p>in diabetic participants, a foot infection consisting of infra‐malleolar full‐skin‐thickness ulcer, cellulitis, myositis or tendonitis with ≥3 symptoms (swelling, erythema, tenderness or increased skin temperature). </p> </li> </ul> </p> <p><b>Exclusion criteria:</b> foreign body infection; osteomyelitis; critical limb ischaemia; septic arthritis </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 168):</b> ceftobiprole 500 mg for 120 minutes iv every 8 h </p> <p><b>Control (n = 89):</b> vancomycin 1000 mg iv every 12 h and ceftazidime 1000 mg iv every 8 h </p> <p>Empirical metronidazole for 48 h at discretion depending on culture results: used in 22 and 17 participants in the Intervention and Control Groups respectively </p> <p><b>Treatment duration:</b> 7‐14 days </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Principal outcome</b> </p> <p> <ul id="CD009061-lst1-0039"> <li> <p>Clinical cure rate at TOC visit (7‐14 days after the end of therapy)</p> </li> </ul> </p> <p><b>Secondary outcomes</b> </p> <p> <ul id="CD009061-lst1-0040"> <li> <p>Microbiological eradication rate at the TOC visit</p> </li> <li> <p>Safety and tolerability</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Funding source:</b> Johnson &amp; Johnson Pharmaceutical Research and Development. All study authors were employees of the funding company </p> <p><b>Other:</b> sample size calculation not performed </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomization was done via a central interactive voice response system</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomization was done via a central interactive voice response system</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8% and 10% of participants of each group did not complete the trial. The most common reason for not completing the trial was loss to follow‐up, which occurred for 3% of participants in both groups. The results of the evaluable participants' analysis were not different from the ITT analysis </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2 secondary outcomes described in the study protocol (NCT00210899) were not reported in the study: clinical cure rate and microbiological relapse rate at the late follow‐up visit </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Double‐blinded study. To ensure this, participants in the ceftobiprole group also received placebo in a manner that matched the vancomycin regimen. An unblinded pharmacist used coloured sleeves to blind the appearance of infusions </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Microbiological assessment was made centrally. An unblinded independent monitor checked the blinded staff at each site </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">RELIEF Study </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design:</b> multicentre (61 centres), international (Belgium, Bulgaria, Germany, Greece, Hungary, Israel, Latvia, Lithuania, Poland, Romania, Russia, South Africa, Spain, Ukraine and the UK), non‐inferiority RCT </p> <p><b>Follow‐up period:</b> 14‐28 days after last dose of study drug </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 813 participants randomised </p> <p><b>N participants with diabetes:</b> 223 </p> <p>For all study participants</p> <p><b>Sex (% male):</b> 64% </p> <p><b>Age (mean):</b> Intervention Group: 53.4 years; Control Group: 52.8 years </p> <p><b>Inclusion criteria:</b> men and women ≥ 18 years; with cSSI of 21 days’ duration and at least 3 of the following: purulent drainage or discharge; erythema of 1 cm from the wound edge; fluctuance, pain or tenderness to palpation; swelling or induration; fever; elevated WBC count &gt; 12000 mm³ or &gt; 15% immature neutrophils or C‐reactive protein &gt; 20 mg/L </p> <p><b>Exclusion criteria:</b> necrotizing fasciitis; burn wound infections; secondary infections of a chronic skin disease; infection of a prosthesis; if a surgical procedure alone was definitive, contraindications to the study drugs; poor prognosis; severe hepatic insufficiency (Child–Pugh C); or creatinine clearance &lt; 0.40 mL/min; lactation or pregnancy; neutropenia; lymphocytopenia; an AIDS defining event; antiretroviral therapy; chronic immunosuppressant therapy; antibacterial treatment for &gt; 24 h in the 7 days before; infection due to MRSA; MR‐<i>S&nbsp;epidermidis</i> or vancomycin‐resistant enterococci </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 123):</b> moxifloxacin 400 mg iv every 24 h + piperacillin‐tazobactam placebo iv every 8 h switched to* moxifloxacin 400 mg po every 24 h + amoxicillin‐clavulanic placebo po every 12 h </p> <p><b>Control (n = 110):</b> piperacillin/tazobactam 4.0 g/0.5 g iv every 8 h + moxifloxacin placebo iv every 24 h switched to* amoxicillin/clavulanate 875 mg/125 mg po every 12 h + moxifloxacin placebo po every 24 h </p> <p><b>*</b> Switch from iv to oral therapy was decided by the investigator but the participant had to be afebrile for ≥ 24 h and to have received iv therapy for ≥ 3 days </p> <p><b>Treatment duration:</b> 7‐21 days </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome</b> </p> <p> <ul id="CD009061-lst1-0041"> <li> <p>Clinical response at TOC (14‐28 days after last dose of study drug).</p> </li> </ul> </p> <p><b>Secondary outcomes</b> </p> <p> <ul id="CD009061-lst1-0042"> <li> <p>Bacteriological response at days 3‐5 (end of treatment) and TOC</p> </li> <li> <p>Safety</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Funding source:</b> Bayer Healthcare AG; 4 authors were employees of Bayer </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomization code generated by the sponsor</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interactive voice‐response system was used</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Sample size calculation that was reached</p> <p>No ITT analysis. Excluded from ITT population: 16% moxifloxacin group and 19% piperacillin‐tazobactam group </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The study protocol reported 2 assessment time points for the clinical efficacy endpoint (during, and end of treatment) apart from the TOC visit </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Double‐blind, double‐dummy</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Double‐blind, double‐dummy</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Saltoglu 2010 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design:</b> open label RCT, single centre </p> <p><b>Follow‐up period:</b> 2 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 68 randomised </p> <p><b>Sex (%male):</b> 47% </p> <p><b>Age (median):</b> Intervention Group: 58.3 years; Control Group: 58.5 years </p> <p><b>Inclusion criteria:</b> hospitalised adults (≥ 18 years), clinical diagnosis of moderate to severe diabetic lower extremity infection (Wagner scale 2‐4), caused by bacteria known or suspected to be susceptible to the antibiotics tested </p> <p><b>Exclusion criteria:</b> antibiotic treatment in the previous 48 h; hypersensitivity to study drugs; epilepsy; psychiatric illness; pregnancy or lactation </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 31):</b> piperacillin‐tazobactam 4.5 g iv every 8 h </p> <p><b>Control (n = 33):</b> imipenem‐cilastatin 500 mg iv every 6 h </p> <p><b>Treatment duration:</b> 14 days (28 days if osteomyelitis present) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome</b> </p> <p> <ul id="CD009061-lst1-0043"> <li> <p>Clinical response (cure/response)</p> </li> </ul> </p> <p><b>Secondary outcomes</b> </p> <p> <ul id="CD009061-lst1-0044"> <li> <p>Relapse rate</p> </li> <li> <p>Microbiological response</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Funding source: The study reported that it was</b> not funded by any pharmaceutical company or other source </p> <p><b>Other:</b> the trial was not registered, no sample size calculation performed </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random‐number table prepared by the university statistics department</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Independent randomisation. Phone call to randomise</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There were only 2 participants (one in each group) excluded as a result of an allergic reaction. No ITT analysis </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The outcomes defined in the methods section were the same as those reported in the results section. The study was not registered </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Open‐label study</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No data provided</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Siami 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design:</b> multicentre (3 centres), international RCT </p> <p><b>Follow‐up period:</b> 21 to 35 days post‐therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 409; 76 participants with DFI: Intervention Group: 42; Control Group: 34 </p> <p>For all included participants</p> <p><b>Sex (%men):</b> 294 (71.8%) </p> <p><b>Age (median):</b> Intervention Group: 52 years; Control Group: 54 years </p> <p><b>Inclusion criteria</b>: adults with severe or limb‐threatening SSTIs that required hospitalisation and iv therapy; acute (&lt; 5 days) physical findings of complicated SSTI of bacterial etiology and a diagnosis of spontaneous infection (phlegmon, cellulitis, lymphangitis), wound infections (trauma wound, surgical wound), or DFI; having material available for culture </p> <p><b>Exclusion criteria</b>: pregnancy or breastfeeding; hepatobiliary or renal dysfunction; immunodeficiency; risk of convulsive disorders; hypersensitivity to study drugs; septic shock; infected burns or decubitus ulcers; osteomyelitis; major amputation; more than a single dose of systemic antibacterial for the current SSTI; topical antibiotic the 24 h before baseline culture collection or actually requiring it; treatment with study medication 7 days prior or other investigational drug during the 4 weeks prior to the trial; corticosteroids or other antibacterial therapy for concomitant infections </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 213):</b> clinafloxacin 200 mg iv every 12 h changed to po every 12 h </p> <p><b>Control (n = 196):</b> piperacillin‐tazobactam 3.4 g in 30 min iv every 6 h changed to amoxicillin‐clavulanate 500 mg po every 8 h. Could also receive vancomycin iv if methicillin‐resistant staphylococci or enterococci were suspected or isolated </p> <p><b>Duration of treatment:</b> &lt; 14 days unless approved by sponsor. Change to po after minimum of 3 days of iv therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary efficacy outcomes</b> </p> <p> <ul id="CD009061-lst1-0045"> <li> <p>Clinical cure rate at TOC visit (6‐14 days post‐therapy)</p> </li> <li> <p>Microbiological eradication at TOC visit</p> </li> </ul> </p> <p><b>Secondary outcomes</b> </p> <p> <ul id="CD009061-lst1-0046"> <li> <p>Clinical cure rate at the long‐term follow‐up visit (21‐35 days post‐therapy)</p> </li> <li> <p>Microbiological eradication rate at the long‐term follow‐up visit</p> </li> <li> <p>Resistance, amputation rate, survival rate at long‐term follow‐up visit</p> </li> <li> <p>Safety</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Funding source:</b> Parke‐Davis Pharmaceutical Research; 2 authors were employees of Parke‐Davis Pharmaceutical Research </p> <p><b>Other:</b> sample size calculation performed </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The study was defined as randomised, but no details of sequence generation were provided</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No information provided</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Sample size accomplished. Similar percentages of participants completed the study treatment in both groups (69.5% and 74%), but more participants discontinued clinafloxacin prematurely because of adverse events (11.4 vs 6.3%, P value 0.05) and more discontinued piperacillin‐tazobactam due to treatment failure (8.7 vs 5.6, P value 0.25). 32.4% and 31.1% of participants of each group were not clinically evaluable, and the reasons were explained. No ITT analysis performed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The outcomes defined in the methods section were all reported in the results section</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>To ensure blinding, participants in the clinafloxacin group also received placebo infusions every 12 h. Defined as investigator‐blind study. To maintain investigator blinding during outpatient therapy, a third‐party member, not involved in assessing participant medical status, dispensed study medication and retrieved participant diaries </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No information provided</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">SIDESTEP Study </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design:</b> randomised, double‐blinded, non‐inferiority trial, multicentred </p> <p><b>Follow‐up period:</b> 10 days after the end of antibiotic therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 586 participants randomised </p> <p><b>Sex (%male):</b> 63.14% </p> <p><b>Age (median (min‐max)):</b> Intervention Group: 59 years (25‐90); Control Group: 57 years (22‐94) </p> <p><b>Inclusion criteria:</b> adults with diabetes mellitus (type 1 or 2) with foot infection that did not extend above the knee </p> <p><b>Exclusion criteria:</b> mild infections that did not require parenteral antibiotic therapy; infection caused by resistant pathogens; thermal burn; necrotizing fasciitis; osteomyelitis unless all the infected bone was removed within 48 h after initiating study therapy; infection complicated by prosthetic material; gangrenous tissue not removed; pregnancy; nursing; fertile women not using contraception; reaction to beta‐lactam antibiotic; need for additional antibacterial agents; secondary diabetes mellitus or impaired glucose tolerance; insufficient arterial perfusion requiring revascularization; rapidly progressive or terminal illness; dialysis; immunosuppression; corticosteroid therapy; abnormal liver function; haematocrit &lt; 25%; haemoglobin &lt; 8; platelet count &lt; 75000; coagulation test altered; more than 24 h of systemic antibiotic therapy within the 72 h before study screening </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 295):</b> ertapenem 1 g iv once daily </p> <p><b>Control (n = 291):</b> piperacillin/tazobactam 3.4 g iv every 6 h </p> <p><b>Treatment duration:</b> minimum of 5 days, then oral amoxicillin‐clavulanate (875 mg/125 mg every 12 h) could be given until day 28 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome</b> </p> <p> <ul id="CD009061-lst1-0047"> <li> <p>Favourable clinical response (cure or improvement) at discontinuation of iv treatment</p> </li> </ul> </p> <p><b>Secondary outcomes</b> </p> <p> <ul id="CD009061-lst1-0048"> <li> <p>Favourable clinical response at the follow‐up assessment (10 days after the last dose of study antibiotic) </p> </li> <li> <p>Adverse effects to treatment</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Funding source:</b> study funded by Merck and Co; the sponsor participated in study design, data collection, data analysis, data interpretation, and writing of the report; 2 study authors were employees of the sponsor </p> <p><b>Other:</b> participants with mild infections and with possible osteomyelitis were excluded </p> <p>Sample size calculation performed and reached</p> <p>Most of the participants received some oral antibiotic therapy after parenteral study medication </p> <p>Authors commented that the trial did not assess long‐term outcomes and this could have had an impact on the durability of infection resolution </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blocks of computer‐generated allocation numbers provided by the manufacturer</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>An unblinded pharmacist randomised participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Missing data, and their reasons, well reported and presented in a CONSORT flowchart. No differences between groups </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial report did not report a secondary variable described in the protocol</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N/A</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Described as double‐blinded. The intervention group was given a saline placebo every 6 h (double‐dummy). Quote: "The pharmacist was responsible for randomising participants (1:1 ratio), and prepared intravenous therapy to be administered by clinical personnel (unaware of treatment allocation)". </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The clinical personnel, who were unaware of treatment allocation, assessed the study's outcomes </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">STIC Study </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design</b>: Multicentre, multinational, non‐inferiority RCT (74 centres, 12 countries) </p> <p><b>Follow‐up period:</b> 14‐28 days </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 804 participants randomised; 134 participants with DFI </p> <p>For all included participants:</p> <p><b>Sex (%male):</b> 60.6% </p> <p><b>Age (mean):</b> Intervention Group: 52.1 years; Control Group: 51.0 years </p> <p><b>Inclusion criteria:</b> ≥ 18 years with a cSSSI or SSSI (DFI, necrotizing fasciitis, post‐surgical wound infection, complicated cellulitis, complicated erysipelas, major abscess of the skin, infection of traumatic lesion, and infected ischaemic ulcer) at one site only; requiring systemic antimicrobial therapy; sample culture taken within 24 h prior to inclusion </p> <p><b>Exclusion criteria:</b> uncomplicated mild‐to‐moderate SSSIs; secondary infected burns; atopic dermatitis; eczema; pregnancy; nursing; life expectancy &lt; 2 months; end‐stage liver cirrhosis; dialysis; septic shock; chronic immunosuppressant treatment; neutropenia ≤ 1000 cells/ml; AIDS with CD4 &lt; 200 cells/μl; HIV with highly activated antiretroviral treatment; syndromes of QTc prolongation or medication that increases the QTc; hypersensitivity to study drugs; tendinopathy with quinolones; SSSI secondary to prosthetic materials; &gt; 18% of the skin and soft tissue affected; osteomyelitis not related to DFI; requirement for systemic concomitant antibacterial agents; failure to respond to previous antibacterial treatment if it contained a fluoroquinolone, amoxicillin or a beta‐lactam/beta‐lactamase inhibitor combination; systemic antibacterial treatment for &gt; 24 h within the 24 h before enrolment </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 63)::</b>moxifloxacin 400 mg once daily iv followed by moxifloxacin 400 mg once daily po. </p> <p><b>Control (n = 71):</b> amoxicillin‐clavulanate 1000 mg/200 mg iv every 8 h followed by amoxicillin‐clavulanate 500 mg/125 mg po every 8 h </p> <p>Switch from iv to po therapy was decided by the investigator based on clinical response</p> <p><b>Treatment duration:</b> iv for at least 3 days; po for 7‐21 days </p> <p><b>Co‐interventions:</b> surgery at investigator's discretion </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome</b> </p> <p> <ul id="CD009061-lst1-0049"> <li> <p>Clinical response at the TOC visit (14‐28 days)</p> </li> </ul> </p> <p><b>Secondary outcome</b> </p> <p> <ul id="CD009061-lst1-0050"> <li> <p>Bacteriological response</p> </li> <li> <p>Safety</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Financial source:</b> Bayer; 4 authors were employees of Bayer </p> <p><b>Other:</b> sample size calculation not reported </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The study was defined as randomised. No additional data described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The study was defined as randomised. No additional data described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No sample size calculation described. Reasons for withdrawal were described and there were no differences between groups (P value &gt; 0.1) </p> <p>Failures were carried forward for the efficacy analysis; ITT and per protocol analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Only data on TOC assessment (14‐28 days) reported. Other assessments were made but not reported: prior to therapy, during treatment (days 1‐3), and day of switch to po </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Open‐label</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Evaluations were performed by investigators (unblinded)</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Tan 1993 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Design:</b> multicentred RCT </p> <p><b>Follow‐up period:</b> 10‐14 days after the completion of therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>N:</b> 251participants randomised; 63 participants with DFIs </p> <p>For all included participants (not only participants with DFIs):</p> <p><b>Sex (%male):</b> 75% (piperacillin‐tazobactam group); 70% (ticarcillin‐clavulante group)‐ </p> <p><b>Age (mean):</b> 52‐53 years </p> <p><b>Inclusion criteria:</b> ≥ 16 years; cSSSI or SSSI (cellulitis with drainage or fluid collection, cutaneous abscess, wound infection, ischaemic or DFI and acute infections of decubitus ulcers); purulent drainage or collection, and at least 2 of the following: fever, &gt; 10,000/mm³ leukocyte count with &gt; 5% immature neutrophils, erythema, swelling, tenderness, pain, or fluctuance </p> <p><b>Exclusion criteria:</b> hypersensitivity to beta‐lactam antibiotics or beta‐lactamase inhibitors; renal dysfunction; active liver disease; leukopenia or thrombocytopenia; &gt; 2 doses of another antibacterial agent in the last 72 h; another investigational drug in the last month; leukaemia; AIDS; dialysis; plasmapheresis; haemoperfusion; osteomyelitis; requirement for amputation; pressure ulcer infections with duration &gt; 2 weeks; concomitant infections </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention (n = 32):</b> piperacillin‐tazobactam 3 g/375 mg iv every 6 h </p> <p><b>Control (n = 31):</b> ticarcillin‐clavulanate 3 g/100 mg iv every 6 h </p> <p><b>Treatment duration:</b> minimum of 5 days and for at least 48 h after the resolution of signs and symptoms </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD009061-lst1-0051"> <li> <p>Clinical response</p> </li> <li> <p>Bacteriological response</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Funding source:</b> supported by Lederle/American Cyanamid </p> <p><b>Other:</b> sample size calculation performed </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Computer‐generated schedule 3:2 ratio</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No information provided</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Sample size calculation not reached. 55.5% of randomised participants were considered not evaluable. The reasons were comparable between the 2 treatment groups. ITT analysis only for the general population but not for subgroups </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The outcomes reported in the methods section were reported in the results section too, but results at early follow‐up were not reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Described as double‐blinded but no further information provided</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No information provided</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>Abbreviations</b> </p> <p>CD4: cluster of differentiation 4 (glycoprotein)<br> cSSSI: complicated skin and skin structure infection<br> DFI: diabetic foot infection<br> h: hour(s)<br> ITT: intention‐to‐treat (analysis)<br> iv: intravascular<br> max: maximum<br> min: minimum<br> MR: meticillin‐resistant<br> MRSA: meticillin‐resistant <i>Staphylococcus aureus</i> <br> po: per oral (by mouth)<br> QTc: corrected QT interval (measurement of heartbeat)<br> SSSI: skin and skin structure infection<br> SSTI: skin and soft tissue infection<br> TOC: test‐of‐cure<br> WBC: white blood cell </p> </div> </div> </p> </section> <section class="characteristicsOfExcludedStudies" lang=""> <div class="section-header" id="CD009061-sec2-0029"> <h3 class="title">Characteristics of excluded studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD009061-sec2-0028" class="jump-to">included studies</a></li> <li><a href="#CD009061-sec2-0030" class="jump-to">ongoing studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reason for exclusion</p> </td> </tr> </thead> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0021">Acevedo 1990</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not an RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0022">Akova 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not an RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0023">Al‐Ebous 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data for participants with DFI unavailable</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0024">Beam 1989</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not an RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0025">Bradsher 1984</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data for participants with DFI unavailable for the main outcome (clinical evaluation).</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0026">Cenizal 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>People with DFIs excluded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0027">Chantelau 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The study did not evaluate any of the systematic review's&nbsp; main&nbsp; outcomes</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0028">Chen 2013</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Review assessed for locating RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0029">Crouzet 2011</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Review assessed for locating RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0030">Daniel 1999</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data for participants with DFI unavailable</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0031">Darwish 1993</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The study did not evaluate systemic antibiotics</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0032">Deresinski 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The study described 2 trials, one included in the review, and the other did not fill the inclusion criteria </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0033">Edmonds 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Review assessed for locating RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0034">Embil 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data for participants with DFI unavailable</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0035">Fernández Montequín 1991</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study with participants post‐amputation</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0036">File 1983</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data for participants with DFI unavailable</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0037">File 1994</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Review assessed for locating RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0038">Foster 1998</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The study was in people with foot ulcers but no infection</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0039">Gentry 1989a</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data for participants with DFI unavailable</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0040">Gentry 1989b</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data for participants with DFI unavailable</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0041">Hughes 1987</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data for participants with DFI unavailable</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0042">Itani 2010</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data for participants with DFI unavailable</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0043">Joshi 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not an RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0044">Lipksy 2011</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Review assessed for locating RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0045">Lipsky 1999a</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data for participants with DFI unavailable</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0046">Nelson 2006b</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Review assessed for locating RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0047">Noel 2008b</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data for participants with DFI unavailable</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0049">Peters 2012</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Review assessed for locating RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0050">Peterson 1989</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data for participants with DFI unavailable</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0048">Pérez‐Ruvalcaba 1987</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data for participants with DFI unavailable</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0051">Siami 2002</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data for participants with DFI unavailable</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0052">Siebert 1985</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Only 2 participants with DFI and both treated with the same antimicrobial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0053">Smith 1992</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The abstract was published approximately 20 years ago; it contained no usable data and appears not to have been published in full subsequently </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0054">Smith 1993</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data for participants with DFI unavailable</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0055">Stevens 1999</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data for participants with DFI unavailable</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0056">Stevens 2000</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>People with diabetic foot ulcer excluded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0057">Stevens 2002</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>People with diabetic foot ulcer excluded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0058">Stupin 2014</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Open clinical trial without randomisation</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0059">Vardakas 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Review assessed for locating RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD009061-bbs2-0060">Weigelt 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data for participants with DFI unavailable</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>Abbreviations</b> </p> <p>DFI: diabetic foot infection<br> RCT: randomised controlled trial </p> </div> </div> </p> </section> <section class="characteristicsOfOngoingStudies" lang=""> <div class="section-header" id="CD009061-sec2-0030"> <h3 class="title">Characteristics of ongoing studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD009061-sec2-0028" class="jump-to">included studies</a></li> <li><a href="#CD009061-sec2-0029" class="jump-to">excluded studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">NCT01199783 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Application of daptomycin in MRSA infected diabetic foot in comparison to vancomycin treatment </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Phase III RCT, parallel assignment, open‐label</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Men and women (age 18‐80 years) with type 1 or type 2 diabetes mellitus and MRSA infected foot ulcers Wagner grades 1‐2 without primary surgical intervention </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention:</b> daptomycin infusion 6 mg/kg/bodyweight once daily </p> <p><b>Control:</b> vancomycin once daily (effective blood‐plasma concentration of 15 mg/L) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome</b> </p> <p> <ul id="CD009061-lst1-0052"> <li> <p>Clinical response of the infection at the TOC at day 14 post‐therapy</p> </li> </ul> </p> <p><b>Secondary outcomes</b> </p> <p> <ul id="CD009061-lst1-0053"> <li> <p>Duration of therapy</p> </li> <li> <p>Time to cure in days</p> </li> <li> <p>Therapy related complications</p> </li> <li> <p>Number of successful treatments at TOC: from clinician point of view and from microbiological analysis </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>July 2011</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Diethelm Tschoepe, Prof Dr Dr Ruhr University of Bochum</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Estimated study completion date: December 2013. No publication available</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">NCT01370616 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A phase III, randomized, double‐blind, active comparator‐controlled clinical trial to study the efficacy and safety of ertapenem sodium (MK‐0826) versus piperacillin/tazobactam sodium in the treatment of diabetic foot infections in Chinese adults </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Phase III RCT, parallel assignment, double‐blind</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Chinese participants with type I or II diabetes mellitus with clinically ‐ or bacteriologically ‐ documented moderate‐to‐severe (non‐life‐threatening) DFI that requires treatment with iv antibiotics </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention:</b> ertapenem sodium 1.0 g iv daily and piperacillin‐tazobactam‐matching placebo for 5 to 28 days </p> <p><b>Control:</b> piperacillin‐tazobactam sodium 4.5 g iv every 6 h for 5 to 28 days </p> <p>Participants in both groups could be switched to oral antibiotics beginning on day 6 if clinically indicated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcomes</b> </p> <p> <ul id="CD009061-lst1-0054"> <li> <p>Number of participants with clinical improvement of cure at the discontinuation of intravenous therapy visit </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>September 2011</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not provided. Responsible party and study sponsor: Merck Sharp &amp; Dohme Corp</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Primary completion date: December 2013. No publication available</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>Abbreviations</b> </p> <p>DFI: diabetic foot infection<br> iv: intravenous<br> MRSA: meticillin‐resistant <i>Staphylococcus aureus</i> <br> TOC: test‐of‐cure </p> </div> </div> </p> </section> </section> <section class="dataAndAnalyses" id="dataAndAnalyses"> <section class="dataAndAnalyses" lang="en"> <div class="section-header section-collapse-header" id="CD009061-sec1-0010"> <h2 class="title section-collapse-title">Data and analyses<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <div class="table" id="CD009061-tbl-0001"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">A. Anti‐pseudomonas penicillins: piperacillin‐tazobactam vs ticarcillin‐clavulanate</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>63</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.16 [0.59, 2.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00101"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-001-01.png?filename=nCD009061-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20A.%20Anti%E2%80%90pseudomonas%20penicillins%3A%20piperacillin%E2%80%90tazobactam%20vs%20ticarcillin%E2%80%90clavulanate%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.1</div> </div> <hr class="top"><img data-id="CD009061-fig-00101" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-001-01.png" alt="Comparison 1 A. Anti‐pseudomonas penicillins: piperacillin‐tazobactam vs ticarcillin‐clavulanate, Outcome 1 Clinical resolution of the infection."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 A. Anti‐pseudomonas penicillins: piperacillin‐tazobactam vs ticarcillin‐clavulanate, Outcome 1 Clinical resolution of the infection. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009061-tbl-0002"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs ampicillin‐sulbactam</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>314</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.02 [0.86, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00201"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-002-01.png?filename=nCD009061-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20A.%20Anti%E2%80%90pseudomonal%20penicillins%3A%20piperacillin%E2%80%90tazobactam%20vs%20ampicillin%E2%80%90sulbactam%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.1</div> </div> <hr class="top"><img data-id="CD009061-fig-00201" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-002-01.png" alt="Comparison 2 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs ampicillin‐sulbactam, Outcome 1 Clinical resolution of the infection."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs ampicillin‐sulbactam, Outcome 1 Clinical resolution of the infection. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00202"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-002-02.png?filename=nCD009061-CMP-002-02.ppt&amp;title=2.2&amp;caption=Comparison%202%20A.%20Anti%E2%80%90pseudomonal%20penicillins%3A%20piperacillin%E2%80%90tazobactam%20vs%20ampicillin%E2%80%90sulbactam%2C%20Outcome%202%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.2</div> </div> <hr class="top"><img data-id="CD009061-fig-00202" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-002-02.png" alt="Comparison 2 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs ampicillin‐sulbactam, Outcome 2 Adverse effects."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs ampicillin‐sulbactam, Outcome 2 Adverse effects. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Any adverse event</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>314</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.14 [0.99, 1.32]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Treatment‐related adverse event</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>314</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.42 [0.85, 2.37]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.3 Serious adverse event</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>314</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.94 [0.66, 1.34]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Amputations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>314</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.97 [0.51, 1.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00203"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-002-03.png?filename=nCD009061-CMP-002-03.ppt&amp;title=2.3&amp;caption=Comparison%202%20A.%20Anti%E2%80%90pseudomonal%20penicillins%3A%20piperacillin%E2%80%90tazobactam%20vs%20ampicillin%E2%80%90sulbactam%2C%20Outcome%203%20Amputations.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.3</div> </div> <hr class="top"><img data-id="CD009061-fig-00203" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-002-03.png" alt="Comparison 2 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs ampicillin‐sulbactam, Outcome 3 Amputations."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs ampicillin‐sulbactam, Outcome 3 Amputations. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009061-tbl-0003"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.66 [0.84, 3.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00301"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-003-01.png?filename=nCD009061-CMP-003-01.ppt&amp;title=3.1&amp;caption=Comparison%203%20A.%20Anti%E2%80%90pseudomonal%20penicillins%3A%20piperacillin%E2%80%90tazobactam%20vs%20imipenem%E2%80%90cilastatin%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.1</div> </div> <hr class="top"><img data-id="CD009061-fig-00301" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-003-01.png" alt="Comparison 3 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin, Outcome 1 Clinical resolution of the infection."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin, Outcome 1 Clinical resolution of the infection. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>320</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.50 [1.56, 7.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00302"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-003-02.png?filename=nCD009061-CMP-003-02.ppt&amp;title=3.2&amp;caption=Comparison%203%20A.%20Anti%E2%80%90pseudomonal%20penicillins%3A%20piperacillin%E2%80%90tazobactam%20vs%20imipenem%E2%80%90cilastatin%2C%20Outcome%202%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.2</div> </div> <hr class="top"><img data-id="CD009061-fig-00302" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-003-02.png" alt="Comparison 3 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin, Outcome 2 Adverse effects."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin, Outcome 2 Adverse effects. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Any adverse event</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.19 [0.95, 10.72]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Hepatotoxicity</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.32 [0.66, 43.05]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.3 Nephrotoxicity</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.39 [0.81, 50.09]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.4 Hematological side effects</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.31 [0.27, 106.46]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.5 Nausea</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.35 [0.01, 8.38]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Amputations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.87 [0.59, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00303"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-003-03.png?filename=nCD009061-CMP-003-03.ppt&amp;title=3.3&amp;caption=Comparison%203%20A.%20Anti%E2%80%90pseudomonal%20penicillins%3A%20piperacillin%E2%80%90tazobactam%20vs%20imipenem%E2%80%90cilastatin%2C%20Outcome%203%20Amputations.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.3</div> </div> <hr class="top"><img data-id="CD009061-fig-00303" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-003-03.png" alt="Comparison 3 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin, Outcome 3 Amputations."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin, Outcome 3 Amputations. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Recurrence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.31 [0.27, 106.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00304"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-003-04.png?filename=nCD009061-CMP-003-04.ppt&amp;title=3.4&amp;caption=Comparison%203%20A.%20Anti%E2%80%90pseudomonal%20penicillins%3A%20piperacillin%E2%80%90tazobactam%20vs%20imipenem%E2%80%90cilastatin%2C%20Outcome%204%20Recurrence.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.4</div> </div> <hr class="top"><img data-id="CD009061-fig-00304" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-003-04.png" alt="Comparison 3 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin, Outcome 4 Recurrence."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin, Outcome 4 Recurrence. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009061-tbl-0004"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">B. Broad‐spectrum penicillins: ampicillin‐sulbactam vs cefoxitin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>36</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.14 [0.02, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00401"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-004-01.png?filename=nCD009061-CMP-004-01.ppt&amp;title=4.1&amp;caption=Comparison%204%20B.%20Broad%E2%80%90spectrum%20penicillins%3A%20ampicillin%E2%80%90sulbactam%20vs%20cefoxitin%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.1</div> </div> <hr class="top"><img data-id="CD009061-fig-00401" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-004-01.png" alt="Comparison 4 B. Broad‐spectrum penicillins: ampicillin‐sulbactam vs cefoxitin, Outcome 1 Clinical resolution of the infection."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 B. Broad‐spectrum penicillins: ampicillin‐sulbactam vs cefoxitin, Outcome 1 Clinical resolution of the infection. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>36</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.17 [0.49, 2.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00402"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-004-02.png?filename=nCD009061-CMP-004-02.ppt&amp;title=4.2&amp;caption=Comparison%204%20B.%20Broad%E2%80%90spectrum%20penicillins%3A%20ampicillin%E2%80%90sulbactam%20vs%20cefoxitin%2C%20Outcome%202%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.2</div> </div> <hr class="top"><img data-id="CD009061-fig-00402" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-004-02.png" alt="Comparison 4 B. Broad‐spectrum penicillins: ampicillin‐sulbactam vs cefoxitin, Outcome 2 Adverse effects."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 B. Broad‐spectrum penicillins: ampicillin‐sulbactam vs cefoxitin, Outcome 2 Adverse effects. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Amputations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>36</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.0 [0.48, 2.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00403"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-004-03.png?filename=nCD009061-CMP-004-03.ppt&amp;title=4.3&amp;caption=Comparison%204%20B.%20Broad%E2%80%90spectrum%20penicillins%3A%20ampicillin%E2%80%90sulbactam%20vs%20cefoxitin%2C%20Outcome%203%20Amputations.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.3</div> </div> <hr class="top"><img data-id="CD009061-fig-00403" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-004-03.png" alt="Comparison 4 B. Broad‐spectrum penicillins: ampicillin‐sulbactam vs cefoxitin, Outcome 3 Amputations."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 B. Broad‐spectrum penicillins: ampicillin‐sulbactam vs cefoxitin, Outcome 3 Amputations. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009061-tbl-0005"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 5.</span>&nbsp;<span class="table-title">C. Cephalosporins: ceftobiprole vs ceftazidime + vancomycin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>257</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.05 [0.90, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00501"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-005-01.png?filename=nCD009061-CMP-005-01.ppt&amp;title=5.1&amp;caption=Comparison%205%20C.%20Cephalosporins%3A%20ceftobiprole%20vs%20ceftazidime%20%2B%20vancomycin%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 5.1</div> </div> <hr class="top"><img data-id="CD009061-fig-00501" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-005-01.png" alt="Comparison 5 C. Cephalosporins: ceftobiprole vs ceftazidime + vancomycin, Outcome 1 Clinical resolution of the infection."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 5 C. Cephalosporins: ceftobiprole vs ceftazidime + vancomycin, Outcome 1 Clinical resolution of the infection. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009061-tbl-0006"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 6.</span>&nbsp;<span class="table-title">C. Cephalosporins: ceftriaxone + metronidazole vs ticarcillin‐clavulanate</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>70</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.94 [0.72, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00601"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-006-01.png?filename=nCD009061-CMP-006-01.ppt&amp;title=6.1&amp;caption=Comparison%206%20C.%20Cephalosporins%3A%20ceftriaxone%20%2B%20metronidazole%20vs%20ticarcillin%E2%80%90clavulanate%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 6.1</div> </div> <hr class="top"><img data-id="CD009061-fig-00601" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-006-01.png" alt="Comparison 6 C. Cephalosporins: ceftriaxone + metronidazole vs ticarcillin‐clavulanate, Outcome 1 Clinical resolution of the infection."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 6 C. Cephalosporins: ceftriaxone + metronidazole vs ticarcillin‐clavulanate, Outcome 1 Clinical resolution of the infection. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009061-tbl-0007"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 7.</span>&nbsp;<span class="table-title">D. Carbapenems: ertapenem vs piperacillin‐tazobactam</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>684</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.07 [0.96, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00701"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-007-01.png?filename=nCD009061-CMP-007-01.ppt&amp;title=7.1&amp;caption=Comparison%207%20D.%20Carbapenems%3A%20ertapenem%20vs%20piperacillin%E2%80%90tazobactam%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.1</div> </div> <hr class="top"><img data-id="CD009061-fig-00701" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-007-01.png" alt="Comparison 7 D. Carbapenems: ertapenem vs piperacillin‐tazobactam, Outcome 1 Clinical resolution of the infection."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 D. Carbapenems: ertapenem vs piperacillin‐tazobactam, Outcome 1 Clinical resolution of the infection. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00702"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-007-02.png?filename=nCD009061-CMP-007-02.ppt&amp;title=7.2&amp;caption=Comparison%207%20D.%20Carbapenems%3A%20ertapenem%20vs%20piperacillin%E2%80%90tazobactam%2C%20Outcome%202%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.2</div> </div> <hr class="top"><img data-id="CD009061-fig-00702" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-007-02.png" alt="Comparison 7 D. Carbapenems: ertapenem vs piperacillin‐tazobactam, Outcome 2 Adverse effects."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 D. Carbapenems: ertapenem vs piperacillin‐tazobactam, Outcome 2 Adverse effects. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Drug related adverse effects</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>586</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.76 [0.53, 1.09]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Diarrhoea</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>586</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.58 [0.36, 0.93]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.3 Nausea</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>586</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.83 [0.44, 1.58]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.4 Headache</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>586</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.62 [0.28, 1.34]</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009061-tbl-0008"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 8.</span>&nbsp;<span class="table-title">D. Carbapenems: imipenem‐cilastatin vs piperacillin + clindamycin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>46</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.73 [0.24, 2.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00801"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-008-01.png?filename=nCD009061-CMP-008-01.ppt&amp;title=8.1&amp;caption=Comparison%208%20D.%20Carbapenems%3A%20imipenem%E2%80%90cilastatin%20vs%20piperacillin%20%2B%20clindamycin%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.1</div> </div> <hr class="top"><img data-id="CD009061-fig-00801" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-008-01.png" alt="Comparison 8 D. Carbapenems: imipenem‐cilastatin vs piperacillin + clindamycin, Outcome 1 Clinical resolution of the infection."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 D. Carbapenems: imipenem‐cilastatin vs piperacillin + clindamycin, Outcome 1 Clinical resolution of the infection. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>46</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.27 [0.09, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00802"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-008-02.png?filename=nCD009061-CMP-008-02.ppt&amp;title=8.2&amp;caption=Comparison%208%20D.%20Carbapenems%3A%20imipenem%E2%80%90cilastatin%20vs%20piperacillin%20%2B%20clindamycin%2C%20Outcome%202%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.2</div> </div> <hr class="top"><img data-id="CD009061-fig-00802" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-008-02.png" alt="Comparison 8 D. Carbapenems: imipenem‐cilastatin vs piperacillin + clindamycin, Outcome 2 Adverse effects."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 D. Carbapenems: imipenem‐cilastatin vs piperacillin + clindamycin, Outcome 2 Adverse effects. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Recurrence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>46</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.61 [0.42, 139.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00803"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-008-03.png?filename=nCD009061-CMP-008-03.ppt&amp;title=8.3&amp;caption=Comparison%208%20D.%20Carbapenems%3A%20imipenem%E2%80%90cilastatin%20vs%20piperacillin%20%2B%20clindamycin%2C%20Outcome%203%20Recurrence.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.3</div> </div> <hr class="top"><img data-id="CD009061-fig-00803" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-008-03.png" alt="Comparison 8 D. Carbapenems: imipenem‐cilastatin vs piperacillin + clindamycin, Outcome 3 Recurrence."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 D. Carbapenems: imipenem‐cilastatin vs piperacillin + clindamycin, Outcome 3 Recurrence. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009061-tbl-0009"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 9.</span>&nbsp;<span class="table-title">D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection at the completion of therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>96</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.95 [0.80, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00901"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-009-01.png?filename=nCD009061-CMP-009-01.ppt&amp;title=9.1&amp;caption=Comparison%209%20D.%20Carbapenems%3A%20imipenem%E2%80%90cilastatin%20vs%20ampicillin%E2%80%90sulbactam%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection%20at%20the%20completion%20of%20therapy.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 9.1</div> </div> <hr class="top"><img data-id="CD009061-fig-00901" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-009-01.png" alt="Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 1 Clinical resolution of the infection at the completion of therapy."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 1 Clinical resolution of the infection at the completion of therapy. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Clinical resolution of the infection at the end of follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>96</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.82 [0.60, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00902"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-009-02.png?filename=nCD009061-CMP-009-02.ppt&amp;title=9.2&amp;caption=Comparison%209%20D.%20Carbapenems%3A%20imipenem%E2%80%90cilastatin%20vs%20ampicillin%E2%80%90sulbactam%2C%20Outcome%202%20Clinical%20resolution%20of%20the%20infection%20at%20the%20end%20of%20follow%E2%80%90up.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 9.2</div> </div> <hr class="top"><img data-id="CD009061-fig-00902" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-009-02.png" alt="Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 2 Clinical resolution of the infection at the end of follow‐up."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 2 Clinical resolution of the infection at the end of follow‐up. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00903"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-009-03.png?filename=nCD009061-CMP-009-03.ppt&amp;title=9.3&amp;caption=Comparison%209%20D.%20Carbapenems%3A%20imipenem%E2%80%90cilastatin%20vs%20ampicillin%E2%80%90sulbactam%2C%20Outcome%203%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 9.3</div> </div> <hr class="top"><img data-id="CD009061-fig-00903" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-009-03.png" alt="Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 3 Adverse effects."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 3 Adverse effects. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Total adverse effects</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>96</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.06 [0.61, 1.85]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 Significant adverse effects</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>96</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.29 [0.52, 3.17]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Amputations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>96</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.85 [0.62, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00904"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-009-04.png?filename=nCD009061-CMP-009-04.ppt&amp;title=9.4&amp;caption=Comparison%209%20D.%20Carbapenems%3A%20imipenem%E2%80%90cilastatin%20vs%20ampicillin%E2%80%90sulbactam%2C%20Outcome%204%20Amputations.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 9.4</div> </div> <hr class="top"><img data-id="CD009061-fig-00904" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-009-04.png" alt="Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 4 Amputations."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 4 Amputations. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Recurrence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>96</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.71 [0.42, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-00905"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-009-05.png?filename=nCD009061-CMP-009-05.ppt&amp;title=9.5&amp;caption=Comparison%209%20D.%20Carbapenems%3A%20imipenem%E2%80%90cilastatin%20vs%20ampicillin%E2%80%90sulbactam%2C%20Outcome%205%20Recurrence.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 9.5</div> </div> <hr class="top"><img data-id="CD009061-fig-00905" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-009-05.png" alt="Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 5 Recurrence."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 5 Recurrence. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009061-tbl-0010"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 10.</span>&nbsp;<span class="table-title">E. Fluoroquinolones: fourth‐generation fluoroquinolones vs anti‐pseudomonal penicillins</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>387</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.03 [0.89, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-01001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-010-01.png?filename=nCD009061-CMP-010-01.ppt&amp;title=10.1&amp;caption=Comparison%2010%20E.%20Fluoroquinolones%3A%20fourth%E2%80%90generation%20fluoroquinolones%20vs%20anti%E2%80%90pseudomonal%20penicillins%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 10.1</div> </div> <hr class="top"><img data-id="CD009061-fig-01001" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-010-01.png" alt="Comparison 10 E. Fluoroquinolones: fourth‐generation fluoroquinolones vs anti‐pseudomonal penicillins, Outcome 1 Clinical resolution of the infection."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 10 E. Fluoroquinolones: fourth‐generation fluoroquinolones vs anti‐pseudomonal penicillins, Outcome 1 Clinical resolution of the infection. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009061-tbl-0011"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 11.</span>&nbsp;<span class="table-title">E. Fluoroquinolones: moxifloxacin vs amoxicillin‐clavulanate</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>134</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.79 [0.57, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-01101"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-011-01.png?filename=nCD009061-CMP-011-01.ppt&amp;title=11.1&amp;caption=Comparison%2011%20E.%20Fluoroquinolones%3A%20moxifloxacin%20vs%20amoxicillin%E2%80%90clavulanate%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 11.1</div> </div> <hr class="top"><img data-id="CD009061-fig-01101" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-011-01.png" alt="Comparison 11 E. Fluoroquinolones: moxifloxacin vs amoxicillin‐clavulanate, Outcome 1 Clinical resolution of the infection."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 11 E. Fluoroquinolones: moxifloxacin vs amoxicillin‐clavulanate, Outcome 1 Clinical resolution of the infection. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009061-tbl-0012"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 12.</span>&nbsp;<span class="table-title">E. Fluoroquinolones: third‐generation fluoroquinolone vs extended‐spectrum penicillin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>67</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.97 [0.60, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-01201"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-012-01.png?filename=nCD009061-CMP-012-01.ppt&amp;title=12.1&amp;caption=Comparison%2012%20E.%20Fluoroquinolones%3A%20third%E2%80%90generation%20fluoroquinolone%20vs%20extended%E2%80%90spectrum%20penicillin%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 12.1</div> </div> <hr class="top"><img data-id="CD009061-fig-01201" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-012-01.png" alt="Comparison 12 E. Fluoroquinolones: third‐generation fluoroquinolone vs extended‐spectrum penicillin, Outcome 1 Clinical resolution of the infection."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 12 E. Fluoroquinolones: third‐generation fluoroquinolone vs extended‐spectrum penicillin, Outcome 1 Clinical resolution of the infection. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009061-tbl-0013"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 13.</span>&nbsp;<span class="table-title">E. Fluoroquinolones: second‐generation fluoroquinolone vs extended‐spectrum penicillin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>108</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.13 [0.88, 1.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-01301"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-013-01.png?filename=nCD009061-CMP-013-01.ppt&amp;title=13.1&amp;caption=Comparison%2013%20E.%20Fluoroquinolones%3A%20second%E2%80%90generation%20fluoroquinolone%20vs%20extended%E2%80%90spectrum%20penicillin%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 13.1</div> </div> <hr class="top"><img data-id="CD009061-fig-01301" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-013-01.png" alt="Comparison 13 E. Fluoroquinolones: second‐generation fluoroquinolone vs extended‐spectrum penicillin, Outcome 1 Clinical resolution of the infection."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 13 E. Fluoroquinolones: second‐generation fluoroquinolone vs extended‐spectrum penicillin, Outcome 1 Clinical resolution of the infection. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>108</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.82 [0.89, 3.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-01302"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-013-02.png?filename=nCD009061-CMP-013-02.ppt&amp;title=13.2&amp;caption=Comparison%2013%20E.%20Fluoroquinolones%3A%20second%E2%80%90generation%20fluoroquinolone%20vs%20extended%E2%80%90spectrum%20penicillin%2C%20Outcome%202%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 13.2</div> </div> <hr class="top"><img data-id="CD009061-fig-01302" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-013-02.png" alt="Comparison 13 E. Fluoroquinolones: second‐generation fluoroquinolone vs extended‐spectrum penicillin, Outcome 2 Adverse effects."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 13 E. Fluoroquinolones: second‐generation fluoroquinolone vs extended‐spectrum penicillin, Outcome 2 Adverse effects. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Amputations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>108</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.11 [0.01, 1.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-01303"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-013-03.png?filename=nCD009061-CMP-013-03.ppt&amp;title=13.3&amp;caption=Comparison%2013%20E.%20Fluoroquinolones%3A%20second%E2%80%90generation%20fluoroquinolone%20vs%20extended%E2%80%90spectrum%20penicillin%2C%20Outcome%203%20Amputations.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 13.3</div> </div> <hr class="top"><img data-id="CD009061-fig-01303" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-013-03.png" alt="Comparison 13 E. Fluoroquinolones: second‐generation fluoroquinolone vs extended‐spectrum penicillin, Outcome 3 Amputations."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 13 E. Fluoroquinolones: second‐generation fluoroquinolone vs extended‐spectrum penicillin, Outcome 3 Amputations. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009061-tbl-0014"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 14.</span>&nbsp;<span class="table-title">F. Other antibiotics: daptomycin vs control</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-01401"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-014-01.png?filename=nCD009061-CMP-014-01.ppt&amp;title=14.1&amp;caption=Comparison%2014%20F.%20Other%20antibiotics%3A%20daptomycin%20vs%20control%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 14.1</div> </div> <hr class="top"><img data-id="CD009061-fig-01401" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-014-01.png" alt="Comparison 14 F. Other antibiotics: daptomycin vs control, Outcome 1 Clinical resolution of the infection."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 14 F. Other antibiotics: daptomycin vs control, Outcome 1 Clinical resolution of the infection. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Daptomycin vs control</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>133</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.94 [0.68, 1.30]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-01402"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-014-02.png?filename=nCD009061-CMP-014-02.ppt&amp;title=14.2&amp;caption=Comparison%2014%20F.%20Other%20antibiotics%3A%20daptomycin%20vs%20control%2C%20Outcome%202%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 14.2</div> </div> <hr class="top"><img data-id="CD009061-fig-01402" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-014-02.png" alt="Comparison 14 F. Other antibiotics: daptomycin vs control, Outcome 2 Adverse effects."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 14 F. Other antibiotics: daptomycin vs control, Outcome 2 Adverse effects.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Advese effects related to treatment</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>133</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.61 [0.39, 0.94]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Severe adverse effects</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>133</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.20 [0.02, 1.59]</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009061-tbl-0015"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 15.</span>&nbsp;<span class="table-title">F. Other antibiotics: linezolid vs aminopenicillin + beta lactamase inhibitor</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>361</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.07 [0.91, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-01501"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-015-01.png?filename=nCD009061-CMP-015-01.ppt&amp;title=15.1&amp;caption=Comparison%2015%20F.%20Other%20antibiotics%3A%20linezolid%20vs%20aminopenicillin%20%2B%20beta%20lactamase%20inhibitor%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 15.1</div> </div> <hr class="top"><img data-id="CD009061-fig-01501" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-015-01.png" alt="Comparison 15 F. Other antibiotics: linezolid vs aminopenicillin + beta lactamase inhibitor, Outcome 1 Clinical resolution of the infection."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 15 F. Other antibiotics: linezolid vs aminopenicillin + beta lactamase inhibitor, Outcome 1 Clinical resolution of the infection. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>361</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.66 [1.49, 4.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-01502"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-015-02.png?filename=nCD009061-CMP-015-02.ppt&amp;title=15.2&amp;caption=Comparison%2015%20F.%20Other%20antibiotics%3A%20linezolid%20vs%20aminopenicillin%20%2B%20beta%20lactamase%20inhibitor%2C%20Outcome%202%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 15.2</div> </div> <hr class="top"><img data-id="CD009061-fig-01502" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-015-02.png" alt="Comparison 15 F. Other antibiotics: linezolid vs aminopenicillin + beta lactamase inhibitor, Outcome 2 Adverse effects."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 15 F. Other antibiotics: linezolid vs aminopenicillin + beta lactamase inhibitor, Outcome 2 Adverse effects. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009061-tbl-0016"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 16.</span>&nbsp;<span class="table-title">F. Other antibiotics: clindamycin vs cephalexin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>56</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.07 [0.79, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-01601"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-016-01.png?filename=nCD009061-CMP-016-01.ppt&amp;title=16.1&amp;caption=Comparison%2016%20F.%20Other%20antibiotics%3A%20clindamycin%20vs%20cephalexin%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 16.1</div> </div> <hr class="top"><img data-id="CD009061-fig-01601" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-016-01.png" alt="Comparison 16 F. Other antibiotics: clindamycin vs cephalexin, Outcome 1 Clinical resolution of the infection."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 16 F. Other antibiotics: clindamycin vs cephalexin, Outcome 1 Clinical resolution of the infection. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>56</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.47 [0.04, 4.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-01602"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-016-02.png?filename=nCD009061-CMP-016-02.ppt&amp;title=16.2&amp;caption=Comparison%2016%20F.%20Other%20antibiotics%3A%20clindamycin%20vs%20cephalexin%2C%20Outcome%202%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 16.2</div> </div> <hr class="top"><img data-id="CD009061-fig-01602" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-016-02.png" alt="Comparison 16 F. Other antibiotics: clindamycin vs cephalexin, Outcome 2 Adverse effects."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 16 F. Other antibiotics: clindamycin vs cephalexin, Outcome 2 Adverse effects.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Ulcer healing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>52</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 [0.59, 2.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-01603"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-016-03.png?filename=nCD009061-CMP-016-03.ppt&amp;title=16.3&amp;caption=Comparison%2016%20F.%20Other%20antibiotics%3A%20clindamycin%20vs%20cephalexin%2C%20Outcome%203%20Ulcer%20healing.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 16.3</div> </div> <hr class="top"><img data-id="CD009061-fig-01603" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-016-03.png" alt="Comparison 16 F. Other antibiotics: clindamycin vs cephalexin, Outcome 3 Ulcer healing."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 16 F. Other antibiotics: clindamycin vs cephalexin, Outcome 3 Ulcer healing.</p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009061-tbl-0017"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 17.</span>&nbsp;<span class="table-title">F. Other antibiotics: tigecycline vs ertapenem</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-01701"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-017-01.png?filename=nCD009061-CMP-017-01.ppt&amp;title=17.1&amp;caption=Comparison%2017%20F.%20Other%20antibiotics%3A%20tigecycline%20vs%20ertapenem%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 17.1</div> </div> <hr class="top"><img data-id="CD009061-fig-01701" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-017-01.png" alt="Comparison 17 F. Other antibiotics: tigecycline vs ertapenem, Outcome 1 Clinical resolution of the infection."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 17 F. Other antibiotics: tigecycline vs ertapenem, Outcome 1 Clinical resolution of the infection. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Patients without OM (main study)</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.09 [1.01, 1.18]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Patients with OM (sub study)</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>118</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.08 [1.27, 3.39]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-01702"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-017-02.png?filename=nCD009061-CMP-017-02.ppt&amp;title=17.2&amp;caption=Comparison%2017%20F.%20Other%20antibiotics%3A%20tigecycline%20vs%20ertapenem%2C%20Outcome%202%20Adverse%20events.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 17.2</div> </div> <hr class="top"><img data-id="CD009061-fig-01702" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-017-02.png" alt="Comparison 17 F. Other antibiotics: tigecycline vs ertapenem, Outcome 2 Adverse events."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 17 F. Other antibiotics: tigecycline vs ertapenem, Outcome 2 Adverse events.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Any adverse event</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.47 [1.34, 1.60]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Fever</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.24 [0.64, 2.41]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.3 Headache</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.18 [0.65, 2.14]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.4 Pain</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.47 [0.71, 3.01]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.5 Hypertension</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.95 [0.60, 1.50]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.6 Diarrhoea</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.51 [0.32, 0.82]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.7 Nausea</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.76 [3.46, 6.56]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.8 Vomiting</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.24 [3.39, 8.12]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.9 Anemia</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.70 [0.31, 1.56]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.10 Insomnia</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.66 [1.23, 10.96]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.11 Increase in serum glutamic oxaloacetic transaminase</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.77 [0.40, 1.50]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.12 Increase in serum glutamic pyruvic transaminase</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.81 [0.42, 1.60]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.13 Hipoglicemia</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.38 [0.83, 2.30]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.14 Osteomyelitis</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.95 [0.96, 3.99]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.15 Discontinuation of treatment for adverse events</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.52 [0.95, 2.42]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Septicaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD009061-fig-01703"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-017-03.png?filename=nCD009061-CMP-017-03.ppt&amp;title=17.3&amp;caption=Comparison%2017%20F.%20Other%20antibiotics%3A%20tigecycline%20vs%20ertapenem%2C%20Outcome%203%20Septicaemia.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 17.3</div> </div> <hr class="top"><img data-id="CD009061-fig-01703" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-017-03.png" alt="Comparison 17 F. Other antibiotics: tigecycline vs ertapenem, Outcome 3 Septicaemia."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 17 F. Other antibiotics: tigecycline vs ertapenem, Outcome 3 Septicaemia.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Patients without osteomyelitis (main study)</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.77 [0.43, 1.39]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 Patients with osteomyelitis (sub study)</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>118</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.06 [0.10, 11.40]</p> </td> </tr> </tbody> </table> </div> </section> </section> <div class="figures-list"> <div class="figure" id="CD009061-fig-0001"> <img data-id="CD009061-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-AFig-FIG01.png" alt="Study flow diagram"> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/full#CD009061-fig-0001" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-AFig-FIG01.png?filename=nCD009061-AFig-FIG01.ppt&amp;title=1&amp;caption=Study%20flow%20diagram&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-AFig-FIG01.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-0002"><img data-id="CD009061-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-AFig-FIG02.png" alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/full#CD009061-fig-0002" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-AFig-FIG02.png?filename=nCD009061-AFig-FIG02.ppt&amp;title=2&amp;caption=Risk%20of%20bias%20graph%3A%20review%20authors%27%20judgements%20about%20each%20risk%20of%20bias%20item%20presented%20as%20percentages%20across%20all%20included%20studies.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-AFig-FIG02.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-0003"><img data-id="CD009061-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-AFig-FIG03.png" alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/full#CD009061-fig-0003" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-AFig-FIG03.png?filename=nCD009061-AFig-FIG03.ppt&amp;title=3&amp;caption=Risk%20of%20bias%20summary%3A%20review%20authors%27%20judgements%20about%20each%20risk%20of%20bias%20item%20for%20each%20included%20study.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-AFig-FIG03.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00101"><img data-id="CD009061-fig-00101" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-001-01.png" alt="Comparison 1 A. Anti‐pseudomonas penicillins: piperacillin‐tazobactam vs ticarcillin‐clavulanate, Outcome 1 Clinical resolution of the infection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 A. Anti‐pseudomonas penicillins: piperacillin‐tazobactam vs ticarcillin‐clavulanate, Outcome 1 Clinical resolution of the infection. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00101" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-001-01.png?filename=nCD009061-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20A.%20Anti%E2%80%90pseudomonas%20penicillins%3A%20piperacillin%E2%80%90tazobactam%20vs%20ticarcillin%E2%80%90clavulanate%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-001-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00201"><img data-id="CD009061-fig-00201" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-002-01.png" alt="Comparison 2 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs ampicillin‐sulbactam, Outcome 1 Clinical resolution of the infection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs ampicillin‐sulbactam, Outcome 1 Clinical resolution of the infection. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00201" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-002-01.png?filename=nCD009061-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20A.%20Anti%E2%80%90pseudomonal%20penicillins%3A%20piperacillin%E2%80%90tazobactam%20vs%20ampicillin%E2%80%90sulbactam%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-002-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00202"><img data-id="CD009061-fig-00202" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-002-02.png" alt="Comparison 2 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs ampicillin‐sulbactam, Outcome 2 Adverse effects."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs ampicillin‐sulbactam, Outcome 2 Adverse effects. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00202" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-002-02.png?filename=nCD009061-CMP-002-02.ppt&amp;title=2.2&amp;caption=Comparison%202%20A.%20Anti%E2%80%90pseudomonal%20penicillins%3A%20piperacillin%E2%80%90tazobactam%20vs%20ampicillin%E2%80%90sulbactam%2C%20Outcome%202%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-002-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00203"><img data-id="CD009061-fig-00203" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-002-03.png" alt="Comparison 2 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs ampicillin‐sulbactam, Outcome 3 Amputations."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs ampicillin‐sulbactam, Outcome 3 Amputations. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00203" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-002-03.png?filename=nCD009061-CMP-002-03.ppt&amp;title=2.3&amp;caption=Comparison%202%20A.%20Anti%E2%80%90pseudomonal%20penicillins%3A%20piperacillin%E2%80%90tazobactam%20vs%20ampicillin%E2%80%90sulbactam%2C%20Outcome%203%20Amputations.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-002-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00301"><img data-id="CD009061-fig-00301" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-003-01.png" alt="Comparison 3 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin, Outcome 1 Clinical resolution of the infection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin, Outcome 1 Clinical resolution of the infection. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00301" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-003-01.png?filename=nCD009061-CMP-003-01.ppt&amp;title=3.1&amp;caption=Comparison%203%20A.%20Anti%E2%80%90pseudomonal%20penicillins%3A%20piperacillin%E2%80%90tazobactam%20vs%20imipenem%E2%80%90cilastatin%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-003-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00302"><img data-id="CD009061-fig-00302" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-003-02.png" alt="Comparison 3 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin, Outcome 2 Adverse effects."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin, Outcome 2 Adverse effects. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00302" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-003-02.png?filename=nCD009061-CMP-003-02.ppt&amp;title=3.2&amp;caption=Comparison%203%20A.%20Anti%E2%80%90pseudomonal%20penicillins%3A%20piperacillin%E2%80%90tazobactam%20vs%20imipenem%E2%80%90cilastatin%2C%20Outcome%202%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-003-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00303"><img data-id="CD009061-fig-00303" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-003-03.png" alt="Comparison 3 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin, Outcome 3 Amputations."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin, Outcome 3 Amputations. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00303" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-003-03.png?filename=nCD009061-CMP-003-03.ppt&amp;title=3.3&amp;caption=Comparison%203%20A.%20Anti%E2%80%90pseudomonal%20penicillins%3A%20piperacillin%E2%80%90tazobactam%20vs%20imipenem%E2%80%90cilastatin%2C%20Outcome%203%20Amputations.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-003-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00304"><img data-id="CD009061-fig-00304" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-003-04.png" alt="Comparison 3 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin, Outcome 4 Recurrence."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin, Outcome 4 Recurrence. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00304" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-003-04.png?filename=nCD009061-CMP-003-04.ppt&amp;title=3.4&amp;caption=Comparison%203%20A.%20Anti%E2%80%90pseudomonal%20penicillins%3A%20piperacillin%E2%80%90tazobactam%20vs%20imipenem%E2%80%90cilastatin%2C%20Outcome%204%20Recurrence.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-003-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00401"><img data-id="CD009061-fig-00401" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-004-01.png" alt="Comparison 4 B. Broad‐spectrum penicillins: ampicillin‐sulbactam vs cefoxitin, Outcome 1 Clinical resolution of the infection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 B. Broad‐spectrum penicillins: ampicillin‐sulbactam vs cefoxitin, Outcome 1 Clinical resolution of the infection. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00401" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-004-01.png?filename=nCD009061-CMP-004-01.ppt&amp;title=4.1&amp;caption=Comparison%204%20B.%20Broad%E2%80%90spectrum%20penicillins%3A%20ampicillin%E2%80%90sulbactam%20vs%20cefoxitin%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-004-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00402"><img data-id="CD009061-fig-00402" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-004-02.png" alt="Comparison 4 B. Broad‐spectrum penicillins: ampicillin‐sulbactam vs cefoxitin, Outcome 2 Adverse effects."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 B. Broad‐spectrum penicillins: ampicillin‐sulbactam vs cefoxitin, Outcome 2 Adverse effects. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00402" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-004-02.png?filename=nCD009061-CMP-004-02.ppt&amp;title=4.2&amp;caption=Comparison%204%20B.%20Broad%E2%80%90spectrum%20penicillins%3A%20ampicillin%E2%80%90sulbactam%20vs%20cefoxitin%2C%20Outcome%202%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-004-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00403"><img data-id="CD009061-fig-00403" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-004-03.png" alt="Comparison 4 B. Broad‐spectrum penicillins: ampicillin‐sulbactam vs cefoxitin, Outcome 3 Amputations."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 B. Broad‐spectrum penicillins: ampicillin‐sulbactam vs cefoxitin, Outcome 3 Amputations. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00403" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-004-03.png?filename=nCD009061-CMP-004-03.ppt&amp;title=4.3&amp;caption=Comparison%204%20B.%20Broad%E2%80%90spectrum%20penicillins%3A%20ampicillin%E2%80%90sulbactam%20vs%20cefoxitin%2C%20Outcome%203%20Amputations.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-004-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00501"><img data-id="CD009061-fig-00501" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-005-01.png" alt="Comparison 5 C. Cephalosporins: ceftobiprole vs ceftazidime + vancomycin, Outcome 1 Clinical resolution of the infection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 C. Cephalosporins: ceftobiprole vs ceftazidime + vancomycin, Outcome 1 Clinical resolution of the infection. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00501" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-005-01.png?filename=nCD009061-CMP-005-01.ppt&amp;title=5.1&amp;caption=Comparison%205%20C.%20Cephalosporins%3A%20ceftobiprole%20vs%20ceftazidime%20%2B%20vancomycin%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-005-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00601"><img data-id="CD009061-fig-00601" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-006-01.png" alt="Comparison 6 C. Cephalosporins: ceftriaxone + metronidazole vs ticarcillin‐clavulanate, Outcome 1 Clinical resolution of the infection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 C. Cephalosporins: ceftriaxone + metronidazole vs ticarcillin‐clavulanate, Outcome 1 Clinical resolution of the infection. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00601" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-006-01.png?filename=nCD009061-CMP-006-01.ppt&amp;title=6.1&amp;caption=Comparison%206%20C.%20Cephalosporins%3A%20ceftriaxone%20%2B%20metronidazole%20vs%20ticarcillin%E2%80%90clavulanate%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-006-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00701"><img data-id="CD009061-fig-00701" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-007-01.png" alt="Comparison 7 D. Carbapenems: ertapenem vs piperacillin‐tazobactam, Outcome 1 Clinical resolution of the infection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 D. Carbapenems: ertapenem vs piperacillin‐tazobactam, Outcome 1 Clinical resolution of the infection. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00701" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-007-01.png?filename=nCD009061-CMP-007-01.ppt&amp;title=7.1&amp;caption=Comparison%207%20D.%20Carbapenems%3A%20ertapenem%20vs%20piperacillin%E2%80%90tazobactam%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-007-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00702"><img data-id="CD009061-fig-00702" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-007-02.png" alt="Comparison 7 D. Carbapenems: ertapenem vs piperacillin‐tazobactam, Outcome 2 Adverse effects."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 D. Carbapenems: ertapenem vs piperacillin‐tazobactam, Outcome 2 Adverse effects. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00702" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-007-02.png?filename=nCD009061-CMP-007-02.ppt&amp;title=7.2&amp;caption=Comparison%207%20D.%20Carbapenems%3A%20ertapenem%20vs%20piperacillin%E2%80%90tazobactam%2C%20Outcome%202%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-007-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00801"><img data-id="CD009061-fig-00801" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-008-01.png" alt="Comparison 8 D. Carbapenems: imipenem‐cilastatin vs piperacillin + clindamycin, Outcome 1 Clinical resolution of the infection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 D. Carbapenems: imipenem‐cilastatin vs piperacillin + clindamycin, Outcome 1 Clinical resolution of the infection. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00801" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-008-01.png?filename=nCD009061-CMP-008-01.ppt&amp;title=8.1&amp;caption=Comparison%208%20D.%20Carbapenems%3A%20imipenem%E2%80%90cilastatin%20vs%20piperacillin%20%2B%20clindamycin%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-008-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00802"><img data-id="CD009061-fig-00802" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-008-02.png" alt="Comparison 8 D. Carbapenems: imipenem‐cilastatin vs piperacillin + clindamycin, Outcome 2 Adverse effects."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 D. Carbapenems: imipenem‐cilastatin vs piperacillin + clindamycin, Outcome 2 Adverse effects. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00802" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-008-02.png?filename=nCD009061-CMP-008-02.ppt&amp;title=8.2&amp;caption=Comparison%208%20D.%20Carbapenems%3A%20imipenem%E2%80%90cilastatin%20vs%20piperacillin%20%2B%20clindamycin%2C%20Outcome%202%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-008-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00803"><img data-id="CD009061-fig-00803" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-008-03.png" alt="Comparison 8 D. Carbapenems: imipenem‐cilastatin vs piperacillin + clindamycin, Outcome 3 Recurrence."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 D. Carbapenems: imipenem‐cilastatin vs piperacillin + clindamycin, Outcome 3 Recurrence. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00803" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-008-03.png?filename=nCD009061-CMP-008-03.ppt&amp;title=8.3&amp;caption=Comparison%208%20D.%20Carbapenems%3A%20imipenem%E2%80%90cilastatin%20vs%20piperacillin%20%2B%20clindamycin%2C%20Outcome%203%20Recurrence.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-008-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00901"><img data-id="CD009061-fig-00901" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-009-01.png" alt="Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 1 Clinical resolution of the infection at the completion of therapy."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 1 Clinical resolution of the infection at the completion of therapy. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00901" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-009-01.png?filename=nCD009061-CMP-009-01.ppt&amp;title=9.1&amp;caption=Comparison%209%20D.%20Carbapenems%3A%20imipenem%E2%80%90cilastatin%20vs%20ampicillin%E2%80%90sulbactam%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection%20at%20the%20completion%20of%20therapy.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-009-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00902"><img data-id="CD009061-fig-00902" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-009-02.png" alt="Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 2 Clinical resolution of the infection at the end of follow‐up."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 2 Clinical resolution of the infection at the end of follow‐up. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00902" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-009-02.png?filename=nCD009061-CMP-009-02.ppt&amp;title=9.2&amp;caption=Comparison%209%20D.%20Carbapenems%3A%20imipenem%E2%80%90cilastatin%20vs%20ampicillin%E2%80%90sulbactam%2C%20Outcome%202%20Clinical%20resolution%20of%20the%20infection%20at%20the%20end%20of%20follow%E2%80%90up.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-009-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00903"><img data-id="CD009061-fig-00903" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-009-03.png" alt="Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 3 Adverse effects."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 3 Adverse effects. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00903" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-009-03.png?filename=nCD009061-CMP-009-03.ppt&amp;title=9.3&amp;caption=Comparison%209%20D.%20Carbapenems%3A%20imipenem%E2%80%90cilastatin%20vs%20ampicillin%E2%80%90sulbactam%2C%20Outcome%203%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-009-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00904"><img data-id="CD009061-fig-00904" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-009-04.png" alt="Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 4 Amputations."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 4 Amputations. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00904" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-009-04.png?filename=nCD009061-CMP-009-04.ppt&amp;title=9.4&amp;caption=Comparison%209%20D.%20Carbapenems%3A%20imipenem%E2%80%90cilastatin%20vs%20ampicillin%E2%80%90sulbactam%2C%20Outcome%204%20Amputations.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-009-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-00905"><img data-id="CD009061-fig-00905" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-009-05.png" alt="Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 5 Recurrence."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9 D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam, Outcome 5 Recurrence. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-00905" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-009-05.png?filename=nCD009061-CMP-009-05.ppt&amp;title=9.5&amp;caption=Comparison%209%20D.%20Carbapenems%3A%20imipenem%E2%80%90cilastatin%20vs%20ampicillin%E2%80%90sulbactam%2C%20Outcome%205%20Recurrence.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-009-05.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-01001"><img data-id="CD009061-fig-01001" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-010-01.png" alt="Comparison 10 E. Fluoroquinolones: fourth‐generation fluoroquinolones vs anti‐pseudomonal penicillins, Outcome 1 Clinical resolution of the infection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 E. Fluoroquinolones: fourth‐generation fluoroquinolones vs anti‐pseudomonal penicillins, Outcome 1 Clinical resolution of the infection. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-01001" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-010-01.png?filename=nCD009061-CMP-010-01.ppt&amp;title=10.1&amp;caption=Comparison%2010%20E.%20Fluoroquinolones%3A%20fourth%E2%80%90generation%20fluoroquinolones%20vs%20anti%E2%80%90pseudomonal%20penicillins%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-010-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-01101"><img data-id="CD009061-fig-01101" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-011-01.png" alt="Comparison 11 E. Fluoroquinolones: moxifloxacin vs amoxicillin‐clavulanate, Outcome 1 Clinical resolution of the infection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 E. Fluoroquinolones: moxifloxacin vs amoxicillin‐clavulanate, Outcome 1 Clinical resolution of the infection. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-01101" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-011-01.png?filename=nCD009061-CMP-011-01.ppt&amp;title=11.1&amp;caption=Comparison%2011%20E.%20Fluoroquinolones%3A%20moxifloxacin%20vs%20amoxicillin%E2%80%90clavulanate%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-011-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-01201"><img data-id="CD009061-fig-01201" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-012-01.png" alt="Comparison 12 E. Fluoroquinolones: third‐generation fluoroquinolone vs extended‐spectrum penicillin, Outcome 1 Clinical resolution of the infection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12 E. Fluoroquinolones: third‐generation fluoroquinolone vs extended‐spectrum penicillin, Outcome 1 Clinical resolution of the infection. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-01201" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-012-01.png?filename=nCD009061-CMP-012-01.ppt&amp;title=12.1&amp;caption=Comparison%2012%20E.%20Fluoroquinolones%3A%20third%E2%80%90generation%20fluoroquinolone%20vs%20extended%E2%80%90spectrum%20penicillin%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-012-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-01301"><img data-id="CD009061-fig-01301" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-013-01.png" alt="Comparison 13 E. Fluoroquinolones: second‐generation fluoroquinolone vs extended‐spectrum penicillin, Outcome 1 Clinical resolution of the infection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13 E. Fluoroquinolones: second‐generation fluoroquinolone vs extended‐spectrum penicillin, Outcome 1 Clinical resolution of the infection. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-01301" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-013-01.png?filename=nCD009061-CMP-013-01.ppt&amp;title=13.1&amp;caption=Comparison%2013%20E.%20Fluoroquinolones%3A%20second%E2%80%90generation%20fluoroquinolone%20vs%20extended%E2%80%90spectrum%20penicillin%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-013-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-01302"><img data-id="CD009061-fig-01302" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-013-02.png" alt="Comparison 13 E. Fluoroquinolones: second‐generation fluoroquinolone vs extended‐spectrum penicillin, Outcome 2 Adverse effects."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.2</div> <div class="figure-caption"> <p>Comparison 13 E. Fluoroquinolones: second‐generation fluoroquinolone vs extended‐spectrum penicillin, Outcome 2 Adverse effects. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-01302" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-013-02.png?filename=nCD009061-CMP-013-02.ppt&amp;title=13.2&amp;caption=Comparison%2013%20E.%20Fluoroquinolones%3A%20second%E2%80%90generation%20fluoroquinolone%20vs%20extended%E2%80%90spectrum%20penicillin%2C%20Outcome%202%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-013-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-01303"><img data-id="CD009061-fig-01303" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-013-03.png" alt="Comparison 13 E. Fluoroquinolones: second‐generation fluoroquinolone vs extended‐spectrum penicillin, Outcome 3 Amputations."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.3</div> <div class="figure-caption"> <p>Comparison 13 E. Fluoroquinolones: second‐generation fluoroquinolone vs extended‐spectrum penicillin, Outcome 3 Amputations. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-01303" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-013-03.png?filename=nCD009061-CMP-013-03.ppt&amp;title=13.3&amp;caption=Comparison%2013%20E.%20Fluoroquinolones%3A%20second%E2%80%90generation%20fluoroquinolone%20vs%20extended%E2%80%90spectrum%20penicillin%2C%20Outcome%203%20Amputations.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-013-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-01401"><img data-id="CD009061-fig-01401" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-014-01.png" alt="Comparison 14 F. Other antibiotics: daptomycin vs control, Outcome 1 Clinical resolution of the infection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14 F. Other antibiotics: daptomycin vs control, Outcome 1 Clinical resolution of the infection. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-01401" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-014-01.png?filename=nCD009061-CMP-014-01.ppt&amp;title=14.1&amp;caption=Comparison%2014%20F.%20Other%20antibiotics%3A%20daptomycin%20vs%20control%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-014-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-01402"><img data-id="CD009061-fig-01402" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-014-02.png" alt="Comparison 14 F. Other antibiotics: daptomycin vs control, Outcome 2 Adverse effects."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.2</div> <div class="figure-caption"> <p>Comparison 14 F. Other antibiotics: daptomycin vs control, Outcome 2 Adverse effects.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-01402" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-014-02.png?filename=nCD009061-CMP-014-02.ppt&amp;title=14.2&amp;caption=Comparison%2014%20F.%20Other%20antibiotics%3A%20daptomycin%20vs%20control%2C%20Outcome%202%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-014-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-01501"><img data-id="CD009061-fig-01501" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-015-01.png" alt="Comparison 15 F. Other antibiotics: linezolid vs aminopenicillin + beta lactamase inhibitor, Outcome 1 Clinical resolution of the infection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.1</div> <div class="figure-caption"> <p>Comparison 15 F. Other antibiotics: linezolid vs aminopenicillin + beta lactamase inhibitor, Outcome 1 Clinical resolution of the infection. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-01501" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-015-01.png?filename=nCD009061-CMP-015-01.ppt&amp;title=15.1&amp;caption=Comparison%2015%20F.%20Other%20antibiotics%3A%20linezolid%20vs%20aminopenicillin%20%2B%20beta%20lactamase%20inhibitor%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-015-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-01502"><img data-id="CD009061-fig-01502" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-015-02.png" alt="Comparison 15 F. Other antibiotics: linezolid vs aminopenicillin + beta lactamase inhibitor, Outcome 2 Adverse effects."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.2</div> <div class="figure-caption"> <p>Comparison 15 F. Other antibiotics: linezolid vs aminopenicillin + beta lactamase inhibitor, Outcome 2 Adverse effects. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-01502" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-015-02.png?filename=nCD009061-CMP-015-02.ppt&amp;title=15.2&amp;caption=Comparison%2015%20F.%20Other%20antibiotics%3A%20linezolid%20vs%20aminopenicillin%20%2B%20beta%20lactamase%20inhibitor%2C%20Outcome%202%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-015-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-01601"><img data-id="CD009061-fig-01601" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-016-01.png" alt="Comparison 16 F. Other antibiotics: clindamycin vs cephalexin, Outcome 1 Clinical resolution of the infection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.1</div> <div class="figure-caption"> <p>Comparison 16 F. Other antibiotics: clindamycin vs cephalexin, Outcome 1 Clinical resolution of the infection. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-01601" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-016-01.png?filename=nCD009061-CMP-016-01.ppt&amp;title=16.1&amp;caption=Comparison%2016%20F.%20Other%20antibiotics%3A%20clindamycin%20vs%20cephalexin%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-016-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-01602"><img data-id="CD009061-fig-01602" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-016-02.png" alt="Comparison 16 F. Other antibiotics: clindamycin vs cephalexin, Outcome 2 Adverse effects."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.2</div> <div class="figure-caption"> <p>Comparison 16 F. Other antibiotics: clindamycin vs cephalexin, Outcome 2 Adverse effects.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-01602" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-016-02.png?filename=nCD009061-CMP-016-02.ppt&amp;title=16.2&amp;caption=Comparison%2016%20F.%20Other%20antibiotics%3A%20clindamycin%20vs%20cephalexin%2C%20Outcome%202%20Adverse%20effects.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-016-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-01603"><img data-id="CD009061-fig-01603" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-016-03.png" alt="Comparison 16 F. Other antibiotics: clindamycin vs cephalexin, Outcome 3 Ulcer healing."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.3</div> <div class="figure-caption"> <p>Comparison 16 F. Other antibiotics: clindamycin vs cephalexin, Outcome 3 Ulcer healing.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-01603" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-016-03.png?filename=nCD009061-CMP-016-03.ppt&amp;title=16.3&amp;caption=Comparison%2016%20F.%20Other%20antibiotics%3A%20clindamycin%20vs%20cephalexin%2C%20Outcome%203%20Ulcer%20healing.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-016-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-01701"><img data-id="CD009061-fig-01701" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-017-01.png" alt="Comparison 17 F. Other antibiotics: tigecycline vs ertapenem, Outcome 1 Clinical resolution of the infection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.1</div> <div class="figure-caption"> <p>Comparison 17 F. Other antibiotics: tigecycline vs ertapenem, Outcome 1 Clinical resolution of the infection. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-01701" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-017-01.png?filename=nCD009061-CMP-017-01.ppt&amp;title=17.1&amp;caption=Comparison%2017%20F.%20Other%20antibiotics%3A%20tigecycline%20vs%20ertapenem%2C%20Outcome%201%20Clinical%20resolution%20of%20the%20infection.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-017-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-01702"><img data-id="CD009061-fig-01702" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-017-02.png" alt="Comparison 17 F. Other antibiotics: tigecycline vs ertapenem, Outcome 2 Adverse events."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.2</div> <div class="figure-caption"> <p>Comparison 17 F. Other antibiotics: tigecycline vs ertapenem, Outcome 2 Adverse events.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-01702" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-017-02.png?filename=nCD009061-CMP-017-02.ppt&amp;title=17.2&amp;caption=Comparison%2017%20F.%20Other%20antibiotics%3A%20tigecycline%20vs%20ertapenem%2C%20Outcome%202%20Adverse%20events.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-017-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD009061-fig-01703"><img data-id="CD009061-fig-01703" src="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-017-03.png" alt="Comparison 17 F. Other antibiotics: tigecycline vs ertapenem, Outcome 3 Septicaemia."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.3</div> <div class="figure-caption"> <p>Comparison 17 F. Other antibiotics: tigecycline vs ertapenem, Outcome 3 Septicaemia.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-fig-01703" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/ppt/CDSR/CD009061/image_n/nCD009061-CMP-017-03.png?filename=nCD009061-CMP-017-03.ppt&amp;title=17.3&amp;caption=Comparison%2017%20F.%20Other%20antibiotics%3A%20tigecycline%20vs%20ertapenem%2C%20Outcome%203%20Septicaemia.&amp;citation=Selva Olid A, Sol%C3%A0 I, Barajas%E2%80%90Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews 2015, 9. Art. No.: CD009061. DOI: http://dx.doi.org/10.1002/14651858.CD009061.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD009061.pub2/media/CDSR/CD009061/image_n/nCD009061-CMP-017-03.png">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD009061-tbl-0018"> <div class="table-heading"><span class="table-label">Table 1.</span>&nbsp;<span class="table-title">Comparisons</span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Study ID</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Comparison</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>A</b> </p> </td> <td align="center" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Anti‐pseudomonal penicillins</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Anti‐pseudomonal penicillins</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Anti‐pseudomonal penicillins</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0020">Tan 1993</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Piperacillin‐tazobactam 3 g/375 mg iv every 6 h (min 5 days)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ticarcillin‐clavulanate 3 g/100 mg iv every 6 h (min 5 days)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Anti‐pseudomonal penicillins</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Broad‐spectrum penicillins</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0009">Harkless 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Piperacillin‐tazobactam 4 g/0.5 g iv every 8 h (4‐14 days, max 21 days)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ampicillin‐sulbactam 2 g/1 g iv every 6 h (4‐14 days, max 21 days)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Anti‐pseudomonal penicillins</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Carbapenems</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0016">Saltoglu 2010</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Piperacillin‐tazobactam 4.5 g iv every 8 h (14 days)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Imipenem‐cilastatin 500 mg iv every 6 h (14 days)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>B</b> </p> </td> <td align="center" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Broad‐spectrum penicillins</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Broad‐spectrum penicillins</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Cephalosporins</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0004">Erstad 1997</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ampicillin‐sulbactam 3 g iv every 6 h (min 5 days)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cefoxitin 2 g iv every 6 h (min 5 days)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>C</b> </p> </td> <td align="center" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Cephalosporins</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Fifth‐generation cephalosporins</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Third‐generation cephalosporins + glycopeptide</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0014">Noel 2008a</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ceftobiprole 500 mg iv every 8 h (7‐14 days)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Vancomycin 1000 mg iv every 12 h plus ceftazidime 1000 mg iv every 8 h (7‐14 days)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>2.</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Third‐generation cephalosporin + nitroimidazole</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Anti‐pseudomonal penicillin</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0003">Clay 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ceftriaxon ‐metronidazole 1 g/1 g iv every 24 h (duration not described)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ticarcillin‐clavulanate 3.1 g iv every 6 h (duration not described)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>D</b> </p> </td> <td align="center" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Carbapenems</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Carbapenems</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Anti‐pseudomonal penicillins</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Ertapenem</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Piperacillin‐tazobactam</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0018">SIDESTEP Study</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ertapenem 1 g iv every 24 h (min 5 days). Switch to amoxicillin‐clavulanate 875 mg/125 mg po every 12 h </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Piperacillin‐tazobactam 3 g/375 mg iv every 6 h (min of 5 days). Switch to amoxicillin‐clavulanate 875 mg/125 mg po every 12 h </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0006">Graham 2002a</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ertapenem 1 g iv every 24 h (7‐14 days)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Piperacillin‐tazobactam 3 g/375 mg iv every 6 h (7‐14 days)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Imipenem + cilastatin</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Piperacillin + clindamycin</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0002">Bouter 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Imipenem‐cilastatin 500 mg iv every 6 h (10 days)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Piperacillin 3 g iv every 6 h plus clindamycin 600 mg iv every 8 h (10 days)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Carbapenems</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Broad‐spectrum penicillins</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0008">Grayson 1994</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Imipenem‐cilastatin 500 mg iv every 6 h (5 days)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ampicillin‐sulbactam 2 g/1 g iv every 6 h (5 days)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>E</b> </p> </td> <td align="center" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b> Fluoroquinolones</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Fourth‐generation fluoroquinolones</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Anti‐pseudomonal penicillins</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0005">Giordano 2005</a>‐<a href="./references#CD009061-bbs2-0082">Lipsky 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Moxifloxacin 400 mg every 24 h (iv for 3 days, then po for 7‐14 days)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Piperacillin‐tazobactam 3 g/375 mg iv every 6 h (3 days). Then amoxicillin‐clavulanate 800 mg po every 12 h (7‐14 days) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0015">RELIEF Study</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Moxifloxacin 400 mg every 24 h (iv for 3 days, then 400 mg every 12 h po for 7‐21 days) </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Piperacillin‐tazobactam 4 g/0.5 g iv every 8 h. Then amoxicillin‐clavulanate 875 mg/125 mg po every 12 h (7‐21 days) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0017">Siami 2001</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cinafloxacin 200 mg iv every12 h (max 14 days), then 200 mg po every 12 h</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Piperacillin‐tazobactam 3 g/375 mg po every 6 h. Then amoxicillin‐clavulanate 500 mg po every 8 h </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Fourth‐generation fluoroquinolones</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Broad‐spectrum penicillins</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0019">STIC Study</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Moxifloxacin 400 mg iv every 24 h for 3 days, then po for 7‐21 days</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Amoxicillin 1000 g‐clavulanate 200 mg iv every 8 h for 3 days, then 500 mg/125 mg po every 8 h for 7‐21 days </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Third‐generation fluoroquinolones</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Antipseudomonal penicillins</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0007">Graham 2002b</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Levofloxacin 750 mg iv or po every 24 h (7‐14 days)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ticarcillin‐clavulanate 3.1g every iv 4 h‐6 h, then changed to amoxicillin‐clavulanate 875 mg po every 12 h (7‐14 days) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Second‐generation fluoroquinolones</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Broad‐spectrum penicillins</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0012">Lipsky 1997</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ofloxacin 400 mg iv every 12 h (then switch to po; 14‐28 days)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ampicillin‐sulbactam 1‐2 g/0.5‐1 g iv every 6 h. Switch to amoxicillin‐clavulanate 500 mg/125 mg po every 8 h (14‐28 days) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>F</b> </p> </td> <td align="center" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Other antibiotics</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0001">Arbeit 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Daptomycin 4 mg/kg iv every 24 h (7‐14 days)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Vancomycin 1 g iv every 12 h (7‐14 days)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0013">Lipsky 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Linezolid 600 mg iv or po every 12 h (≥ 7 days ≤ 28)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ampicillin/sulbactam 1.5 g‐3 g iv every 6 h OR amoxicillin/clavulanate 500 mg/875mg po every 12 h (≥ 7 days ≤ 28) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0011">Lipsky 1990</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Clindamycin 300 mg iv every 6 h (14 days)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cephalexin 500 mg every 6 h po (14 days)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD009061-bbs2-0010">Lauf 2014</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Tigecycline 150 mg iv every 24 h (28 days)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ertapenem 1 g iv every 24 h (28 days)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p><b>Abbreviations</b> </p> <p>h: hour(s)<br> iv: intravenous<br> max: maximum<br> min: minimum<br> po: per oral (by mouth) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span>&nbsp;<span class="table-title">Comparisons</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/full#CD009061-tbl-0018" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD009061-tbl-0019"> <div class="table-heading"><span class="table-label">Table 2.</span>&nbsp;<span class="table-title">Detailed comparisons</span></div> <tbody> <tr> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ticarcillin‐clavulanate iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ampicillin‐sulbactam iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ceftriaxone‐metronidazol iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ceftazidime‐vancomicyn iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cefoxitin iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ertapenem iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ertapenem iv followed by amoxicillin‐clavulanate po</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Imipenem‐cilastatin iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Moxifloxacin iv</p> <p>followed by po</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cinafloxacin iv</p> <p>followed by po</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Levofloxacin iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ofloxacin iv followed by po</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Linezolid iv or po</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Clindamycin iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Tigecycline</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Vancomycin</p> </td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Anti‐pseudomonal penicillins</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Piperacillin‐tazobactam iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1 <a href="./references#CD009061-bbs2-0020">Tan 1993</a> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1 <a href="./references#CD009061-bbs2-0009">Harkless 2005</a> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1 <a href="./references#CD009061-bbs2-0006">Graham 2002a</a> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1<a href="./references#CD009061-bbs2-0016">Saltoglu 2010</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Piperacillin‐tazobactam iv followed by amoxicillin po</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1 <a href="./references#CD009061-bbs2-0018">SIDESTEP Study</a> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2 <a href="./references#CD009061-bbs2-0005">Giordano 2005</a>; <a href="./references#CD009061-bbs2-0015">RELIEF Study</a> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1 <a href="./references#CD009061-bbs2-0017">Siami 2001</a> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ticarcillin‐clavulanate iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1 <a href="./references#CD009061-bbs2-0003">Clay 2004</a> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ticarcillin‐clavulanate iv followed by amoxicillin‐clavulanate po</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1 <a href="./references#CD009061-bbs2-0007">Graham 2002b</a> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Piperacillin‐clindamycin iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1 <a href="./references#CD009061-bbs2-0002">Bouter 1996</a> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Broad‐spectrum penicillins</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Amoxicillin‐clavulanate iv followed by po</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1 <a href="./references#CD009061-bbs2-0019">STIC Study</a> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ampicillin‐sulbactam iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1 <a href="./references#CD009061-bbs2-0004">Erstad 1997</a> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1 <a href="./references#CD009061-bbs2-0008">Grayson 1994</a> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ampicillin‐sulbactan followed by amoxicillin‐clavulanate po</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1 <a href="./references#CD009061-bbs2-0012">Lipsky 1997</a> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1 <a href="./references#CD009061-bbs2-0013">Lipsky 2004</a> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Cephalosporins</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ceftobiprole iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1 <a href="./references#CD009061-bbs2-0014">Noel 2008a</a> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ceftriaxone‐metronidazol iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ceftazidime‐vancomicyn iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cefoxitin iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cephalexin iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1 <a href="./references#CD009061-bbs2-0011">Lipsky 1990</a> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Carbapenems</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ertapenem iv&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1 <a href="./references#CD009061-bbs2-0010">Lauf 2014</a> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ertapenem iv followed by amoxicillin‐clavulanate po</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Imipenem‐cilastatin iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Fluoroquinolones</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Moxifloxacin iv followed by po</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cinafloxacin iv followed by po</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Levofloxacin iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ofloxacin iv followed by po</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Other antibiotics</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Daptomycin iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1 <a href="./references#CD009061-bbs2-0001">Arbeit 2004</a> </p> </td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Linezolid iv or po</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Clindamycin iv</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Tigecycline</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="left" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Vancomycin</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&nbsp;</p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>&nbsp;</b> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="17"> <div class="table-footnote"> <p>This table shows all the comparisons included in the review and the number of evaluations for each comparison. To simplify, only different type of antibiotics are represented, irrespective of dose. The grey shaded areas represent comparisons between the same antibiotic. The numbers in the cells shown refer to number of RCT assessing that comparison. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span>&nbsp;<span class="table-title">Detailed comparisons</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/full#CD009061-tbl-0019" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD009061-tbl-0001" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">A. Anti‐pseudomonas penicillins: piperacillin‐tazobactam vs ticarcillin‐clavulanate</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>63</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.16 [0.59, 2.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">A. Anti‐pseudomonas penicillins: piperacillin‐tazobactam vs ticarcillin‐clavulanate</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-tbl-0001" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD009061-tbl-0002" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs ampicillin‐sulbactam</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>314</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.02 [0.86, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Any adverse event</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>314</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.14 [0.99, 1.32]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Treatment‐related adverse event</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>314</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.42 [0.85, 2.37]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.3 Serious adverse event</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>314</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.94 [0.66, 1.34]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Amputations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>314</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.97 [0.51, 1.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs ampicillin‐sulbactam</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-tbl-0002" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD009061-tbl-0003" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.66 [0.84, 3.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>320</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.50 [1.56, 7.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Any adverse event</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.19 [0.95, 10.72]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Hepatotoxicity</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.32 [0.66, 43.05]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.3 Nephrotoxicity</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.39 [0.81, 50.09]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.4 Hematological side effects</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.31 [0.27, 106.46]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.5 Nausea</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.35 [0.01, 8.38]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Amputations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.87 [0.59, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Recurrence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.31 [0.27, 106.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">A. Anti‐pseudomonal penicillins: piperacillin‐tazobactam vs imipenem‐cilastatin</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-tbl-0003" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD009061-tbl-0004" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">B. Broad‐spectrum penicillins: ampicillin‐sulbactam vs cefoxitin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>36</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.14 [0.02, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>36</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.17 [0.49, 2.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Amputations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>36</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.0 [0.48, 2.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">B. Broad‐spectrum penicillins: ampicillin‐sulbactam vs cefoxitin</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-tbl-0004" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD009061-tbl-0005" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 5.</span>&nbsp;<span class="table-title">C. Cephalosporins: ceftobiprole vs ceftazidime + vancomycin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>257</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.05 [0.90, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span>&nbsp;<span class="table-title">C. Cephalosporins: ceftobiprole vs ceftazidime + vancomycin</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-tbl-0005" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD009061-tbl-0006" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 6.</span>&nbsp;<span class="table-title">C. Cephalosporins: ceftriaxone + metronidazole vs ticarcillin‐clavulanate</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>70</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.94 [0.72, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span>&nbsp;<span class="table-title">C. Cephalosporins: ceftriaxone + metronidazole vs ticarcillin‐clavulanate</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-tbl-0006" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD009061-tbl-0007" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 7.</span>&nbsp;<span class="table-title">D. Carbapenems: ertapenem vs piperacillin‐tazobactam</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>684</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.07 [0.96, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Drug related adverse effects</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>586</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.76 [0.53, 1.09]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Diarrhoea</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>586</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.58 [0.36, 0.93]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.3 Nausea</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>586</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.83 [0.44, 1.58]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.4 Headache</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>586</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.62 [0.28, 1.34]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span>&nbsp;<span class="table-title">D. Carbapenems: ertapenem vs piperacillin‐tazobactam</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-tbl-0007" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD009061-tbl-0008" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 8.</span>&nbsp;<span class="table-title">D. Carbapenems: imipenem‐cilastatin vs piperacillin + clindamycin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>46</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.73 [0.24, 2.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>46</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.27 [0.09, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Recurrence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>46</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.61 [0.42, 139.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span>&nbsp;<span class="table-title">D. Carbapenems: imipenem‐cilastatin vs piperacillin + clindamycin</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-tbl-0008" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD009061-tbl-0009" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 9.</span>&nbsp;<span class="table-title">D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection at the completion of therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>96</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.95 [0.80, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Clinical resolution of the infection at the end of follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>96</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.82 [0.60, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Total adverse effects</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>96</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.06 [0.61, 1.85]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 Significant adverse effects</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>96</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.29 [0.52, 3.17]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Amputations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>96</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.85 [0.62, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Recurrence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>96</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.71 [0.42, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span>&nbsp;<span class="table-title">D. Carbapenems: imipenem‐cilastatin vs ampicillin‐sulbactam</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-tbl-0009" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD009061-tbl-0010" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 10.</span>&nbsp;<span class="table-title">E. Fluoroquinolones: fourth‐generation fluoroquinolones vs anti‐pseudomonal penicillins</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>387</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.03 [0.89, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span>&nbsp;<span class="table-title">E. Fluoroquinolones: fourth‐generation fluoroquinolones vs anti‐pseudomonal penicillins</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-tbl-0010" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD009061-tbl-0011" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 11.</span>&nbsp;<span class="table-title">E. Fluoroquinolones: moxifloxacin vs amoxicillin‐clavulanate</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>134</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.79 [0.57, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span>&nbsp;<span class="table-title">E. Fluoroquinolones: moxifloxacin vs amoxicillin‐clavulanate</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-tbl-0011" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD009061-tbl-0012" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 12.</span>&nbsp;<span class="table-title">E. Fluoroquinolones: third‐generation fluoroquinolone vs extended‐spectrum penicillin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>67</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.97 [0.60, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span>&nbsp;<span class="table-title">E. Fluoroquinolones: third‐generation fluoroquinolone vs extended‐spectrum penicillin</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-tbl-0012" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD009061-tbl-0013" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 13.</span>&nbsp;<span class="table-title">E. Fluoroquinolones: second‐generation fluoroquinolone vs extended‐spectrum penicillin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>108</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.13 [0.88, 1.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>108</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.82 [0.89, 3.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Amputations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>108</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.11 [0.01, 1.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span>&nbsp;<span class="table-title">E. Fluoroquinolones: second‐generation fluoroquinolone vs extended‐spectrum penicillin</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-tbl-0013" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD009061-tbl-0014" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 14.</span>&nbsp;<span class="table-title">F. Other antibiotics: daptomycin vs control</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Daptomycin vs control</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>133</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.94 [0.68, 1.30]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Advese effects related to treatment</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>133</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.61 [0.39, 0.94]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Severe adverse effects</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>133</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.20 [0.02, 1.59]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span>&nbsp;<span class="table-title">F. Other antibiotics: daptomycin vs control</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-tbl-0014" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD009061-tbl-0015" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 15.</span>&nbsp;<span class="table-title">F. Other antibiotics: linezolid vs aminopenicillin + beta lactamase inhibitor</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>361</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.07 [0.91, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>361</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.66 [1.49, 4.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 15.</span>&nbsp;<span class="table-title">F. Other antibiotics: linezolid vs aminopenicillin + beta lactamase inhibitor</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-tbl-0015" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD009061-tbl-0016" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 16.</span>&nbsp;<span class="table-title">F. Other antibiotics: clindamycin vs cephalexin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>56</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.07 [0.79, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>56</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.47 [0.04, 4.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Ulcer healing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>52</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 [0.59, 2.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 16.</span>&nbsp;<span class="table-title">F. Other antibiotics: clindamycin vs cephalexin</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-tbl-0016" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD009061-tbl-0017" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 17.</span>&nbsp;<span class="table-title">F. Other antibiotics: tigecycline vs ertapenem</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Clinical resolution of the infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Patients without OM (main study)</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.09 [1.01, 1.18]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Patients with OM (sub study)</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>118</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.08 [1.27, 3.39]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Any adverse event</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.47 [1.34, 1.60]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Fever</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.24 [0.64, 2.41]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.3 Headache</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.18 [0.65, 2.14]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.4 Pain</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.47 [0.71, 3.01]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.5 Hypertension</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.95 [0.60, 1.50]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.6 Diarrhoea</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.51 [0.32, 0.82]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.7 Nausea</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.76 [3.46, 6.56]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.8 Vomiting</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.24 [3.39, 8.12]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.9 Anemia</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.70 [0.31, 1.56]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.10 Insomnia</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.66 [1.23, 10.96]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.11 Increase in serum glutamic oxaloacetic transaminase</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.77 [0.40, 1.50]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.12 Increase in serum glutamic pyruvic transaminase</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.81 [0.42, 1.60]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.13 Hipoglicemia</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.38 [0.83, 2.30]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.14 Osteomyelitis</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.95 [0.96, 3.99]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.15 Discontinuation of treatment for adverse events</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.52 [0.95, 2.42]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Septicaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Patients without osteomyelitis (main study)</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>955</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.77 [0.43, 1.39]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 Patients with osteomyelitis (sub study)</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>118</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.06 [0.10, 11.40]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 17.</span>&nbsp;<span class="table-title">F. Other antibiotics: tigecycline vs ertapenem</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD009061.pub2/references#CD009061-tbl-0017" class="tableList">Navigate to table in Review</a></div> </div> </div> <section class="translation-notes-modal" style="display: none" data-modal-title="Translation notes" data-modal-class="translation-notes" data-ok-btn-selector=".ok-btn"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD009061-note-1204">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD009061-note-1208">Español</a> </li> <li class="section-language"> <a class="" href="fr#CD009061-note-1207">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD009061-note-1206">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD009061-note-1205">Bahasa Malaysia</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" id="citeProcText" data-load-error="Unable to load citation data"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a href="#" class="addthis_button_citeulike at300b btn btn-link">CiteULike</a></li> <li><a href="#" class="addthis_button_mendeley at300b btn btn-link">Mendeley</a></li> <li><a href="#" class="citation-btn-refworks at300b btn btn-link" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <h4>Copy or download citation</h4> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button type="button" class="btn btn-link">Plain text</button></li> <li class="citation-option" data-option="endnote"><button type="button" class="btn btn-link">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button type="button" class="btn btn-link">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button type="button" class="btn btn-link">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button type="button" class="btn btn-link">BibteX</button></li> </nav> <div class="citation-content"> <pre id="citationContent" tabindex="0" data-load-error="Unable to load citation data"></pre> </div> <div class="clearfix"> <form class="download-citation-form" method="GET" target="citation-download-iframe" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=citation-citeproc&p_p_cacheability=cacheLevelPage&p_p_col_id=column-1&p_p_col_count=1"> <input type="hidden" id="siteId" name="siteId" value="" /> <input type="hidden" id="downloadType" name="downloadType" value="" /> <input type="hidden" id="style" name="style" value="" /> <input type="hidden" id="articleId" name="articleId" value="" /> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay" /><input name="p_p_lifecycle" type="hidden" value="2" /><input name="p_p_state" type="hidden" value="normal" /><input name="p_p_mode" type="hidden" value="view" /><input name="p_p_resource_id" type="hidden" value="citation-download" /><input name="p_p_cacheability" type="hidden" value="cacheLevelPage" /><input name="p_p_col_id" type="hidden" value="column-1" /><input name="p_p_col_count" type="hidden" value="1" /> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withAbstract"> <input class="checkbox" type="checkbox" name="withAbstract" /> <span class="checkbox-label">Include abstract</span> </label> </div> </form> <iframe title="Citation download frame" name="citation-download-iframe" src="" style="display: none; visibility: hidden" aria-hidden="true"></iframe> </div> </div> </div> </div> <div class="print-modal" style="display: none;" data-modal-title="Print this review"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input title="Select/deselect all" type="checkbox" class="print-options-select-all" checked="checked" /> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i class="fa fa-print" aria-hidden="true"></i> Print</button> </div> </div> <div class="download-stats-data-modal" style="display: none;" data-modal-title="Download statistical data"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <p> Downloaded data can only be viewed using <a class="external" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/tools/review-production-tools/revman-5" target="_blank">Review Manager software.</a> </p> <p> Please note that: <ul> <li>data are only available for Cochrane Reviews that contain one or more forest plots; and</li> <li>data in the downloaded RevMan file are editable and therefore the review data can be amended without warning.</li> </ul> </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input type="hidden" name="content-disposition" value="attachment" /> <input type="hidden" name="mime-type" value="application/octet-stream" /> <p class="print-options-controls"> <input type="checkbox" class="download-stats-data-toc-check-box" aria-label="I agree to these terms and conditions" /> <span class="checkbox-label" aria-hidden="true">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i class="fa fa-download" aria-hidden="true"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" style="display:none;" data-modal-title="Share this review"> <div class="add-this"> <div class="addthis_toolbox addthis_default_style addthis_32x32_style"> <nav class="stacked-nav-list"> <li> <a href="#" class="addthis_button_twitter at300b" title="Tweet">Twitter</a> </li> <li> <a href="#" class="addthis_button_mendeley at300b" target="_blank" title="Mendeley">Mendeley</a> </li> <li> <a href="#" class="addthis_button_facebook at300b" title="Facebook">Facebook</a> </li> <li> <a href="#" class="addthis_button_linkedin at300b" target="_blank" title="LinkedIn">LinkedIn</a> </li> <li> <a href="#" class="addthis_button_email at300b" target="_blank" title="Email">Email</a> </li> <li> <a href="#" class="addthis_button_whatsapp at300b" target="_blank" title="WhatsApp">WhatsApp</a> </li> <li class="clearfix"> <a href="#" class="addthis_button_more btn primary pull-right" target="_blank" title="View more"> <i class="fa fa-plus" aria-hidden="true"></i> View more</a> </li> </ul> </div> </div> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button type="button" class="btn btn-link" id="figureOptionBtn">Figures</button></li> <li class="table-options-btn-container"><button type="button" class="btn btn-link" id="tableOptionBtn">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div id="figureThumbnails" class="figure-thumbnails is-visible"></div> <div id="tableThumbnails" class="table-thumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a href="#" class="figure-viewer-menu-toggle"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-table-show-text="Show table list" data-table-hide-text="Hide table list" data-figure-show-text="Show thumbnails" data-figure-hide-text="Hide thumbnails">Hide thumbnails</span> </a> <a href="#" class="figure-viewer-zoomin"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a href="#" class="figure-viewer-zoomout"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a href="#" class="figure-viewer-nav previous"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a href="#" class="figure-viewer-nav next"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_  portlet-static portlet-static-end kaleo-designer-portlet " id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a title="Cochrane logo" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/">
<img class="footer-logo logo-part-1" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-1.png" alt="Cochrane logo" /> <img class="footer-logo logo-part-2" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-2.png" alt="" /> </a> </div> <nav class="footer-links"> <ul class="root"> <li class="footer-item"> <a class="footer-item-link" href="/about-cochrane1">About Cochrane</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/evidence" target="_blank">Cochrane.org</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank">Who we are</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NJYXT5SPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Get involved</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX665WNWTYE63PMNYXG4DTMFYGKLUQPJUB/" target="_blank">Consumer Network</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-funders-and-partners" target="_blank">Partners</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYXZ5DQPF4XT7LNF3SX8Z5IPJRX63JPN73GH/" target="_blank">Colloquium</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news" target="_blank">In the news</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/publications">Publications</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="/library">Cochrane Library</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/" target="_blank">Library Homepage</a> </li> <li class="footer-item"> <a class="footer-item-link" href="cdsr/about-cdsr" target="_blank">Cochrane Reviews (CDSR)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/central" target="_blank">Trials (CENTRAL)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cca/about" target="_blank">Cochrane Clinical Answers</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/cochrane-library-app" target="_blank">Cochrane Library App</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cdsr/journal-club" target="_blank">Journal Club</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/podcasts" target="_blank">Podcasts</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/community">Community</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Community</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MF3GG4DJMVYGG55DNB3GC5UFF3YYE3D/" target="_blank">Archie log-in</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/PS3GC4LPNFYGPLUDN7SXR6UBN3TT655TMH/" target="_blank">Training and support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/NWTYI4DQMS3T6Z5QMNVHEZLPMVYG86UH/" target="_blank">Methods</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/help" target="_blank">Software</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news/jobs" target="_blank">Jobs and opportunities</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/contact-us">Contact Us</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/contact" target="_blank">General enquiries</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/help/contact-us" target="_blank">Cochrane Library support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/chief-executive-officers-office/team" target="_blank">Chief Executive Officer</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/editorial-methods/team" target="_blank">Editor in Chief</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-global-community" target="_blank">Cochrane groups</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/media" target="_blank">Media</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/accessibility" target="_blank">Accessibility</a> </li> </ul> </li> </ul> </nav> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/advertisers">Advertisers & Agents</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Help & Support</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/terms-and-conditions">Terms & Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright &copy; 2000 - 2020 by <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUYNFXGK8JPMNYXN/" class="">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br /> Review our <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUYNFXGK8JPMNYXN/en-gb/privacy"><strong>Privacy Policy</strong></a> </p> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MW4T675JNSTYTLUDN7XB/"><img class="logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_wiley-footer-logo.png" alt="Wiley logo" /></a> </div> </div> <span class="wiley-semi-circle"></span> </div> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" style="display: none" data-modal-title="Feature in English only" data-modal-class="english-only-modal"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1581422282000" type="text/javascript"></script> <!--<![endif]--> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/theme.js?t=1581422282000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/checkout.js"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MN3G865UNWRYE43NMNTG6LUDPJYYG65TMWUC655TMH/widget/v2.0/widget.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MRZXE8DIHB4XC63SNWYHPN3PMNXG87LEM33G85UVF3YGK7A/assets/embed.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718173000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718249000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718249000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718173000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009061\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009061\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009061\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009061\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009061\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009061\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009061\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009061\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009061\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009061\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009061\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009061\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009061\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009061\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009061\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009061\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009061\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009061\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581422282000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a href="#" class="rh-nav-close-btn"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a href="#" class="rh-nav-open-btn"> <span>Review tools & navigation</span> </a> </div> <iframe title="Print frame" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" aria-hidden="true"></iframe> <div class="mobile-navigation"> <div class="close-container"> <a href="#" class="main-nav-back-btn" aria-label="Navigate back"><i class="fa fa-chevron-left"></i></a> <a href="#" class="main-nav-close-btn" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="ymag__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=EfT7x5RD&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009061.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009061.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<a href="/en/browse-by-topic" class="btn secondary">Browse </a>
<a href="/en/advanced-search" class="btn secondary advanced-search-button">Advanced search</a>
</div>
<div class="menu-items parent">
<ul>
<li class="nav-root-item parent">
<a href="#" title="Select language" class="language-selection-title-link">
<span class="mobile-nav-language-title">Select your preferred language</span><span class="icon fa fa-caret-down"></span>
<ul class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="fdkn__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div id="active-content-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div id="active-portal-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="/en/cdsr/doi/10.1002/14651858.CD009061.pub2/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD009061.pub2/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</ul>
</a>
</li>
<li class="parent">
<a class="mobile-link signin" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009061.pub2%2Freferences" data-redirect="false" rel="nofollow">
Sign In
</a>
</li>
</ul>
<div class="menu-items-footer">
<div class="utility-links">
<a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/" class="cochrane-link" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
<div class="basic-login-form-content" style="display: none;" data-modal-title="Sign in">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="dbam__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1583244617359" /> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x2f;references" /> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value="" /> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true" /> <input checked class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onClick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true" /> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user-registration" target="_blank" class="btn secondary">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=0&p_p_state=normal&p_p_mode=view&_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" style="display: none;" data-modal-title="Institutional login">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="obft__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text">
</div>
<button class="btn primary" type="submit" name="button">Go</button>
</div>
<div id="institutionLookupErrorDiv" class="message error" style="display:none">
'<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
</div>
</div>
<input type="hidden" id="entityId" name="entityId" value="">
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="joiu__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1583244617363" /> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD009061&#x2e;pub2&#x2f;references" /> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value="" /> </div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true" /> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" style="display: none;" data-modal-title="Unlock the potential of Cochrane evidence">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="wpdq__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text"> </div> <button class="btn primary" type="submit" name="button">Go</button> </div> <div id="institutionLookupErrorDiv" class="message error" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input type="hidden" id="entityId" name="entityId" value=""> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'> <input type="hidden" name="openlabel" id="openlabel" value='Open access'> </div> </section> </div> </div>  <script>window.urlTitle="/cdsr/doi/10.1002/14651858.CD009061.pub2";addthis_config={pubid:"ra-593597d01cdf9a55",ui_508_compliant:true};addthis_share={url:window.location.href,title:document.title};</script> <script src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-593597d01cdf9a55"></script> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> </body> </html> 